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CHAPTER I 
INTRODUCTION 
TREATMENT OF ACUTE NONLYMPHOBLASTIC LEUKAEMIA 
Induct ion therapy 
Untreated a d u l t p a t i e n t s with a c u t e nonlymphoblast ic leukemia (ANLL) have 
a median s u r v i v a l of 1.7 months a f te r d i a g n o s i s (1). I n t e n s i v e combination 
chemotherapeut ic regimens i n c l u d i n g a n t h r a c y c l i n e a n t i b i o t i c s , Cytarabine 
and/or 6-Thioguanine have been reported to Induce a complete remiss ion in 
60-Θ5Ϊ of newly diagnosed a d u l t ANLL (2,3,4,5). A r e c e n t r e p o r t even claimed 
a 92% complete remiss ion r a t e in ch i ldren and young a d u l t s (age range : 2-30 
y e a r s ) (6). P a t i e n t s who achieve a complete remiss ion have a median surv iva l 
of a, 100 weeks (7) . F a i l u r e of achiev ing a complete remiss ion i s a c ­
companied with a s u r v i v a l of l e s s than 7 weeks (7). 
Maintenance therapy 
The median dura t ion of complete remiss ion following i n t e n s i v e chemo-
i n d u c t i o n therapy appeared to be 2-9 months without any maintenance 
therapy (8,9). Maintenance of remiss ion by chemotherapy, immunotherapy or a 
combination of both fa i l ed to produce any s u b s t a n t i a l improvement of 
remiss ion durat ion or s u r v i v a l (5,10,11). The median durat ion of remiss ion in 
most r e c e n t i n v e s t i g a t i o n s i s 12-15 months (10,11,12), with the long-term 
s u r v i v o r s h i p among such p a t i e n t s being 10-25 % (5,13). Recent i n t r o d u c t i o n 
of more i n t e n s i v e maintenance therapy, impl ica t ing r e p e t i t i v e p h a s e s of 
s e v e r e bone marrow hypoplas ia seems to have improved remiss ion durat ion at 
l e a s t in young p a t i e n t s (6,9,14). 
Al logeneic bone marrow t r a n s p l a n t a t i o n 
The f a i l u r e of " s t a n d a r d " chemotherapy to induce long term d i s e a s e free 
s u r v i v a l in ANLL may be due to inadequate r e d u c t i o n of the leukaemia c e l l 
number. Bone marrow t r a n s p l a n t a t i o n (BMT) al lows an i n t e n s i f i c a t i o n of the 
c y t o r e d u c t i v e therapy, because the engrafted marrow r e s c u e s the p a t i e n t 
from otherwise l e t h a l bone marrow a p l a s i a . Early a t tempts of BMT without 
matching for the major h i s t o c o m p a t i b i l i t y complex (MHC) were d i s a p p o i n t i n g 
and fa i l ed with a few e x c e p t i o n s (15). MHC compatible s i b l i n g s are commonly 
used as bone marrow donors, but unfor tunate ly only 25-30? of the p a t i e n t s 
have a s u i t a b l e donor. I n i t i a l l y BMT was performed in endstage a c u t e 
leukemia with a '\2% d i s e a s e free two years s u r v i v a l (16). I n i t i a l mortal i ty 
was due to advanced s t a g e of i l l n e s s , but r e c u r r e n c e of leukemia was a major 
cause of death 6-24 months a f t e r BMT. Relapses more than 2 year a f te r BMT 
were a r a r e except ion (16). This has led to t r i a l s of marrow t r a n s p l a n t a t i o n 
in p a t i e n t s with ANLL in f i r s t remiss ion. A d i s e a s e free surv iva l at two years 
of 50-80? has been r e p o r t e d (17,18,19,20). The chance of r e c u r r e n t leukemia 
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in these p a t i e n t s has been ex t rapo la ted to be l e a s than 10$ (16). The major 
causes of e a r l y morbidity and mortal i ty a f t e r BMT are due to d i r ec t t o x i c i t y 
of the bone marrow a b l a t i v e therapy, i nc reased s u s c e p t i b i l i t y to i n f e c t i o n s 
and acute graf t ve r sus host d i sease (GVHD). Later mortal i ty i s mainly due to 
chronic GVHD and i n t e r s t i t i a l pneumonit is . 
GRAFT VERSUS HOST DISEASE 
Incidence of graf t ve r sus host d i s e a s e 
The i n c i d e n c e of graf t ve rsus host d i s e a s e (GVHD) appears to i n c r e a s e with 
r ec ip i en t age and i t has been repor ted to occur in 60-80 Í of a d u l t 
a l l ogene i c graf t r e c i p i e n t s desp i te s tandard p rophylax i s with Methotrexate 
(MTX) (21 ,22) . The c l i n i c a l p ic ture of acu te GVHD v a r i e s from a mild t r a n s i e n t 
skin e rup t ion to a fulminant syndrome of a g e n e r a l i s e d erythematous, 
maculopapular rash , enteropathy with severe d ia r rhoea and h e p a t i t i s often 
complicated by i n t e r s t i t i a l pneumonitis and f a t a l i n f e c t i o n s (23). 
GVHD i s conven t iona l ly explained by a cy to tox ic effect of donor lymphocytes 
d i rec ted a g a i n s t hos t h i s tocompa t ib i l i ty an t i gens (24,25) and e s p e c i a l l y 
di rected towards an t i gens coded a t non - HLA l o c i (26). Some au tho r s 
suggested t h a t the syndrome may r e s u l t from an imbalance of T-lymphocyte 
subse t s , r e s u l t i n g in a p ro l i f e ra t ion of cy to tox ic T-lymphocytes, normally 
cont ro l led by suppresso r T - c e l l s , but c o n f l i c t i n g r e p o r t s have been 
published (27,28,29,30) . 
Prevention of graf t ve r sus host d i s e a s e 
The u s u a l approach of prevent ing GVHD i s suppres s ion of the immuno-
competent c e l l s a f t e r bone marrow infus ion . Administrat ion of Methotrexate 
for 100 days a f t e r BMT reduced the inc idence and s e v e n t y of GVHD and i t i s 
most commonly used according to the S e a t t l e p ro toco l (21). However, s t i l l 
50-70$ of p a t i e n t s r ece iv ing a l l ogene i c bone marrow from i d e n t i c a l s i b l i n g s 
develop GVHD (21). Recently, anti lymphocyte g lobul in (31) and Cyclosporin A 
(32,33) have shown to prevent and/or to delay severe forms of GVHD. The value 
of t he se approaches has not been confirmed in randomised s t u d i e s , but 
unpubl ished s t u d i e s (Thomas) have not shown supe r io r r e s u l t s when 
Cyclosporin A was compared to Methotrexate . 
Several s t u d i e s in animals have shown a c l e a r a s s o c i a t i o n between t h e 
number of T-lymphocytes present in the graf ted mate r ia l and seve r i t y of GVHD 
(25). Removal of immunologically competent mature T-lymphocytes from the 
marrow graf t has been explo i ted in an at tempt to reduce the inc idence and/or 
s e v e n t y of GVHD. Using d i f fe rences in c e l l densi ty , albumin g rad ien t 
c e n t n f u g a t i o n has been performed, but the l imited y ie ld of hematopoiet ic 
stem c e l l s has r e s t r i c t e d c l i n i c a l a p p l i c a t i o n to ch i ld ren ( 3 Ό . In v i t r o 
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incubation of donor marrow with specific, purified antiaera raised in rabbits 
to human thymocytes has been reported by Rodt et al (35). Unfortunately i t is 
difficult to prepare and standardize this reagent in sufficient quantity. In 
vitro opsomsation of donor T-lymphocytes with monoclonal antibodies with 
"pan-T" specificity has been attempted, but conflicting resul ts appeared in 
2 reports (36,37). Depletion of donor T- lymphocytes from HLA-A and -B 
nomdentical parenteral marrow before grafting by differential agglutin-
ation with the lectin soybean agglutin followed by rosett ing procedures 
resulted in a successful bone marrow repopulation of an infant with acute 
lymphoblastic leukaemia(30). 
Physical separation of human bone marrow 
Ini t ial ly, buoyant density gradient centrifugation systems were used for 
physical fractionation of complex cell mixtures l ike human bone marrow. 
Discontinuous albumin gradients were employed by Dicke et al.to eliminate 
lymphocytes from the hematopoietic stem cel ls (39). Disadvantages of 
albumin density gradients are problems in controlling osmolanty of 
different batches of bovine serum albumin (BSA) and the aphysiological pH of 
5.1 of the gradients (40, 41). Isopaque-Ficoll" density gradients (40,42) 
have the disadvantage of high viscosity (43) and select ive retention of B-
lymphocytes (44). Polyvinylpyrrolidone coated s i l ica gel (Percoli") has 
been introduced more recently (45). Density gradients of physiological 
osmolanty are easily obtained due to the low osmolanty of Percoli. 
Additional advantages are: high stabi l i ty of the gradient, constant 
physico-chemical properties between different batches and low viscosity 
(41). 
Several methods have been used to separate human bone marrow cel ls 
according to cell s ize. Velocity gradient sedimentation at unit gravity in 
different types of sedimentation chambers has been described, including one 
in our laboratory (46,47). The main disadvantages are the limited number of 
cel ls (2x 10°) that can be separated and the long duration of the separation 
procedure (3-5 hours) (40). 
Counterflow centrifugation (CC) exposes cel ls to a centrifugal force and an 
opposing flow force (48,49,50). Cell separation takes place in a small 
chamber, (4.2 ml) and cel ls leave the chamber, mainly depending on cell size, 
by decreasing the rotor speed or by increasing the flow rate. After several 
adaptations (51,52) a reliable separation system was obtained with im-
portant advantages: short duration of the separation procedure, high 
capacity, good recovery, excellent cell viability and homogeneity of cell 
size in the different fractions, related to cel l cycle phase within the 
various subpopulations (53). 
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PURPOSE OF THE STUDY AND OUTLINE OF INVESTIGATIONS 
The i n i t i a l purpose of t h i s study was the development of s e p a r a t i o n systems 
in order to obta in bone marrow f r a c t i o n s enr iched for hematopoie t ic 
s t e m c e l l s . These f r a c t i o n a t i o n s were performed with i sopycn ic g r ad i en t 
c e n t n f u g a t i o n and counterflow c e n t n f u g a t i o n . When i t appeared f ea sab l e to 
s epa ra t e lymphocytes almost completely from the hematopoie t ic p rogen i to r 
c e l l s , e f for t s were d i r ec t ed to a new approach to prevent ion of graft ve r sus 
hos t d i s e a s e (GVHD) by e l iminat ion of the lymphocytes from the bone marrow 
g ra f t s , us ing a combination of dens i ty cen t r i fuga t ion and counterflow 
e l u t r i a t i o n . 
For assessment of the v i a b i l i t y and q u a n t i f i c a t i o n of numbers of stem c e l l s 
in the d i f fe ren t f r a c t i o n s m vi t ro c lonogenic a s s a y s were developed for the 
committed p rogen i to r c e l l s and p lu r i po t en t stem c e l l s ( chap t e r I I ) . 
I sopycnic g rad ien t cen t r i fuga t ion in Percol i was developed to obta in a low 
dens i ty f rac t ion devoid of e r y t h r o c y t e s and most mature g r anu locy t e s 
without any s u b s t a n t i a l l o s s of committed stem c e l l s ( chap te r I I I ) . 
Bone marrow c e l l s of varying dens i ty were s epa ra t ed in d i f fe ren t f r ac t i ons 
by counterflow e l u t r i a t i o n and ana lysed for morphology, in v i t ro c lonogenic 
c e l l s and T-lymphocyte subpopu la t ions ( chap te r IV). 
Counterflow cen t r i fuga t ion s e p a r a t e s c e l l popu la t ions mainly depending on 
c e l l s i ze and within each c e l l popula t ion accord ing to the c e l l cycle phase 
(chapter V). 
Low dens i ty c e l l s from normal human bone marrow were f r ac t i o n a t ed in two 
f r ac t ions by means of counterflow c e n t r i f u g a t i o n . These two f r ac t i ons were 
ana lysed in v i t ro for the p resence of the p lu r i po t en t stem c e l l s and for the 
mitogenic r e a c t i v i t y (chap te r VI). 
Bone marrow from 6 donors for a l l o g e n e i c bone marrow t r a n s p l a n t a t i o n was 
separa ted by dens i ty g rad ien t cen t r i fuga t ion followed by counterflow 
e l u t r i a t i o n . In v i t ro cu l tu re r e s u l t s , immunological eva lua t ion , in vivo bone 
marrow repopu la t ion capac i ty in 6 p a t i e n t s with acu t e leukemia in f i r s t 
remiss ion and the inc idence of GVHD are desc r ibed in chap t e r VII. 
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CHAPTER II 
QUANTIFICATION OF PLURIPOTENT AND COMMITTED HEMATOPOIETIC CLONOGENIC 
CELLS IN HUMAN BONE MARROW 
T. de Witte, R. Holdrinet, R. Raymakera, E. Koekman, G. Blankenborg, J. Weasels 
and С Haanen. 
Part of th is chapter has been published in Neth. J. Med. (1983) 26:67-73. 
Part of th is chapter wil l be submitted for publ ication in Experimental 
Hematology. 
SUMMARY 
Accurate and r e p r o d u c a b l e in v i t r o а з з а у з of c l o n o g e n i c 3tem c e l l s are 
mandatory in order to e v a l u a t e the a c c u r a t e number of hematopoiet ic atem 
c e l l s (HSC) a f t e r manipulat ion of human bone marrow. Media obta ined from 
p l a c e n t a l t i s s u e c o n d i t i o n e d in the presence of e n d o t o x i n provided a CSF-
source with high colony s t imula t ing a c t i v i t y and almost no i n h i b i t o r y 
a c t i v i t y . The use of frozen marrow samples from one h e a l t h y donor allowed a 
s t a n d a r d i z a t i o n of media and s t imulat ing f a c t o r s . Estimation of blood 
contaminat ion in bone marrow samples by a simple method based upon the 
assumption t h a t almost a l l hemoglobin in a bone marrow sample o r i g i n a t e s 
from blood showed a s i g n i f i c a n t n e g a t i v e c o r r e l a t i o n between blood 
contaminat ion and t h e number of BFU-E and CFU-GM p r e s e n t in bone marrow. 
The normal v a l u e s of CFU-GM, BFU-E and CFU-GEMM a f t e r exc lus ion of bone 
marrow samples contaminated with more than 15$ p e r i p h e r a l n u c l e a t e d c e l l s 
are p r e s e n t e d . 
INTRODUCTION 
Haematopoies is implies a cont inuous product ion of e r y t h r o c y t e s , g r a n u l o ­
c y t e s , thrombocytes , lymphoid c e l l s , o s t e o c l a s t s and v a r i o u s stromal c e l l s . 
The g e n e r a l concept i s t h a t c e l l production t a k e s p l a c e a t three l e v e l s . The 
f i r s t l e v e l i s the stem c e l l popula t ion, which i s p l u n p o t e n t i a l in t h e s e n s e 
t h a t i t g ives r i s e to d i f fe rent c e l l p o p u l a t i o n s and i t i s capable of self-
renewal. The second l e v e l i s a f i r s t d i f f e r e n t i a t i o n s t e p producing 
p r o g e n i t o r c e l l p o p u l a t i o n s . These are morphological ly unrecognizab le , but 
they can be demonstrated by in v i t r o colony formation under a p p r o p r i a t e 
c u l t u r e c o n d i t i o n s . The t h i r d l e v e l i s ach ieved dur ing a second dif­
f e r e n t i a t i o n s t e p a t which the progeni tor c e l l g i v e s r i s e to a morphologi­
c a l l y r e c o g n i z a b l e b l a s t c e l l popula t ion ( p r e c u r s o r - p o p u l a t i o n ) . This 
p o p u l a t i o n d i f f e r e n t i a t e s fur ther by s e v e r a l c e l l d i v i s i o n s t i l l an end 
s t a g e c e l l o c c u r s , which has l o s t i t s p r o l i f e r a t i o n p o t e n t i a l and matures 
t i l l f u n c t i o n a l i t y . I t i s c l e a r t h a t mature c e l l s have a d e f i n i t e l i fe span and 
have t o be r e p l a c e d c o n t i n u o u s l y from t h e stem c e l l pool. 
Experimental data in mice (1) suggest t h a t about 10 % of the stem c e l l s a re 
d i f f e r e n t i a t i n g per day. One hemopoietic stem c e l l (HSC) e n t e r i n g the 
ampl i f ica t ion compartment produces 60 p r o g e n i t o r c e l l s and about 1000 
g r a n u l o c y t e s (t 1/2 <1 day) or 200.000 e r y t h r o c y t e s (t 1/2 ^ 100 days) in 
t h e p e r i p h e r a l blood. This means t h a t t h e r a t i o of murine stem c e l l s t o 
p r o g e n i t o r c e l l s t o r e c o g n i z a b l e n u c l e a t e d c e l l s in bone marrow wil l be: 
10:60:4000. In o t h e r words about 0.25? of t h e bone marrow c e l l s are r e a l stem 
c e l l s and 1.5$ p r o g e n i t o r c e l l s , assuming t h a t bone marrow i s not 
contaminated with blood. 
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The development of semiaolid c u l t u r e systems has allowed probably a l l 
hemopoietic p rogen i to r and stem c e l l s to be cloned in v i t r o with r e l a t i v e 
high p l a t i ng e f f i c i e n c i e s . Cell p ro l i f e r a t i on in v i t ro depends on presence 
of s p e c i f i c growth r e g u l a t o r s , such as colony s t imula t ing f ac to r (CSF) for 
the granulocyte-macrophage p ro l i f e r a t i on and e ry th ropo ie t i n (EPO) for the 
erythroid p r o l i f e r a t i o n (2) . P lur ipotent hemopoiet ic stem c e l l s (3) p r o -
l i f e r a t e and d i f f e r e n t i a t e in the p resence of medium condi t ioned by 
phytoheraagglutinin s t imula ted l e u k o c y t e s : PHA-LCM (4). Fauser and Messner 
(5) observed the p resence of e o s i n o p h i l i c and n e u t r o p h i l i c g r anu locy te s , 
e r y t h r o b l a s t s , macrophages and megakaryocytes in mixed c o l o n i e s , o r i -
g ina t ing from p lu r ipo t en t stem c e l l s : colony forming uni t - g ranulocyte -
e ry th rob l a s t - macrophage - megakaryocyte (CFU-GEMM). Recent ly, a l so the 
presence of T-lymphocytes in t h e s e mixed co lon i e s was demonstrated (6). 
Limited s e l f renewal capac i ty of CFU-GEMM has been repor ted (7), making the 
CFU-GEMM a s t rong cand ida te for the HSC. The low number of t he se c e l l s in 
human bone marrow ( ^0 .01 %) hampers a r e l i a b l e q u a n t i f i c a t i o n of stem c e l l s 
p resen t in a bone marrow f rac t ion . 
The committed g ranu locy te - macrophage/monocyte p rogen i to r c e l l (CFU-GM) 
p r o l i f e r a t e s in v i t ro to form co lon i e s of g ranu locy tes ( e o s i n o p h i l i c and 
neu t roph i l i c ) and macrophages (8,9). These c e l l s , h a v i n g a r e l a t i v e l y high 
p ro l i f e r a t i on r a t e , could be s epa ra t ed p a r t i a l l y from the murine HSC by 
ve loc i ty sedimenta t ion and i sopycn ic cen t r i fuga t ion t e c h n i q u e s (10). None 
the l e s s the number of CFU-GM presen t in c e l l f r a c t i o n s has proven to 
provide a r e l i a b l e i n d i c a t i o n of the capac i ty to r e g e n e r a t e hematopoies is 
(11). The e ry thro id p rogen i to r popula t ion c o n s i s t s of two d i s t i n c t c e l l 
t y p e s : a more immature stem c e l l , c a l l ed the e ry thro id burs t forming un i t 
(BFU-E) and a more d i f f e r e n t i a t e d descendan t from the BFÜ-E: e ry thro id 
colony forming uni t (CFU-E) (12). P ro l i f e ra t ion of BFU-E r e q u i r e s s t imula t ion 
by a burs t promoting a c t i v i t y (BPA): a f ac to r p r e sen t in l eukocyte 
condi t ioned medium (13) and EPO; growth of CFU-E depends only on the 
presence of EPO. 
MATERIALS AND METHODS 
Preparat ion of bone marrow c e l l s 
Normal bone marrow, obta ined from p a t i e n t s undergoing c a r d i a c surgery or 
from hea l thy bone marrow donors, i s c o l l e c t e d in buffered a c i d - c i t r a t e 
dext rose (pH 7.0). Bone marrow p a r t i c l e s are d i s rup ted by repea ted 
a s p i r a t i o n s through 16 gauge need les and the suspens ion i s f i l t e r e d through 
a nylon f i l t e r (pore - s i z e 70 pm). The c e l l s are washed in Ca++/Mg++ - f r ee 
Hanks balanced s a l t so lu t ion (HBSS) for removal of plasma and fa t and 
resuspended in HBSS conta in ing 5% (v/v) f e t a l ca l f serum (FCS). A number of 
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150-200 χ 10° n u c l e a t e d c e l l a in 35 ml s u s p e n s i o n i s layered on 15 ml 
F i c o l l - I s o p a q u e ( s p e c i f i c d e n s i t y : 1.085 g/ml; pH 6.6; osmolal i ty : 300 
mosm/kg) and centr i fuged a t 500 g and 18° С for 20 minutes to remove the red 
c e l l s (14). The n u c l e a t e d c e l l s a t the i n t e r p h a s e are c o l l e c t e d , washed and 
r e s u s p e n d e d in 3-5 ml FCS. This f ract ion c o n t a i n s 76 ± 4 Ï of the o r i g i n a l 
nuc lea ted c e l l s , 19 ± 12$ of the mature myeloid c e l l s and 105 ± 21? of the 
CFU-GM (15). 
Prepara t ion of condi t ioned media 
Human p l acen t a condi t ioned medium (HPCM) i s prepared according to the 
method descr ibed by Schlunk and Schleyer (16). In some experiments the 
p l a c e n t a s are condi t ioned in the presence of endotoxin: l i p o p o l y s a c h a n d e W 
(LPS) from E-Coli (3120-25, Difco): lOyg/ml (LPS-HPCM) (17). 
Human leukocyte condi t ioned medium (HLCM) i s prepared from human p e -
r i p h e r a l blood l eukocy tes immobilized in 0.5? agar for 7 days as desc r ibed 
by I scove e t a l . (18). Venous blood i s obta ined from normal vo lun tee r s or 
p a t i e n t s with hemochromatosis and c o l l e c t e d in p r e se rva t i ve free hepar in . 
Human mononuclear pe r i phe ra l blood l eukocy te s are prepared by i sopycn ic 
dens i ty cut s e p a r a t i o n through F i c o l l - I s o p a q u e (d: 1.077 g/ml). Human 
mononuclear condi t ioned medium i s prepared in the p resence of phytohera-
agglutinin(Wellcome MR 10): 90 ug/ml for 7 days as desc r ibed by Aye (4) (PHA-
HMCM). 
Granulocyte/macrophage colony forming c e l l s (CFU-GM)-as3ay (19) 
All c u l t u r e s are performed in 2 ml volumes in 35 mm^ p l a s t i c Pet r i d i s h e s 
(Costar) . Dulbecoo's Modified Eagle 's Medium i s used with 20 % heat 
i n a c t i v a t e d FCS from a p r e s e l e c t e d batch in 0.3 % Bacto-agar(Difco) . 
Nucleated c e l l s (2x10^) are seeded per p l a t e with 4% (w/v) colony 
s t imula t ing fac tor (CSF) obta ined from p l a c e n t a s (LPS-HPCM) or CSF der ived 
from a GCT-cell l i ne (Gibco) (20) .Duplicate c u l t u r e s are incubated a t 37° С 
in a fully humidified atmosphere of 5 % CO2 in a i r for 10-12 days. Cul tures 
are scored a t 20-40 χ magnif icat ion. Aggregates c o n s i s t i n g of 40 and more 
c e l l s are scored as c o l o n i e s . 
Erythroid colony forming c e l l s (BFU-E/CFU-E)-assay. 
The b a s i c c u l t u r e t e c h n i q u e i s adapted from the method of Iscove e t a l . ( 2 1 ) . 
The c e l l s u s p e n s i o n s a t a c o n c e n t r a t i o n of 1 χ lO^/ml are p l a t e d in a 
s u b s t a n t i a l l y modified Dulbecoo's Medium, prepared from powder (IMDM, Gibco 
formula 78 - 5220) (22), to which i s added 0.8? m e t h y l c e l l u l o s e (Fluka, 
Schweiz), ΙΟ-^Μ t h i o g l y c e r o l , 10 % d e i o m z e d bovine serum albumin (12) 20 % 
h e a t i n a c t i v a t e d f o e t a l ca l f serum of a p r e s e l e c t e d batch (Rehatuin), 20 % 
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l e u k o c y t e c o n d i t i o n e d medium (14) and 2 Units sheep ery thropoie t in/ml (Step 
I I I , Connaught Lab, Willowdale Ont. Can.). One-tenth m i l l i l i t e r s of t h i s 
s u s p e n s i o n are p laced in f l a t bottomed microwells (Limbro, T i t e r t e x ) . 
Orange-to-red c o l o n i e s of a t l e a s t e ight c e l l s are scored as CFU-E in four 
microwells on t h e 7th day of c u l t u r e . Orange-to-red b u r s t s of a t l e a s t t h r e e 
s u b c l u s t e r s or one s i n g l e colony of more than 300 c e l l s a re scored as BFU-E 
in the o t h e r four wel l s on day fourteen of t h e c u l t u r e . 
P l u r i p o t e n t colony forming c e l l s (CFU-GEMMj-assay 
The bas ic c u l t u r e c o n d i t i o n s were o u t l i n e d by F a u s e r and Messner (5), but 
some modi f icat ions accord ing t o Ash e t a l . (7) a re followed. Cell s u s ­
p e n s i o n s a t a c o n c e n t r a t i o n of 1 χ lO^/ml are p l a t e d in I s c o v e ' s modified 
Dulbecco's medium c o n t a i n i n g m e t h y l c e l l u l o s e (Fluka, Schweiz) as v i s c o u s 
support (0.9$ f i n a l c o n c e n t r a t i o n ) , 201 heat i n a c t i v a t e d FCS from a 
p r e s e l e c t e d batch (Rehatuin), 5% PHA-HMCM, 10Í d e i o m z e d bovine serum 
albumin, 10~^M t h i o g l y c e r o l and 1.5 Unit sheep e ry th ropoe t in (Step I I I EPO; 
Connaught Lab. Willowdale Ont. Can). Dupl icate 0.5 ml a l i q u o t e are cu l tu red 
in 16 mm wel ls ( C l u s t e r ^ , Costar) and mixed co lon i e s a re i den t i f i ed on day 
16 of c u l t u r e by t h e i r composite appea rance . Ind iv idua l co lon ie s a re 
removed by micropipe t t ing in to t h i n - t i p p e d Pas teur p i p e t t e s , t r ans fe r red 
onto s l i d e s and forceful ly air-blown to spread the c e l l s . S l ides are s t a ined 
with May Grünwald-Giemsa to a s s e s s t h e i r morphological composit ion. 
RESULTS 
Colony s t imula t ing and i n h i b i t i n g f a c t o r s in HPCM 
The colony s t imula t ing a c t i v i t y (CSA) of s ix d i f fe ren t ba t ches of HPCM was 
compared to t ha t of a commercially a v a i l a b l e batch from a g ian t c e l l tumor 
c e l l l ine (GCT-CSF). The r e s u l t s are l i s t e d in t a b l e I and show the v a r i a b l e 
and often suboptimal CSA. Condit ioning in the p resence of E. Coli endotoxin 
(LPS) y ie lded i n c r e a s e d l e v e l s of CSA. 
Different ba tches of HPCM were t e s t e d for the p resence of s t imula t ing and 
i nh ib i t i ng f ac to r s by performing CFU-GM-assays with varying d i l u t i o n s of 
condi t ioned medium. Inc reas ing q u a n t i t i e s of HPCM condi t ioned without LPS 
r e s u l t e d in cons ide rab l e i nh ib i t i on of colony formation ( t ab le I I ) . This 
i nh ib i t i on was absen t or l e s s apparent i f HPCM was prepared in the p resence 
of endotoxin. For t h e s e r ea sons i t was decided to use in t h i s study only HPCM 
condi t ioned in the p resence of endotoxin a t a concen t r a t i on of 4% v/v. 
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Batch HPCM LPS CSA% 
* mean ± SD (n=4) 
Table I. 
78 ± 24* 
42 ± 8 
72 ± 32 
58 ± 12 
111 ± 51 
140 ± 54 
118 + 10 
144 ± 18 
Colony stimulating activity (CSA) of different batches human placenta 
conditioned medium (HPCM) compared to CSA of one batch GCT - CSF. CSA 
of GCT - CSF is put at 100 %. Two batches were also prepared in 
presence of LPS. 
Batch HPCM Volume % of HPCM in CFU-GM assay 
40 30 20 10 4 2 
1 -LPS 
2 -LPS 
5 -LPS 
6 -LPS 
5 +LPS 
6 +LPS 
Table II. 
19 
1 
86 
0 
103 
75 
69 
10 
86 
15 
97 
99 
113 
70 
107 
93 
91 
111 
100 
100 
100 
100 
100 
100 
77 
77 
98 
142 
103 
117 
. 
24 
-
151 
96 
114 
Colony stimulating and inhibiting factors present in HPCM. Influence of 
presence of endotoxin (LPS). Each batch of HPCM was tested 3-6 times. 
Results are expressed as mean percentage of the number of CFU-GM obtained 
with 10 % w/v HPCM. Batch nrs correspond with those of table I. 
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Frozen marrow serving аз standard control 
The use of different batches FCS, conditioned media and the varying culture 
conditions in the CO2 incubators asks for an internal standard control. 
Therefore a batch of 2 ml ampoules (Nunc, Intermed) with normal human bone 
marrow at a concentration of 1 χ 10° nucleated cells per ml autologous 
plasma with 10 % DMSO was stored in liquid nitrogen аз described before 
(24). One single batch of ampoules containing normal bone marrow from one 
bone marrow donor was used during the observation period. CFU-GM were 
cultured on 67 occasions: normal growth was observed 56 times: 18 ± 5 CFU-
GM/IO^ nucleated cells; subnormal growth: И times and no growth 7 times due 
to an inadequate batch of culture medium. BFU-E were cultured on 24 
occasions: normal growth was observed 16 times: 39 ± 11 BFU-E/IO^ nucleated 
cells; subnormal growth: 3 times and 5 cultures were found to have dried out. 
The variation from month to month during the observation period was 
acceptable (figure 1). 
% 
140 
120 
100 
SO 
6 0 
May June Jubf *uo Sep O c l 
Figure 1 
The average number of CFU-GM ( · · ) and BFU-E (àr—A) per month of one 
s ing le batch of ampoules conta in ing frozen normal bone marrow c e l l s . The 
average number of CFU-GM and BFU-E of c u l t u r e s with normal growth was put 
100$, Numbers re fe r to number of c u l t u r e s of t h a t p a r t i c u l a r month with 
normal growth and each v e r t i c a l bar r e p r e s e n t s one s t andard dev ia t ion of the 
mean of t h a t month. 
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Normal v a l u e s of p l u r i p o t e n t stem c e l l s and p r o g e n i t o r c e l l s 
In f luence of p e r i p h e r a l blood contaminat ion 
The number of c i r c u l a t i n g CFU-GM and BFU-E per 2 χ 10 5 n u c l e a t e d c e l l s in 
human blood i s l e s s than one percent of t h e number of p r o g e n i t o r c e l l s 
p r e s e n t in bone marrow. Bone marrow contaminated with a high number of 
p e r i p h e r a l n u c l e a t e d c e l l s wi l l exh ib i t a low number of colony forming c e l l s . 
In order t o determine t h e normal va lues of committed and p l u r i p o t e n t stem 
c e l l s , t h e blood contaminat ion was compared with t h e a c t u a l number of 
committed e r y t h r o i d and myeloid p r o g e n i t o r c e l l s in bone marrow samples. The 
contaminat ion of p e r i p h e r a l n u c l e a t e d c e l l s in bone marrow a s p i r a t e s was 
c a l c u l a t e d as d e s c r i b e d by H o l d n n e t et a l . (23) with use of the formula: 
Hb
 B M χ NC B 1 
F r a c t i o n Bl = — — — — — — 
Hb B 1 χ NCBM 
where Hb=hemoglobin, BM=bone marrow, Bl=blood and NC=nucleated c e l l s . 
CFU-GM from 65 normal bone marrow samples are p l o t t e d a g a i n s t t h e 
p e r i p h e r a l blood contaminat ion in f igure 2. The c a l c u l a t e d c o r r e l a t i o n 
f a c t o r r was: - 0.51 (p <0 .001) . 
The r e l a t i o n of CFU-E and BFU-E with blood contaminat ion 13 p r e s e n t e d in 
f igure 3 . Normal v a l u e s of ery throid, myeloid and p l u r i p o t e n t c lonogenic 
c e l l s are shown in t a b l e l l l .Bone marrow samples with more than 15Í of the 
nuc lea ted c e l l s o r i g i n a t i n g from blood admixture were excluded. 
CFU-GM 55 ± 19 n=48 
BFU-E 124 ± 45 n=22 
CFU-E 344 ± 131 n=13 
CFU-GEMM 1 1 ± 6 n= 8 
Table I I I . 
Normal values of bone marrow samples obtained from hematologically 
normal persons. Bone marrow samples with more than 15 percent blood 
contamination were excluded. The results are expressed as mean number 
± one SD per 1(И nucleated cells, η is number of observations. 
The number of CFU-GM in normal bone marrow samples observed in 3 month 
periods during 3 years are presented in figure 1. 
GCT-CSF was used until March 19Θ1 and two batches of HPCM+LPS since then. 
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CFU-GM/iosNC 
N=65 
R = - 0 51 
ρ<αοοι 
(%) BLOOD 
Figure 2 
The i n f l u e n c e of p e r i p h e r a l n u c l e a t e d c e l l (NC) contaminat ion on t h e number 
of CFU-GM in 65 bone marrow a s p i r a t e s of hematological lynormal p e r s o n s . The 
c o r r e l a t i o n f a c t o r (r) was: - 0.51 c o r r e s p o n d i n g with a ρ < 0.001. 
DISCUSSION 
Manipulat ion of human bone marrow by p h y s i c a l s e p a r a t i o n procedures 
r e q u i r e s an a c c u r a t e monitoring of t h e s u r v i v a l of t h e HSC in order t o 
p r e d i c t bone marrow r e p o p u l a t i o n c a p a c i t y . Unti l r e c e n t l y i n v e s t i g a t i o n s of 
t h i s n a t u r e were l imited to committed p r o g e n i t o r c e l l p o p u l a t i o n s (CFU-GM 
and BFU-E), which form t h e immediate progeny of t h e p l u r i p o t e n t hema­
t o p o i e t i c stem c e l l s . The number of myeloid p r o g e n i t o r c e l l s has been shown 
t o be of va lue in p r e d i c t i n g hematopoie t ic recovery a f t e r bone marrow 
a b l a t i v e therapy (11). However, s e v e r a l problems concerning s t a n d a r d i z a t i o n 
remained t o be so lved. 
F i r s t l y , t h e f l u c t u a t i n g a c t i v i t y of CSF depending on t h e s o u r c e and a c t i v i t y 
of condi t ioned media. The o r i g i n a l CSF - s o u r c e a s d e s c r i b e d by Pike and 
Robinson (18) was formed by p e r i p h e r a l blood l e u k o c y t e s immobilized in a 
feeder l a y e r of 0.5 % agar . The colony s t i m u l a t i n g a c t i v i t y (CSA) var ied 
c o n s i d e r a b l y , even when blood from one s i n g l e donor was used (24). 
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Figure 3 
The influence of peripheral nucleated cell (NC) contamination on the number 
of erythroid progenitor cel ls in bone marrow aspirates of hematologically 
normal persons. 
The correlation factor for the BFU-E was - 0.55 and for the CFU-E - 0.67 
corresponding with a ρ <0.01. 
Conditioned media from placenta (26) provide large quantities of CSF, but 
although culture conditions were improved (15) the level of CSA in different 
batches appeared to be suboptiraal (table I) . Moreover dose-response curves 
showed the presence of inhibitors m most batches (table II) . Low CSA-
levels and presence of inhibitors may result in fluctuating datas due to 
direct or indirect interaction through monocytes, T-lymphocytes, and mature 
granulocytes, which are present in high number in several bone marrow 
fractions. Medium conditioned in the presence of endotoxin (HPCM+LPS) 
showed a higher CSA-level and a low level of inhibitors. An additional 
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advantage with t h i s CSF-эоигсе was the complete recovery of CFU-GM, which 
could be achieved a f t e r c r y o p r e s e r v a t i o n in l iquid n i t rogen, as we d e s c r i b e d 
before (25). This c o n t r a s t e d the suboptimal recovery obta ined with o t h e r 
CSF-sources l ike HPCM-CSF, GCT-CSF and PHA-HMCM (25). 
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Figure k 
The mean number of CFU-GM (± SD) per t r i m e s t e r in bone marrow a s p i r a t e s of 
heraatological ly normal p e r s o n s . Numbers r e f e r to number of c u l t u r e s of t h a t 
p a r t i c u l a r month. Bone marrow a s p i r a t e s with more than 15Í blood c o n t a -
mination were excluded. 
The second problem of s t anda rd i za t i on i s due to the wide v a r i a t i o n s in the 
number of CFU-GM in normal human bone marrow, even within the same donor. 
The use of frozen marrow samples for s t a n d a r d i z a t i o n of media, CSF and 
cu l tu re cond i t ions can overcome t h i s problem. We were ab le to show tha t one 
batch of normal bone marrow samples r e s u l t e d m rep roduc ib le numbers of CFU-
GM and BFU-E (fig. 1). By c o n s i s t e n t a p p l i c a t i o n of t h i s I n t e r n a l s t anda rd , 
the r e p r o d u c a b i l i t y of the in v i t ro c u l t u r e s was improved. 
Contamination of marrow a s p i r a t e s with blood may a l s o cause e r ro r s when t h e 
number of co lon i e s a re r e l a t ed only to 10-' nuc lea ted c e l l s . Complicated 
methods to determine blood contamination of bone marrow have been advoca ted 
(27), but Holdrinet e t a l . developed a p r a c t i c a l formula, based upon 
experiments with l abe l l ed red c e l l s , t h a t showed tha t near ly a l l hemoglobin 
p resen t in a bone marrow a s p i r a t e o r i g i n a t e s from blood contaminat ion (23). 
Taking in to account the obvious i n t e r m d i v i d u a l v a r i a t i o n in normal bone 
marrow, t h i s method showed a c l ea r nega t ive c o r r e l a t i o n between the number 
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of clonogenic cel ls per 1CP nucleated ce l l s and the amount of blood 
contamination (figs. 2 and 3). The normal values of clonogenic ce l l s were 
calculated after exclusion of bone marrow samples contaminated with more 
than 15 Í peripheral nucleated cel ls . 
In conclusion: standardization of in vitro culture assays is crucial for the 
evaluation of bone marrow fractions obtained by different separation 
techniques. This could be accomplished by using a highly active source of 
CSF, frozen bone marrow samples as internal control and estimation of 
peripheral nucleated cel l contamination. 
30 
1. Becker AJE, Mc Culloch A, Siminoviteh С et al. (1965). The 
effects of differing demands for blood cell production on DNA 
synthesis by hemopoietic colony forming cells of mice. Blood 
26:296-308. 
2. Metcalf D. (1977). Recent results in cancer research: 
hemopoietic colonies. Berlin, Heidelberg, New York, Springer 
Verlag. 
3. Lajtha LG. (1979). Haemopoietic stem cells: concepts and 
definitions. Blood Cells 5:447-55. 
4. Aye MT, Niho Y, Till JE. (1974). Studies of leukemic cell 
populations in culture. Blood 44:205-19. 
5. Fauser AA, Messner HA. (1979). Identification of 
megakaryocytes, macrophages, and eosinophils in colonies of 
human bone marrow containing neutrophilic granulocytes and 
erythroblasts. Blood 53:1023-27. 
6. Messner HA, Izaquirre CA, lamal N. (1981). Identification of T-
lymphocytes in human mixed hemopoietic colonies Blood 58:402-10 
7. Ash RC, Detrick RA, Zanjan! ED et al. (1981). Studies of human 
pluripotential hemopoietic stem cells (CFU-GEMM) in vitro. 
Blood 58:309-16. 
8. Doa C, Metcalf D, Zittoun R et al. (1977). Normal human bone 
marrow cultures in vitro: cellular composition and maturation 
of the granulocytic colonies. Brit. J. Haematol. 37:127-36. 
9. Dresch C, Johnson GR, Metcalf D. (1977). Eosinophil colony 
formation in semisolid cultures of human bone marrow cells. 
Blood 49:835-44. 
10. Haskil JS, Mc Neil ТА, Moore MJAS. (1970). Density distribution 
analysis of in vivo and in vitro colony forming cells in bone 
marrow. J. Cell. Physiol. 75:167-79. 
11. Spitzer G, Verma DS, Fisher R. (1980). The myeloid progenitor 
cell: its value in predicting hematopoietic recovery after 
autologous bone marrow transplantation. Blood 55:317-23. 
12. Tepperman AD, Curtis JR, Mc Culloch EA. (1974). Erythroid 
colonies in cultures of human bone marrow. Blood 44:659-69. 
13. Aye MT. (1977). Erythroid colony formation in cultures of human 
marrow: effect of leucocyte conditioned medium. J. Cell. 
Physiol. 91:69-77. 
14. Loos J, Roos D. (1974). Ficoll-Isopaque gradients for the 
determination of density distributions of human lymphocytes and 
other reticulo-endothelial cells. Exp. Cell. Res. 86: 333-41. 
15. De Witte Τ, Scheltinga E et al. (1982). Enrichment of myeloid 
clonogenic cella by isopycnic density equilibrium 
centrifugation in Percoli gradients and counterflow 
centnfugation. Stem Cells 2:380-20. 
16. Schlunk Τ, Schleyer E. (1980). The influence of culture 
conditions on the production of colony stimulating activity by 
human placenta. Exp. Hematol. 81:179-84. 
17. Verma DS, Spitzer G, Beran M. (1980). Colony stimulating factor 
augmentation in human placentas. Exp. Hematol. 8:917-23. 
18. Iscove NN, Senn JS, Till JE. (1971). Colony formation by normal 
and leukemic human marrow cells in culture: effect of 
conditioned medium from human leukocytes. Blood 37:1-5. 
19. Pike BL, Robinson WA. (1970). Human bone marrow colony growth 
in agar gel. J. Cell. Physiol. 76:77-84. 
20. Di Persio JF, Brennan JK, Lichtman MA. (1978). Human cell lines 
that elaborate colony-stimulating activity for the marrow cells 
of man and other species. Blood 51:507-19. 
21. Iscove NN, Sieber F, Winterholter KH. (1974). Erythroid colony 
formation in cultures of mouse and human bone marrow: analysis 
of the requirement for erythropoietin by gel filtration and 
affinity chromatography on agarose-concanavalin-A. J. Cell. 
Physiol. 83:309-20. 
22. Iscove NN, Melchers F. (1978). Complete replacement of serum by 
albumin, tranfenn and soybean lipid in cultures of 
lipopolysachande-reactive lymphocytes. J. Exp. Med. 147:923-
32. 
23. Holdrinet R, van Egmond J, Wessels J et al. (1980). A method 
for quantification of peripheral blood admixture in bone marrow 
aspirates. Exp. Hematol. 8:103-6. 
24. van den Ouwenland F, de Witte Τ, Geerdink Ρ et al. (1982). 
Enrichment and cryopreservation of bone marrow cells for 
autologous reinfusion. Cryobiology 19:292-8. 
25. de Witte Τ, Raymakers R, van den Ouwenland F et al. (1983). 
Cryopreservation and reinfusion of autologous bone marrow 
enriched for clonogenic stem cells by discontinuous cell 
centrifugation. Neth. J. Med. 26:67-73. 
26. Burgess AW, Wilson E, Metcalf D. (1977). Stimulation by human 
placental conditioned medium of hematopoietic colony formation 
by human bone marrow cells. Blood 49:573-583. 
27. Parmentier C, Morardet N, Tcherma G et al. (1979). 
Methylcellulose culture of human granulocytic progenitor cells 
(CFC): resulta of bone marrow and blood cultures for normal 
subjects. Nouv. Rev. Fr. Hematol 21:231-8. 
32 
CHAPTER III 
ENRICHTMENT OF MYELOID CLONOGENIC CELLS BY ISOPYCNIC DENSITY EQUILIBRIUM 
CENTRIFUGATION IN PERCOLL GRADIENTS AND COUNTERFLOW CENTRIFUGATION 
T. de Witte, E.Koekman, A.Pias, G.Blankenborg, M.Salden, J.Wessels, С. 
Haanen 
Stem Cells (1982) 2 : 308-320. 
SUMMARY 
Continuous dens i ty g r a d i e n t s made from p o l y v i n y l - p y r r o l i d o n e - c o a t e d s i l i c a 
gel (Percoli) were used to obta in f r ac t ions enr iched with human myeloid 
progeni tor c e l l s . I sopycn ic separa t ion with sample app l i c a t i on to the bottom 
of the g rad ien t ( f l o t a t ion ) improved the recovery and y ie lded a f rac t ion 25 
times enr iched for the CFU-GM. The dens i ty of t h i s f r ac t ion was 1.0615 g/ml. 
Lymphocytes accounted for almost 10Í of t h i s f r ac t ion . Removal of the small 
s i zed lymphocytes was accomplished by counterflow cen t r i fuga t ion with 
cont inuous c e l l - a i z e monitoring of the e f f luent by l igh t s c a t t e r . The 
obta ined l a rge c e l l f rac t ion conta in ing a l l myeloid progeni tor c e l l s was 
subsequent ly sub jec ted to i sopycnic f l o t a t i o n cen t r i fuga t ion . Only 0.2% of 
the o r i g i n a l number of lymphocytes contaminated the two f r ac t ions with the 
h ighes t number of c lonogenic c e l l s . Phys ica l s e p a r a t i o n methods based on 
counterflow cen t r i fuga t ion and i sopycnic cen t r i fuga t ion may offer a new 
approach to the e l iminat ion of lymphocytes from human bone marrow in order 
to prevent or mi t iga te GVHD in a l logene ic bone marrow t r a n s p l a n t a t i o n . 
INTRODUCTION 
Normal human bone marrow con ta ins committed myeloid progeni tor c e l l s (CFU-
GM). These c e l l s r e p r e s e n t the immediate progeny of the p l u r i p o t e n t 
hematopoie t ic stem c e l l s (1). The number of CFU-GM in c e l l f r ac t ions has 
proven to provide a r e l i a b l e i nd ica t ion of the capac i ty to r e g e n e r a t e 
hematopoies i s (2). The purpose of t h i s study i s the development of a method 
to obta in a f r ac t ion of human bone marrow, highly enr iched for myeloid 
p rogen i to r c e l l s and almost devoid of lymphoid c e l l s . The dens i ty (3) and 
the s i z e (4) of c e l l s are the main p h y s i c a l c h a r a c t e r i s t i c s , which can be 
used for s e p a r a t i o n of he terogeneous c e l l p o p u l a t i o n s . Density g rad ien t 
cen t r i fuga t ion i s mainly used to f r ac t iona te bone marrow according to the 
var ious s t a g e s of maturat ion (5). Col lo ida l s i l i c a coated with po lyv iny l -
pyrrol idone (Percol i ) has been claimed to provide g r a d i e n t s super io r to 
bovine serum albumin and F ico l l due to high s t a b i l i t y , cons tan t p h y s i c o -
chemical p r o p e r t i e s , low v i s c o s i t y and easy p repa ra t ion of i s o t o n i c 
s o l u t i o n s with each des i red pH (6). 
Counterflow cen t r i fuga t ion ( e l u t n a t i o n ) s e p a r a t e s c e l l s mainly accord ing 
to t h e i r s i z e (7, 8) . This method provides the p o s s i b i l i t y of s epa ra t ing small 
s i zed lymphocytes from the l a rge r s i zed myeloid p rogen i to r c e l l s (9). 
In t h i s study the r e c o v e r i e s of nuclea ted c e l l s and myeloid progeni tor c e l l s 
have been s tud ied а з obta ined a f t e r i s o p y c n i c s e p a r a t i o n with sample 
a p p l i c a t i o n to the top or the bottom of the g r a d i e n t ( f l o t a t i o n ) . The d e n s i t y 
and c e l l composit ion in the f r a c t i o n s with the h i g h e s t enrichment of 
p r o g e n i t o r c e l l s , o b t a i n e d before and a f t e r removal of the small s i z e d 
lymphocytes by means of counterflow c e n t r i f u g a t i o n , i s descr ibed in d e t a i l . 
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MATERIALS AND METHODS 
Preparat ion of bone marrow c e l l s 
Normal bone marrow from p a t i e n t s undergoing c a r d i a c surgery i s c o l l e c t e d in 
buffered a c i d - c i t r a t e dextrose (pH 7.0). Bone marrow p a r t i c l e s are d i s r u p t e d 
by r e p e a t e d a s p i r a t i o n s through Іб-gauge n e e d l e s and t h e s u s p e n s i o n i s 
f i l t e r e d through a nylon f i l t e r (pore s i z e 70 um). The c e l l s are washed in 
Ca++/Mg++- free Hanks' balanced s a l t s o l u t i o n (HBSS) for removal of plasma 
and fat and r e s u s p e n d e d in HBSS c o n t a i n i n g 5% (w/v) f e t a l ca l f serum (FCS). 
P r e p a r a t i o n of i s o t o n i c p e r c o l i d e n s i t y g r a d i e n t 
An i s o t o n i c s tock s o l u t i o n of Percol i (Pharmacia, Uppsala, Sweden) i s made 
by mixing 9 p a r t s of P e r c o l i with 1 part of 10 χ c o n c e n t r a t e d HBSS (osmolal i ty 
285 mosm/kg). S o l u t i o n s with the d e s i r e d d e n s i t y (d) are made by mixing X ml 
of the P e r c o l i s tock s o l u t i o n (densi ty a) with Y ml of i s o t o n i c HBSS ( d e n s i t y 
b) accord ing to the formula: 
X a - d 
Y d - b 
Density is measured by reading the refractive index (RI) and converting the 
HI values to density from a standard curve made for Percoli suspended in 
HBSS. The pH is adjusted to 7.1» by flushing the suspensions with 7% COj in 
air. 
Preparation of continuous linear density gradients 
Linear gradients of 35 ml in 50 ml centrifuge tubes are prepared as 
described by Loos and Roos (3) with the use of a conical bore universal 
gradient mixer (Buckler Instruments, Fort Lee, N.J., USA). The gradients are 
introduced under a 5 ml solution with the same density as the top end of the 
gradient to avoid perturbation of the l inearity. The linearity is always 
checked by reading the RIs of the collected fractions. The gradients, with 
caps tightly screwed, are stored at 40C unti l used. The l inearity i s 
maintained for at least 3 months, and is not disturbed by centrifugation. 
Isopycnic sedimentation centrifugation 
A number of (100-150) χ 10" nucleated bone marrow cel l s in 10 ml of 
suspension are carefully layered on the linear gradient and centrifugea at 
500 g and 18^ for 30 mm. After sedimentation, a s ta in les s-s tee l needle fixed 
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in a gradient sampler is introduced from above and fractions are collected 
by a per i s ta l t ic pump at a rate of 2 ml/min. 
Isopycnic flotation centrifugation 
A 10 ml suspension is prepared with a density equal to the bottom end of the 
gradient by mixing 6.7 ml Percoli stock solution, 2.3 ml HBSS, 1 ml FCS and 
100-150 χ 10° bone marrow cel ls . The tota l cel l volume of this suspension 
influences the density of the suspension. The desired density is obtained 
by the addition of a small volume of HBSS to correct the refractive index. The 
cell suspension is layered under the gradient using a syringe fitted with a 
blunted, large-bore needle. Centrifugation and collection of the fractions 
are identical to the sedimentation centrifugation. 
Counterflow centrifugation 
Counterflow centrifugation (CC) is performed with a Beekman J2- 21С 
refrigerated centrifuge equipped with a Beekman JE-6 elutriation rotor with 
a standard separation chamber (Beekman Instruments Inc., Palo Alto, Calif.). 
A constant flow rate is obtained by a per i s ta l t ic pump (Masterflex-Cole-
Parmer Instruments, Chicago, 111., USA). The pump is connected to a pulse 
flattening air chamber. The elutriation system is disinfected by overnight 
incubation with 70$ ethanol. HBSS supplemented with 1Í (w/v) heat-
inactivated FCS is used as elutriation medium, and maintained at 180C. The 
output of the elutr iator is continuously sampled by means of a T-drain and 
analyzed for cel l number and light scatter by the electro-optical unit of a 
Hematolog D (Technicon Instrument Corp., Tarrytown, N.J., USA). The light 
scat ter signals are accumulated and displayed on a ND-600 multichannel 
analyzer (Nuclear Data Inc., Schaumberg, 111., USA) (9). The specimens are 
introduced by means of an infusor pump (0.3 ml/min) into the elutriator rotor 
spinning at 2.200 rpm and a counter flow rate of 9 ml/min. Only thrombocytes, 
erythrocytes and small lymphocytes are eluted at this flow rate. The rotor 
speed is maintained at 2.200 rpm throughout the procedure and the 
counterflow rate is increased stepwise 1-2 ml/min whenever the number of 
elutriated cel ls detected by the electro-optical system falls below 100 
c e l l s / s . 
Granulocyte/macrophage colony forming ce l l s (CFU-GMi-assay 
9 All cultures are performed in 2-ml vol in 35 -mm plast ic Petri dishes 
(Costar). Dulbecco's modified Eagle's medium (Flow) is used with 20% heat-
inactivated FCS from a preselected batch in 0.3% Bacto-agar (Difco). 
Nucleated ce l l s (2 χ 10^ or less) are seeded per plate with 4$ (w/v) colony 
stimulating factor derived from human placenta conditioned medium (HPCM) 
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(10,11). Dupl icate c u l t u r e s are i n c u b a t e d a t 37 0C in a ful ly humidified 
atmosphere of 5% COj in a i r for 10-12 days . Cul tures are scored a t 20-40 χ 
magni f icat ion. Aggregates c o n s i s t i n g of 40 and more c e l l s are scored as 
c o l o n i e s , and a g g r e g a t e s of 3-40 c e l l s a s c l u s t e r s . 
Morphological s t u d i e s 
Cel l counts are performed with a Coulter Counter (Model ZF; Coulter 
E l e c t r o n i c s , Hialeah, Fla. , USA). S l ides of t h e f r a c t i o n s obta ined by d e n s i t y 
sed imentat ion and e l u t n a t i o n are made with a c y t o c e n t n f u g e and s t a i n e d 
with May Grünwald- Giemsa. Dif ferent ia l count ing of 400 c e l l s i s ca r r i ed out 
by a s i n g l e i n v e s t i g a t o r (G.B.). 
S t a t i s t i c s 
The Wilcoxon sign rank t e s t 13 used to c a l c u l a t e s t a t i s t i c a l d i f fe rences in 
paired and unpai red o b s e r v a t i o n s . All r e s u l t s a re exp res sed as mean ± one 
SD. 
RESULTS 
I sopycn ic cen t r i fuga t ion in l i n e a r g r a d i e n t s with a dens i ty ranging from 
1.050 to 1.085 g/ml 
Linear g r a d i e n t s with a dens i ty ranging from 1.050 to 1.085 g/ml were 
prepared, and a f t e r cen t r i fuga t ion f r a c t i o n s of 3 ml were c o l l e c t e d as 
descr ibed under 'Methods' . The r e c o v e r i e s of the nuc lea ted c e l l s and the 
myeloid p rogen i to r c e l l s were only 70% ( t ab le I) probably due to entrapment 
of t he se c e l l s by the e ry throcy tes in the p e l l e t . Therefore, f l o t a t i o n 
Nucleated cell 
CFU-GM 
Cluster 
ND - Not determined. 
Flotat 
(n -
gradient 
80.2 ± 1 0 6 
81.9 ± 12.1 
97 6 ± 19.9 
:ion 
13) 
pellet 
6.0 ± 2.9 
1.0 ± 1.2 
1.0 ± 1.5 
Sedimentation 
( η » 
gradient 
71.9 ± 13.0 
69.0 ± 9.8 
86.2 1 8.0 
7) 
pellet 
11.3 ± 5.1 
ND 
ND 
Table I 
Comparison of the recovery (%) after two wash steps in the fractions of linear 
gradients after isopycnic sedimentation and flotation centrifugation ( d • 1 050-
1.059 g/ml ) 
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757f?, 5ml 1.050 
3 5 m l 1085-1050 
l inear gradient 
9ml cellsuspension 
2 ^ Ь Д А 
5 m l H B S S 
5 m l 1 0 5 5 
25ml 1065-1.055 
6ml 1.085-1.065 
9ml cellsuspension 
Fig. 1. Continuous density gradients with sample application under the 
linear gradient in a cell suspension with a density of 1.086-1.085 g/ml. la: 
linear gradient from 1.085 to 1.050 g/ml; lb: shallow linear gradient from 
1.065 to 1.055 g/ml (for detai ls see: "Materials and Methods"). 
1084 1078 1072 1066 1060 105A 1050 
density (g/ml ) 
Fig. 2. Isopycnic centrifugation of normal bone marrow from 6 patients in 
continuous l inear gradients with a density ranging from 1.050 to 1.086 g/ml. 
a-o Recovery of the nucleated (a) and the clonogenic cells (b,c) per 
fraction expressed as percentage of number in the loaded sample, d 
Enrichment of CFU-GM (O———O) and cluster-forming cel ls (О O) per 
fraction. The loaded sample was put at 100Í. 
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centrifugation was tried with cel l suspensions made in Percoli with a 
density equal to the highest density in the l inear gradient, introduced at 
the bottom (fig. la). These flotation experiments resulted in a considerably 
better yield as compared to sedimentation centrifugation, although i t did 
not reach sigmficancy due to the low number of experiments. The loss of 
clonogenic cel ls in the pellet fractions was only minimal. Distribution and 
enrichment of the clonogenic cells in the collected fractions from six 
different bone marrow samples is presented in figure 2. A sharp peak of 
clonogenic cel ls was obtained: the absolute and relative peak of CFU-GM was 
found in the fraction with a density of 1.0615 g/ml. The peak fractions 
contained only 3.5 % of the nucleated cel ls , 41 % of the CFU-GM and 35$ of the 
cluster-forming ce l l s . The relative peak of the cluster-forming cells was 
found in the same fraction, but the absolute peak was shifted to the fraction 
with a density of 1.0645 g/ml. The total number of CFU-GM in the fraction with 
a density of 1.0615 g/ml was s ta t i s t ica l ly higher than the number of clusters 
(p<0.05), although the density of the whole CFU-GM population was not 
s ta t i s t ica l ly different from that of the cluster-forming cel l s . The recovery 
of these cel l s in the peak fraction and the two adjacent fractions is shown 
in table I I . Myeloblasts form the major cel l population in peak fractions. The 
morphological composition of the clonogenic cel l peak fraction is presented 
in table IIIA. 
Peak fraction Peak fraction ± one fraction 
d - 1 064-1 061 g/ml d = 1 067-1 058 g/ml 
Nucleated cell 3.5 t 1 5 10 0 ± 3 6 
CFU-GM 41.1 ± 12 0 81 7 ± 13.7 
Cluster 35.0 ± 8.4 70.6 ±11.1 
Table II. 
Recovery (Z) of nucleated cells and progenitor cells in peak fractions 
obtained from continuous linear gradients (density ranging from 1.085 
to 1.050 g/ml ) ( η - 6 ). 
Isopycnic centrifugation in linear gradients with a density ranging from 
1.055 to 1.065 g/ml 
The majority of the clonogenic cells was found in the fractions with 
densities ranging from 1.055 to 1.065 g/ml (fig. 2b,c). A shallow density 
gradient was developed to determine more exactly the density of the CFU-GM 
and the morphological composition of these fractions. Figure lb gives some 
details of the gradient. A linear gradient of 25 ml with a density from 1.065 
to 1.055 was introduced below 5 ml of a Percoli solution with a density of 
1.055 g/ml. A 6-ml l inear gradient with a density from 1.065 to 1.085 g/ml and 
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Peak BM (A) Peak. BM (B) 
1 2 
fraction fraction 
Myeloblast 
Promyelocyte 
Myelocyte 
Metamyelocyte 
Mature granulocyte 
Lymphocyte 
Monocyte 
Plasma cell 
Normoblast 
CPU-GM 
Cluster 
27.1 
10.9 
12.0 
6.1 
4.7 
13.0 
10.0 
4.4 
11.4 
0.53 
0.58 
± 
+ 
+ 
± 
± 
+ 
± 
± 
± 
± 
± 
6.0 
2.4 
6.0 
2.9 
1 .5 
5.4 
4.5 
1.7 
6.6 
0.21 
0.21 
1.7 
0.7 
5.1 
10.3 
51.7 
8.0 
3.0 
0.6 
18.4 
0.03 
0.05 
+ 
+ 
± 
± 
+ 
+ 
+ 
+ 
± 
± 
+ 
1.0 
1.0 
3.2 
3.3 
7.3 
2.8 
1.3 
0.8 
4.2 
0.01 
0.03 
29.3 
8.3 
9.8 
3.0 
3.8 
8.8 
15.8 
3.8 
17.3 
0.92 
0.86 
± 
± 
± 
± 
± 
± 
± 
+ 
± 
± 
± 
8.4 
5.2 
1.5 
2.2 
2.2 
4.0 
8.5 
1.0 
9.9 
0.43 
0.30 
2.5 
1.5 
6.5 
8.0 
44.3 
13.3 
2.5 
1.0 
20.5 
0.04 
0.05 
± 
± 
± 
± 
± 
+ 
± 
± 
± 
+ 
+ 
0.6 
1.3 
2.5 
1.2 
12.6 
6.8 
1.0 
0.0 
11.4 
0.01 
0.02 
d = 1.064-1.061 g/ml 
2d = 1.062-1.061 g/ml 
Table III. 
Composition of peak fraction obtained by isopycnic centrifugation in gradients with a 
density ranging from 1.085 to 1.050 g/ml ( A; η = 7 ) and from 1.065 to 1.055 g/ml 
( Β; η = 4). 
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cel l эизрепзюп were underlayered аз described under 'Methods'. Fractions 
of 2.5 ml were collected from the linear gradient. The fractions with a 
density of 1.0645 contained the highest number of cluster forming ce l l s . 
The relative peak of CFU-GM was found in the fractions with a density of 
1.0615 g/ml with an enrichment factor of 24.6 ± 7.4. The morphological 
composition of this peak fraction is presented in table III B. The recovery 
Fractions with 
density 1.065-1.057 g/ml 
Nucleated cell 8.7 ± 3.21 
CFU-GM 88.8 ± 3.7 
Cluster 80.3 ± 9.7 
Myeloblast 58.6 ± 17.2 
Promyelocyte 31 3 ± 10.5 
Myelocyte 7.0 ± 3.0 
Metamyelocyte 4 3 ± 1.5 
Mature granulocyte 1.7 ± 1.2 
Lymphocyte 6.3 ± 2.1 
Monocyte 6«.7 ± 19.7 
Normoblast 12.3 ± 8.5 
The recovery of all fractions was put at 100Z. 
Table IV 
Recovery (Z) of different cell types in fractions obtained by 
isopycnic ccntnfugation in linear gradients with a density ranging 
from 1.065 to 1.055 g/ml (n = 3). 
of the different cel l types in the fractions of the shallow gradient which 
contained the clonogemc cells is shown in table IV. The fractions 
underlying the shallow gradient (d i 1.065/ml) contained 84.3 ±8.3Í of the 
nucleated ce l l s , 5.9 ± 5.2% of the CFU-GM and 13.3 ± 12.9$ of the c luster 
forming ce l l s . 
Reduction of the number of lymphocytes by counterflow centrifugation 
followed by density gradient centrifugation 
The interphase fraction from a discontinuous Ficoll-Isopaque gradient with 
a density of 1.085 g/ml was introduced into the counterflow centrifuge as 
described under 'Methods'. Lymphocytes, being the smallest nucleated human 
bone marrow cel ls , leave the separation chamber f irst , followed by small 
normoblasts. The appearance of the normoblasts i s visualized by a dist inct 
peak on the display screen of the scatter unit. In an attempt to eliminate the 
lymphocytes from the progenitor ce l l - r ich fraction, bone marrow was 
separated in two different fractions monitored by the scat ter device. The 
composition of the large-cel l fraction is shown in table V. This fraction 
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Large-cell fraction Peak fraction 
( d = 1.0615 g/ml) 
enrichment 
factor 
% enrichment 
factor 
CFU-GM 
Cluster 
Myeloblast 
Promyelocyte 
Myelocyte 
Metamyelocyte 
Mature granulocyte 
Lymphocyte 
Monocyte 
Normoblast 
Plasma cell 
0.045 ± 0.011 
0.091 ± 0.030 
5.5 ± 1.3 
3.3 ± 2.6 
8.8 ± 5.1 
13.8 ± 5.1 
49.0 ± 2.2 
0.5 ± 1.0 
5.5 ± 2.9 
11.3 ± 7.7 
2.3 ± 1.0 
2.3 ± 0.5 
2.8 ± 1.4 
2.3 ± 0.6 
2.0 ± 1.0 
5.5 ± 3.5 
1.0 ± 0.3 
0.9 ± 0.1 
0.06 ± 0.10 
2.3 ± 0.8 
0.9 ± 0.2 
1.6 ± 0.5 
0.33 ± 0.09 
0.50 ± 0.16 
28.8 ± 7.4 
20.8 ± 7.2 
13.0 ± 4.7 
9.3 ± 5.6 
5.0 ± 3.8 
0.5 ± 1 .0 
12.0 ± 3.9 
4.0 ± 4.2 
6.8 ± 4.3 
17.4 ± 3.6 
17.5 ± 1.6 
11.5 ± 3.9 
15.3 + 4.7 
10.6 ± 6.7 
1.5 ± 0.9 
0.2 ± 0.2 
0.06 ± 0.1 
2.4 ± 0.6 
0.4 ± 0.01 
6.1 + 4.8 
Table V. 
Relative number (%) and enrichment of different cell types in a large cell size fraction 
obtained by counterflow centrifugation, and the fraction with the highest concentration 
of CFU-GM obtained by flotation centrifugation of the large cell size cells ( η = 4 ). 
contained 74.8 $ of the nucleated cel ls , 5,3$ of the lymphocytea, and 94.9$ 
of the CFU-GM. Further purification of the lymphocyte depleted fraction was 
carried out by flotation centnfugation in a continuous linear gradient of 
Percoli with a density ranging from 1.050 to 1.085 g/ml. Fractions of 3 ml 
were collected. The fraction with a density of 1.0615 g/ml was maximally 
enriched (17.5 times) for the myeloid clonogenic ce l l s . Lymphocytes were 
hardly observed (table V). The three fractions with the highest number of 
CFU-GM contained 4.1 ± 0.8$ of the original number of nucleated ce l l s , 59.8 + 
8.4$ of the CFU-GM and 0.2 ± 0.1 $ of the lymphocytes (n = 3). In another set 
of experiments described elsewhere (9) the absolute number of E rose t t e -
positive cel ls in large cell fractions obtained by counterflow c e n t n -
fugation of low density cells (d á 1.070 g/ml) had decreased proportionally 
to the absolute number of lymphocytes, suggesting a nonselective removal of 
T-lymphocytes. 
DISCUSSION 
The main objective of this study to obtain a human bone marrow cell 
population enriched for CFU-GM was achieved by isopycnic centnfugation in 
Percoli gradients. The Percoli solutions were s t r ic t ly maintained at an 
isotonic osmolality of 285 mosm/kg to avoid fluctuations in the density 
sedimentation profiles of the CFU-GM as described by Messner et a l . (12). 
Many investigators subject the bone marrow to a preseparation procedure, 
e.g. hypotonic lysis (13), phagocytosis oif iron (14) or dextran sedi -
mentation (6). These procedures are time-consuming, nonreproducible, and 
responsible for lower recoveries of the myeloid progenitor ce l l s . The 
recovery of the nucleated cells and progenitor cel ls after density 
sedimentation was not satisfactory due to the entrapment of the low-density 
cells in the pellet caused by shear forces exerted by the red cel ls during 
sedimentation. Application of bone marrow cel ls in Percoli solution with a 
density just at the highest density of the gradient at the bottom end 
followed by isopycnic flotation centnfugation improved the cell recovery. 
Only 6$ of the nucleated cells and 1$ of the original number of progenitor 
cel ls was lost in the pellet. An absolute and relat ive peak of the myeloid 
progenitor cel ls was found in the fractions with a density of 1.0615 g/ml. 
The enrichment of the CFU-GM in this peak fraction was 10 times. The colony-
and cluster-forming cel ls appeared to have similar physical properties, 
although a tendency of the cluster-forming cel ls towards a higher density 
was noted. The myeloid progenitor cel ls formed a dist inct narrow band in the 
density gradient as shown in table II: 81.7$ of the CFU-GM were found in the 
fraction which contained only 10$ of the nucleated ce l ls . A shallow density 
gradient in the range of the density of the myeloid progenitor cel l did 
increase the relative number of progenitor cel ls to almost 2$ (table III) and 
the enrichment factor to more than 20. Morphologically, myeloblasts formed 
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the main population of the progenitor cel l-r ich fractions, but lymphocytes 
s t i l l represented an important subpopulation. Graft versus host disease 
(GVHD) is one of the major obstacles in allogeneic bone marrow transplant­
ation (15) in which donor lymphocytes play a pathogenic role (16). 
Separation of lymphocytes from hematopoietic stem cel l s by bovine serum 
albumin gradients has not been very succesful t i l l now (Dicke et al., 17). 
This is in agreement with our results . Lymphocytes are known to be smaller 
than human CFU-GM (18) and murine CFU-GM (19). For this reason we attempted 
to separate the lymphocytes fl-om the CFU-GM by counterflow centnfugation 
(9), and this CFU-GM-rich fraction devoid of lymphocytes was subsequently 
fractioned by isopycmc flotation centnfugation. The peak fraction was 17.5 
times enriched for clonogenic cells, contained almost 1 % of clonogenic 
cel l s (table IV), and was highly enriched for myeloblasts. Only 0.2 % of the 
original number of lymphocytes contaminated the three fractions with the 
highest number of clonogenic cel ls . These findings confirm earlier data (18, 
19) that the committed progenitor cell population is found in a cell fraction 
with a cel l size larger than the lymphocytic fraction. Opsonization of Τ 
lymphocytes in a bone marrow graft by treatment of the bone marrow with an 
anti-pan T-cell antibody (OKT-3) reduced the number of acute GVHD in 
allogeneic bone marrow transplantation (20). Korbling et al. (21, 22) 
succeeded in prevention of GVHD by an albumin density gradient purification 
of canine allogeneic hematopoietic stem cel l s obtained by leukapheresis. 
The transfused CFU-GM-ennched fraction contained 0.2 % of the original 
number of mononuclear ce l l s . Further studies including those on the 
pluripotent progenitor cel ls (CFU-GEMM), T-lymphocyte progenitor cel ls and 
on the different lymphocytic subpopulations are needed. But the results of 
these studies may indicate a new approach to prevent or mitigate GVHD by 
reduction of the to ta l number of lymphocytes in human bone marrow using 
physical separation methods based on counterflow centrifugation and 
isopycmc flotation centrifugation. 
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SUMMARY 
Human bone marrow c e l l s were f r a c t i o n a t e d by p h y s i c a l methods in order to 
obtain cel l fractions enriched for clonogenic cel ls and devoid of immuno­
competent lymphocytes. The bulk of erythrocytes was removed by ізоруспіс 
gradient centnfugation on Ficoll - Isopaque" (d =1.085 g/ml) and the 
majority of mature granulocytes on Percoli (d = 1.070 g/ml). The nucleated 
cel l s were separated into various fractions by means of counterflow 
centnfugation. Continuous monitoring of the effluent of the e l u t n a t o r by a 
light scatter device improved the reproducibility of the separation 
profiles. Progenitor cel l s did not form a single dis t inct peak and the 
maximal enrichment factor was 8.5. Lymphocytes were eliminated almost 
completely from the progenitor cell rich fraction (both CFU-GM and BFU-E). 
Physical elimination of lymphocytes from human bone marrow may offer an 
alternative approach to the prevention of GVHD in allogeneic bone marrow 
transplantation. 
INTRODUCTION 
Human bone marrow c o n s i s t s of a h e t e r o g e n e o u s c e l l - p o p u l a t i o n with a 
v a r i e t y of hematopoie t ic c e l l s at d i f f e r e n t s t a g e s of maturat ion. This 
h e t e r o g e n e i t y i s e s s e n t i a l for normal bone marrow c e l l product ion which i s 
governed to a l a r g e e x t e n t by a number of c e l l t o c e l l i n t e r a c t i o n s . Various 
c e l l s e p a r a t i o n methods have been a p p l i e d in order to obta in more 
homogeneous c e l l f r a c t i o n s ( Ι ^ , Β , Ό , as needed for exper imenta l s t u d i e s 
about f a c t o r s which r e g u l a t e growth and maturat ion of t h e d i f fe rent bone 
marrow c e l l p o p u l a t i o n s . 
This s tudy d e s c r i b e s s e p a r a t i o n p r o f i l e s of t h e myeloid (CFU-GM) and 
ery thro id (BFU-E) colony forming c e l l s as obta ined with an improved 
counterflow c e n t n f u g a t i o n system, in which t h e output of the e l u t n a t o r was 
c o n t i n u o u s l y monitored for c e l l number and l i g h t s c a t t e r . The e l iminat ion of 
t h e immunocompetent c e l l s from t h e p r o g e n i t o r c e l l r i c h f r a c t i o n s was 
a n a l y s e d by Ε-rosette formation, by monoclonal a n t i - T a n t i b o d i e s , and by in 
v i t r o a s s a y s of CFU-GM and BFU-E. 
MATERIALS AND METHODS 
P r e p a r a t i o n of bone marrow c e l l s . 
Normal bone marrow i s c o l l e c t e d in buffered a c i d - c i t r a t e dextrose (pH 7.0). 
Bone marrow p a r t i c l e s are d i s rupted by r e p e a t e d a s p i r a t i o n s through 16 
gauge n e e d l e s and t h e suspens ion i s f i l t e r e d through a nylon f i l t e r (pore-
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size 70 μη). The cel l s are washed in Ca +',"/Mg++-free Hanks'balanced salt 
solution (HBSS) for removal of plasma, fat, and spicules and resuspended in 
HBSS containing 5% (w/v) fetal calf serum (FCS). A number of 150 - 200 χ IO6 
nucleated cel l s in 35 ml suspension is layered on 15 ml Ficoll-Isopaque 
(specific density : 1.085 g/ml; pH 6.6; osmolality : 300 mosmol/kg and 
centrlfuged (500 χ g) at 18° С during 20 minutes for removal of the red ce l l s . 
The nucleated cel l s at the interphase are collected, washed and resuspended 
in 3 - 5 ml FCS. This fraction contains 76 ± 4% of the original nucleated 
cel ls , 49 ± 12$ of the mature myeloid cel ls and 105 ± 21 $ of the CFU-GM (n = 
14). 
Preparation of low density cells (d ¿ 1.070 g/ml) 
Linear Percoli" gradients (35 ml, density range 1.050 - 1.085 g/ml) are 
prepared as described elsewhere (5). After centrifugation (500 χ g; 18° С; 30 
min) the fraction with a density lower than 1.070 g/ml is collected by a 
per i s ta l t ic pump at a rate of 2 ml/min. 
This fraction contains 33 ± 1 $ of the nucleated cel ls , 83 * 8$ of the CFU-GM 
and 5 ± 1% of the mature granulocytes (n=7). 
Counterflow Centrifugation 
Counterflow Centrifugation (CO is performed with a Beekman J2- 21C 
refrigerated centrifuge equipped with a Beekman JE-6 elutr iator rotor with a 
standard separation chamber (Beekman Instruments Inc. Palo Alto, CA, U.S.A.). 
The rotor speed is adjusted exactly by instalment of a finescaled 
speedselector (one scale unit : 2.6 ± 0.15 rpm). A high resolution counter 
(120 HMZ pH 6667 Philips, Eindhoven, The Netherlands) allows an accurate 
rotorspeed control. A constant counterflowrate is obtained by a per i s ta l t ic 
pump (Masterflex-Cole-Parmer Instr. Chicago, 111. USA), connected to a pulse 
flattening air-chamber. The elutriation system is disinfected by overnight 
incubation with 70 % ethanol. HBSS supplemented with 1Í (w/v) heat 
inactivated FCS is used as elutriation medium and maintained at 18° С The 
output of the e lutr iator is continuously sampled by means of a T-drain and 
analyzed for cel l number and light scatter by the electro-optical unit of an 
Hemalog D (Technicon Instr. Corp., Tarrytown, USA). The light scat ter 
signals are accumulated and displayed on a ND-600 multichannel analyser 
(Nuclear Data Ine, Schaumberg, 111. USA) (6). The specimens are introduced at 
a flowrate of 0.3 ml/min by means of an infusor into the elutr iator rotor 
spinning at 2200 rpm and at a counterflowrate of 9 ml/min. Only thrombocytes, 
erythrocytes and small lymphocytes are eluted at th i s rotorspeed and 
counterflow ra te . The rotorspeed is maintained at 2200 rpm throughout the 
whole procedure, while the counterflow rate i s increased stepwise 1-2 ml/min 
whenever the number of elutriated cel ls detected by the electro-optical 
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system falls below 100 cel ls /sec . The collected volumes vary from 50-250 ml 
per fraction. An average of 17 fractions is obtained during each e lu tna t ion 
separation. 
Morhological studies 
Cell counts are performed with a Coulter Counter (Model ZF Coulter 
Electronics, Hialeah, Florida, USA). Slides of the fractions, obtained by 
density sedimentation and elutnat ion, are made with a cytocentnfuge and 
stained with May Grünwald-Giemsa. Differential counting of 200 cel ls is 
carried out by a single investigator (G.B.). 
Granulocyte/macrophage colony forming cel ls (CFU-GM)-a3say. 
All cultures are performed in 2 ml volumes in 35 ml plast ic pe tn dishes 
(Costar). Dulbecco's modified Eagle's medium (Flow) is used with 20$ heat 
inactivated PCS from a preselected batch in 0.3% Bacto-agar (Difco). 
Nucleated cel ls (2 χ 10^ or less) are seeded per plate with 4$ (w/v) colony 
stimulating factor derived from a GCT-cell line (GCT-CSF) (7) or from human 
placenta conditioned medium (HPCM) (8,9). In some experiments the double 
layer agar technique is used with 1 χ 10° mononuclear peripheral blood cells 
from one donor in the feeder layer (10). Duplicate cultures are incubated at 
37° С in a fully humidified atmosphere of 5% CO2 in air for 1 0 - 1 2 days. 
Cultures are scored at 20 - 40 χ magnification. Aggregates consisting of 40 
and more cel l s are scored аз colonies, and aggregates of 3 - 40 cel ls as 
c lusters . 
Erythroid colony forming cel ls (BFU-E)-a3say 
The basic culture technique is adapted from the method of Iscove et al. (11). 
Cell suspensions at a concentration of 0.25 - 1 χ loVml are plated in 
substantially modified Dulbecco's medium prepared from powder (IMDM, Gibco 
formula 78-5220) (12) to which is added 0.8$ methylcellulose (Fluka, 
Schweiz), 10"^ M a-thioglycerol, 10$ deionized bovine serum albumin (13), 
20$ heat inactivated foetal calf serum of a preselected batch (Rehatuin), 
20$ leukocyte conditioned medium (14) and 2 Units sheep erythropoietin/ml 
(Step III, Connaught Med. Res. Lab., Toronto, Ont. Can.). One-tenth mill i l i ters 
of this suspension are placed in flat bottomed microwells (Limbro, Titertex) 
and incubated at 37° С in a fully humidified, 5$ C02-air mixture. Orange to 
red colonies of at least eight cells are scored as CFU-E in four microwells 
on the 7th day of culture. Orange to red bursts of at least three subclusters 
or one single aggregate of more than 300 cel l s are scored аз BFU-E in the 
other four wells on day fourteen of the culture. 
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E - r o s e t t e formation 
The n u c l e a t e d c e l l s of t h e d i f ferent f r a c t i o n s a re Incubated with AET-
t r e a t e d sheep red blood c e l l s (15) in p r e s e n c e of human complement. All 
n u c l e a t e d c e l l s r o s e t t e d by 3 or more red c e l l s are cons idered p o s i t i v e . 
Determination of c e l l s r e a c t i n g with monoclonal a n t i b o d i e s 
Nucleated c e l l s of t h e v a r i o u s bone marrow f r a c t i o n s are a s sayed by means of 
the c o n v e n t i o n a l i n d i r e c t immunofluorescence t e c h n i q u e a f te r a p p l i c a t i o n 
of f l u o r e s c i n a t e d goat ant i-mouse-Ig (Cappel Lab. Cochranvi l le , Penn., 
USA).Mature Τ c e l l s were d e t e c t e d by ant ibody 0KT3; T - c e l l s u b s e t s were 
eva luated by ant ibody 0KT4 and 0KT8 for i n d u c e r / h e l p e r and s u p p r e s -
s o r / c y t o t o x i c a c t i v i t i e s (16,17). The OKT monoclonal a n t i b o d i e s were 
obta ined from Ortho Diagnostics. Addit ional a n a l y s i s i s performed with a 
murine a n t i - T antibody WT1, which r e c o g n i s e s a human pre-T l ineage s p e c i f i c 
a n t i g e n (18). The WT1 monoclonal ant ibody was kindly donated by Dr W. Tax 
(Department of Nephrology, University H o s p i t a l Nijmegen). The p e r c e n t a g e of 
c e l l s binding monoclonal a n t i b o d i e s i s determined by flowcytometry a t a 
wavelength of 488 nm (Cytofluorograf 30, Ortho I n s t r u m e n t s , Westwood, Mass., 
USA). 
RESULTS 
C e l l - s e p a r a t i o n of normal bone marrow c e l l s with use of counterflow 
c e n t n f u g a t i o n 
Contaminating red c e l l s p resent in the bone marrow s u s p e n s i o n were removed 
by g rad ient c e n t n f u g a t i o n on a cushion of 1.085 g/ml F i c o l l - I sopaque . The 
i n t e r p h a s e f r a c t i o n was introduced i n t o t h e e l u t n a t o r centr i fuge and 
s e p a r a t e d with c o n s t a n t monitoring of c e l l s i z e and c e l l number by l i g h t 
s c a t t e r . A t y p i c a l example of the composit ion of the obta ined c e l l f r a c t i o n s 
i s shown in f igure 1. Two minor peaks of n u c l e a t e d c e l l s were observed 
r e p r e s e n t i n g a lymphocyte and a normoblast peak r e s p e c t i v e l y and one major 
peak r e p r e s e n t i n g t h e mature g r a n u l o c y t e s (fig. IE). The CFU-GM formed a 
broad peak (fig. 1 B) and they were found in t h e f r a c t i o n s obta ined a t 
counterflow r a t e s ranging from 14 to 27 ml/rain, corresponding to median 
s i z e d c e l l s . The s e p a r a t i o n prof i le of the c l u s t e r forming c e l l s was almost 
i d e n t i c a l t o t h a t of t h e CFU-GM (not shown). The majority of the e r y t h r o i d 
p r o g e n i t o r c e l l s was recovered in t h e same f r a c t i o n s as t h e myeloid 
progeni tor c e l l s , but t h e BFU-E formed a more d i s t i n c t popula t ion in t h e 
f r a c t i o n s obta ined a t a counterflow r a t e of 14 to 17 ml/min (fig. 1С). The 
recovery of the var ious c e l l types in each f r a c t i o n i s shown in fig. 1 D and 
1E. Most s t r i k i n g was the almost complete s e p a r a t i o n of t h e small 
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Fig. 1 
Counterflow oentrifugation of bone marrow cel l s with a density ¿1.085 g/ml. 
Example of one separation. The number per fraction was expressed as 
percentage of the number in the loaded sample (panel A/E). 
lymphocytes from the committed progenitor ce l l s . The first 2 fractions were 
almost pure lymphocytic (flowrates: 9 and 11 ml/min) followed by two dist inct 
peaks of normoblasts and monocytes. Myeloblasts formed a subpopulation of 
the monocyte-rich fractions (flowrates: 13 to 16 ml/min). The different 
stages of maturation of the myeloid cel ls showed a smooth transition from 
one to the other fraction. 
Table I represents the resul ts of 9 subsequent counterflow oentrifugation 
experiments. A peak fraction is defined as the fraction with the highest 
concentration of the concerning celltype in each separation. The counter-
flow rate of each peak fraction appeared to be remarkably reproducible 
(table I) . The enrichment for CFU-GM and cluster forming cells was only 
modest and the enrichment was maximally 2.5 times. A relative increase of the 
percentages of progenitor cel ls was found in the fractions obtained at 
counterflow rates of 15 and 16 ml/min followed by a peak at 17 ml/min and a 
gradual decline at increasing counterflow rates . This phenomenon is well 
known from velocity sedimentation procedures and i t probably reflects the 
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various oeil cycle stages of the progenitor cells (19). The recovery of the 
nucleated cells was : 96 ± Hf, of the CFU-GM 106 ± 20% and of the cluster 
forming cells: 91 ± 19* (N=6). Reconstitution of all fractions after 
elutriation yielded a recovery of CFU-GM of 107 ± 16 Л (N=3). 
The source of CSF for the cultures of all previous experiments Jas GCT-CSF 
From studies of Boll et al. (20) it is known that different sources of CSF can 
stimulate subpopulations of murine CFU-GM differing in cell size and 
density. Parallel cultures were performed on the fractions obtained from 3 
different CC separations. Three sources of CSF were used : GCT-CSF, HPCM-
CSF and feeders with peripheral blood mononuclear cells. The culture 
profiles for the 3 sources of CSF were almost identical for both colony and 
clusterforming cells except for the tendency of GCT-CSF to stimulate the 
larger sized cells better (fig 2). 
peic*i-4oi loaded мтрІс-(*Л) 
Fig. 2 
Enrichment profiles of CFU-GM and cluster forming cells obtained by 
counterflow centnfugation of 1.085g/ml interphase cells, using 3 different 
sources of CSF: GCT (O O), feeders (A *)
 a n d p i a c e n t a ( # . ) . 
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Peak fraction Celltype Bone marrow Interphase Peak fraction 
Flow rate 
ml/min 
9.3 
14.1 
15.7 
16.1 
16.0 
17.0 
20.2 
22.7 
26.1 
26.1 
+ 
+ 
+ 
± 
± 
± 
± 
± 
± 
± 
** 
4.1 
0.5 
1 .1 
2.9 
0.9 
1.0 
1.1 
0.8 
2.6 
2.9 
Lymphocyte 
Normoblast 
Monocyte 
Myeloblast 
Cluster forming cell 
Colony forming cell 
Mature granulocyte 
Metamyelocyte 
Promyelocyte 
Myelocyte 
cone. 
% 
8.6 
17.4 
3.5 
1.4 
0.029 
0.029 
49.4 
10.4 
0.9 
6.4 
+ 
± 
± 
± 
± 
± 
± 
± 
± 
± 
3.5 
7.2 
1.3 
0.5 
0.014 
0.011 
7.3 
2.4 
0.5 
3.8 
cone. 
% 
13.2 
14.7 
5.9 
3.4 
0.037 
0.040 
41.6 
10.1 
2.3 
3.4 
± 
+ 
± 
+ 
+ 
+ 
+ 
+ 
± 
± 
4.5 
6.1 
2.0 
1.6 
0.010 
0.007 
4.9 
3.0 
1.5 
1.6 
cone. 
% 
93.9 
50.6 
30.8 
13.6 
0.089 
0.089 
65.4 
24.7 
13.7 
13.6 
+ 
± 
± 
± 
+ 
± 
± 
± 
± 
± 
4.1 
16.7 
11.9 
16.4 
0.049 
0.023 
5.1 
6.5 
6.3 
6.4 
enric hment 
factor 
11.9 
3.3 
8.8 
13.2 
3.1 
3.1 
1.4 
2.5 
16.9 
5.8 
± 3.4 
± 1.2 
± 3.6 
± 7.8 
± 0.7 
± 0.9 
± 0.2 
± 0.7 
± 6.3 
± 3.1 
* 
Peak fraction was defined as the fraction with the highest concentration of the concerning celltype. 
** 
Mean ± standard deviation. 
Table I. 
Concentration and enrichment of different celltypes in the peak fractions, obtained by counterflow 
centrifugation ( η = 9 ) of interphase cells ( d i 1.085 g/ml ). 
Peak, fraction Celltype Bone marrow 
Flow rate 
ml/min 
Low density 
cells 
Peak fraction 
7.3 
20.5 
3.5 
± 3.0 
± 1.7 
± 1.0 
10.6 ± 0.9 Lymphocyte 
14.8 ± 0.8 Normoblast 
16.0 ± 1.6 Monocyte 
19.8 ± 2.0 Colony forming cell 0.032 ± 0.011 
20.4 ± 1.5 Cluster forming cell 0.036 ± 0.013 
20.6 ± 1.5 Myeloblast 1.5 ±1.0 
21.2 ± 1.3 Mature granulocyte 54.0 ± 2.7 
24.4 ± 1.9 Metamyelocyte 7.5 ± 4.2 
27.4 ± 1.9 Promyelocyte 1.0 ± 0.5 
27.8 ± 2.3 Myelocyte 3.5 ± 1.3 
33.8 ± 14.8 
24.5 ± 8.2 
7.8 ± 2.2 
0.105 ± 0.041 
0.086 ± 0.043 
6.3 ± 2.0 
8.8 ± 3.8 
4.0 ± 1.4 
3.5 ± 1.3 
7.5 ± 1.7 
cone. 
% 
92.5 
48.5 
28.3 
0.263 
0.221 
15.3 
34.5 
17.8 
17.0 
40.8 
± 
± 
± 
+ 
± 
+ 
± 
± 
± 
± 
4.8 
8.7 
7.3 
0.076 
0.078 
5.2 
6.8 
6.2 
6.5 
12.9 
enrichment 
16.7 
2.4 
8.6 
8.5 
5.9 
11 .4 
0.7 
3.5 
17.0 
11 .4 
± 6.5 
± 0.9 
± 3.3 
± 1.5 
± 2.3 
± 2.5 
± 0.1 
± 1.7 
± 6.5 
± 2.5 
Mean ± standard deviation 
Table II. 
Concentration and enrichment of different celltypes in the peak fraction, obtained by counterflow 
centrifugation ( η = 6 ) of low density cells ( d s 1.070 g/ml ). 
Elutriation of low density bone marrow cel ls (d < 1.070 g/ml) 
The small size of the separation chamber in the elutr iator rotor limits the 
number of cel l s to be separated. To reduce the number of contaminating 
mature granulocytes bone marrow was separated in a continuous gradient, and 
the low density fraction (d s 1.070 g/ml) was collected. The elutriat ion 
profile of the progenitor cel ls in this fraction (fig. 3) was similar to that of 
4 "I 
c h m e n l factor 
d< 1070 g / m l 
L/ 
·/. 
100 
"rAi 
^ Н mature myeloid cells 
[ | immature myeloid cells 
| I normoblasts 
^^^^^^^^^^^я^^^^^^ 
9 -4 13 ""Л 15 16 "7 1θ 19 20 21 22 23 25 27 R 
f lowrate ( m l / m m ) 
Fig. ЗА 
Enrichment of CFU-GM ( · — · ) and cluster forming cel ls (О—O) in fractions 
obtained by counterflow centrifugation of light density cells (d < 1.070 
g/ml). 
Fig. 3B 
Normoblasts: all nucleated red cells; immature myeloid cells: myeloblasts + 
promyelocytes + myelocytes; mature myeloid cells: segmented, band forms and 
metamyelocytes. The loaded sample was put at 100Í. 
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the 1.085 g/ml interphase cells, but an additional increase of CFU-GM could 
be observed in the fractions obtained at flowrates ranging from 19 to 25 
ml/min due to a select ive removal of the mature granulocytes by density 
centrifugation. Table II presents the resul ts of 6 separations. The sequence 
of the peak fractions of the different cel l types has not changed apart from 
a shift of the myeloblast peak fraction from 16 to 21 ml/min. The enrichment 
factor for the CFU-GM obtained from the low density fraction has increased 
to 8.5 compared to^1 in the peak fraction obtained from bone marrow cel ls with 
a density s 1.085 g/ml. 
In an attempt to eliminate the lymphocytes from the progenitor cel l rich 
fraction, light density bone marrrow cel l s were separated in 2 different 
fractions monitored by a scatter device. A very dist inct lymphocyte peak was 
always observed. The appearance of a shoulder in the scatterhistogram 
indicated elutriation of the first normoblasts (fig. U). As soon as such a 
• 1 1 I • 
0 600 
channel number 
scatter (size) 
Fig. 4 
Scatterhistograms of fractions obtained by counterflow centrifugation. 
Fractions 9 and 11 showed one single peak of lymphocytes. An additional 
peak (arrow) in fraction 13 visualized the appearance of normoblasts. 
Fraction > 13 contained the remaining ce l l s (large cel l fraction). 
shoulder became visible on the display screen, the counterflow rate was not 
increased further until the number of ce l l s in the effluent had fallen below 
100 ce l l s / sec . The obtained fractions were pooled and designated small size 
fraction containing: 95.1? of the lymphocytes, 3.0$ of the CFU-GM, and 5.4% 
of the BFU-E (table III) . The large cel l fraction contained 53.2$ of the 
nucleated cel ls from the loaded sample, 90.0$ of the CFU-GM and 98.6$of the 
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Small cell Large cell 
fraction fraction 
All nucleated cells 37.3 ± 6.9* 53.2 ± 5.5 
Lymphocytes 95.1 ± 13.9 6.6 ± 3.1 
Normoblasts 10.7 ± 3.2 105.0 ± 15.6 
Myeloblasts 4.9 ± 4.3 85.1 + 9.6 
CFU-GM 3.0 ± 2.1 90.0 ± 15.6 
Cluster forming cells 3.6 ± 2.6 88.0 ±11.2 
BFU-E 5.4 ± 8.0 98.6 ± 14.3 
CFU-E 2.0 + 2.2 94.5 ± 22.4 
E rosette pos.cells 88.0 ± 22.0 4.8 ± 4.0 
Mean % ± standard deviation of loaded sample 
Table III. 
Recovery of nucleated cells and different celltypes in the small cell 
fraction ( flowrate ranging from 7 to 10-12 ml/min ) and the large 
cell fraction ( flowrate > 10-12 ml/min ) as monitored by scatter 
signal during elutriation of low density bone marrow cells ( d i 
1.070 g/ml)( η = 6 ). 
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Monoclonal antibodies WT-1 OKT-3 OKT-4 OKT-8 
Low density cells 7.0 ± 0.3* 20.4 + 4.7 13.8 ± 4.8 8.3 ± 1.6 
Small cell fraction 30.3 ± 3.2 53.6 ± 8.2 33.2 ± 6.8 22.8 ± 6.1 
Large cell fraction 2.2 ± 1.2 3.2 ± 1.4 0.8 ± 0.7 2.4 ± 1.2 
* 
Mean % ± standard deviation 
Table IV. 
Determination of the number of ргае-Т-lymphocytcs (WT-1), mature T-lymphocytes 
(0KT-3), T-helper c e l l s (OKT-4) and T-suppressor c e l l s (OKT-8) i n t h e low d e n s i t y 
f r a c t i o n ( d Ì 1.070 g/ml ) and the "lymphocytic" and "progeni to r r i c h " f r ac t ion 
obtained by counterflow cen t r i fuga t ion ( η = 4 ) . 
BFU-E. The contaminat ion of t h i s p r o g e n i t o r c e l l r i c h f r a c t i o n with AET 
t r e a t e d E - r o a e t t e p o s i t i v e c e l l s was 4.8 %. The v i a b i l i t y of the p r o g e n i t o r 
c e l l s was not compromised, as demonstrated by the complete recovery of BFU-
E and CFU-GM ( t a b l e I I I ) . 
Determination of t h e p r e s e n c e of sur face a n t i g e n s for monoclonal T-
a n t i b o d i e s was performed to confirm and extend the data on T-lymphocytes 
and T - c e l l s u b s e t s in t h e s e f r a c t i o n s . Table IV shows the d i s t r i b u t i o n of t h e 
sur face a n t i g e n p o s i t i v e c e l l s in the low d e n s i t y f r a c t i o n : WT1 (7.0 ± 0.3%), 
0KT3+ (20.4 ± 4 . 7 Ϊ ) , 0KT4 (13.8 ± 4.8$) and 0KT8+ (8.3 ± 1.6%). The 
percentage p o s i t i v e c e l l s in the lymphocyte r i c h f r a c t i o n was: WT1 (30.3 ± 
3.2%), 0KT3 (53.6 ± 8.2$), 0KT4 (33.2 ± 6.8$) and 0KT8 (22.8 ± 6 . 1 $ ) . 
Monoclonal ant ibody binding in t h e p r o g e n i t o r c e l l r i c h f r a c t i o n was only 
minimal ( t a b l e IV. 
DISCUSSION 
Counterflow c e n t r i f u g a t i o n provides a r a p i d and r e p r o d u c i b l e s e p a r a t i o n 
technique mainly based on d i f fe rences in c e l l - s i z e (21,22). S e v e r a l 
a d a p t a t i o n s were n e c e s s a r y to improve t h e s t a b i l i t y of the r o t o r s p e e d and 
the f lowrate ( see Mater ia l s and Methods). An e s s e n t i a l improvement was t h e 
connect ion of a s c a t t e r dev ice to the e f f luent of the e l u t r i a t o r by means of a 
T-drain. Constant monitoring of c e l l s c a t t e r and c e l l number in the e f f luent 
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improved the reproducibility and enrichment factors of the different 
cellpopulationa in peak fractions (see table I and II) . Pretreatment of the 
marrow cells by a discontinuous gradient (Ficoll-Isopaque) with a density of 
I.O85 g/ml was found to be necessary for removal of erythrocytes. The 
complete recovery of the progenitor cel ls proved that the viability of the 
myeloid precursor ce l l s was not compromised during the density sedi­
mentation and counterflow centrifugation procedures. Counterflow oentri-
fugation did not result in a single dist inct peak highly enriched for CFU-GM. 
This might not be expected, as each cell population shows an increase in 
cel l size as i t passes through its reproductive cycle (23). 
It appeared feasible to separate the lymphocytes almost completely from the 
committed progenitor ce l l s . This 13 in agreement with the velocity 
sedimentation studies of Wells et al. (4). Further analysis of the obtained 
fractions for the presence of surface receptors for AET-treated sheep 
erythrocytes and monoclonal anti-T antibodies confirmed that the progenitor 
cel l rich fraction was almost completely devoid of T-lymphocytes, both the 
suppressor and the helper subset. A recent study of Inoue et al. (24) on CFU-
S in murine bone marrow fractions obtained by counterflow centrifugation 
showed that the average volume of cells in the peak fraction of murine CFU-S 
was 175 ym3f whereas the average volume of murine lymphocytes was 100 μπΗ. 
The human pluripotent hematopoietic progenitor cel ls (CFU-GEMM) (25) are 
expected to be present in fractions rich in small CFU-GM and BFU-E. If th i s 
i s true, one may use counterflow centrifugation for the elimination of T-
lymphocytes from donor bone marrow in an attempt to prevent or mitigate GVHD 
in allogeneic marrow transplantation. 
In conclusion: these studies show that counterflow centrifugation provides 
a rapid and simple method for separation of human bone marrow cells with 
excellent recovery and viability. The separation is mainly based on cel l 
size and therefore each celltype is separated depending on i t s cellcycle 
phase. Enrichment of CFU-GM and BFU-E was modest, but elimination of 
lymphocytes from the committed myeloid and erythroid progenitor cells was 
almost complete. 
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CELL CYCLE SPECIFIC SEPARATION OF HUMAN BONE MARROW CELLS BY COUNTERFLOW 
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SUMMARY 
Human bone marrow was f r a c t i o n a t e d by counterflow o e n t r i f u g a t i o n in 16 
f r a c t i o n s with i n c r e a s i n g c e l l s i z e . Three d i s t i n c t s u b p o p u l a t i o n s could be 
r e c o g n i z e d : small lymphocytic c e l l s , medium-sized n u c l e a t e d red c e l l s and 
l a r g e myeloid e lements . DNA-flowcytometry, Зн-thymidine uptake and in v i t r o 
c e l l c u l t u r e s showed t h a t within the e r y t h r o i d and myeloid c e l l f r a c t i o n s 
counterflow o e n t r i f u g a t i o n s e p a r a t e s the c e l l p o p u l a t i o n s according to t h e 
c e l l cyc le p h a s e . Hypotonic t reatment of bone marrow r e s u l t e d in a complete 
abrogat ion of t h e p r o l i f e r a t i n g erythroid c e l l s . I t appeared f e a s i b l e t o 
s e p a r a t e t h e small lymphocytic c e l l s from t h e majority of BFU-E and CFU-GM, 
due to t h e l a r g e r s i z e of the p r o l i f e r a t i n g normoblasts and committed 
p r o g e n i t o r c e l l s in comparison to the small lymphocytic c e l l s . 
INTRODUCTION 
Human bone marrow c o n s i s t s of a var ie ty of hematopoie t ic c e l l p o p u l a t i o n s a t 
d i f ferent s t a g e s of maturat ion and c e l l c y c l e p h a s e . 
In v i t r o a n a l y s i s of the hematopoiet ic c e l l growth r e g u l a t i o n , the p e r t u r -
bance of hematopoie t ic c e l l s by c y t o s t a t i c a g e n t s and the s e p a r a t i o n of 
immunocompetent c e l l s from t h e hematopoiet ic stem c e l l s (HSC) r e q u i r e s 
s e p a r a t i o n t e c h n i q u e s with minimal manipulat ion and optimal surv iva l of t h e 
hematopoiet ic s t e m c e l l s . 
Counterflow o e n t r i f u g a t i o n (CC) offers a rap id and g e n t l e method with 
obvious a d v a n t a g e s t o o t h e r s e p a r a t i o n p r o c e d u r e s l i k e v e l o c i t y s e d i ­
mentat ion and r a t e zona l oent r i fuga t ion (1,2,3,1). Continuous monitoring of 
t h e output of the e l u t n a t o r - r o t o r for c e l l number and l i g h t s c a t t e r (5) made 
t h i s s e p a r a t i o n method s e n s i t i v e and r e p r o d u c i b l e . 
This paper r e p o r t s the data from c e l l f r a c t i o n s o b t a i n e d by counterflow 
o e n t r i f u g a t i o n of bone marrow, analysed for morphology, the p r e s e n c e of 
myeloid and e r y t h r o i d p r o g e n i t o r c e l l s and t h e c e l l cyc le s t a g e s . At tent ion 
i s drawn t o t h e e x i s t e n c e of 2 d i s t i n c t p r o l i f e r a t i n g p o p u l a t i o n s r e ­
p r e s e n t i n g t h e n u c l e a t e d red c e l l s and myeloid c e l l s . 
P h y s i c a l s e p a r a t i o n of the lymphocytic c e l l s from the HSC appeared almost 
complete, which may offer an approach to p r e v e n t i o n of graft v e r s u s hos t 
d i s e a s e (GVHD) in a l l o g e n e i c bone marrow t r a n s p l a n t a t i o n (BMT). 
A rap id de terminat ion of t h e percentage S-phase c e l l s by DNA- flow 
cytometry f a c i l i t a t e s the d i sc r iminat ion of t h e lymphocyte r i c h f r a c t i o n s 
from t h e o t h e r c e l l f r a c t i o n s , as obta ined by counterflow o e n t r i f u g a t i o n . 
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MATERIALS AND METHODS 
Preparat ion of bone marrow c e l l s 
Normal bone marrow from p a t i e n t s undergoing c a r d i a c surgery i s c o l l e c t e d in 
buffered a c i d - c i t r a t e d e x t r o s e (pH 7.0). Bone marrow p a r t i c l e s are d i s r u p t e d 
by r e p e a t e d a s p i r a t i o n s through 16 gauge n e e d l e s and t h e s u s p e n s i o n i s 
f i l t e r e d through a nylon f i l t e r ( p o r e - s i z e 70 цт) . 
The c e l l s are washed in Ca/Mg-free Hanks' ba lanced s a l t s o l u t i o n (HBSS) for 
removal of plasma and fat and then resuspended in HBSS c o n t a i n i n g 5 % (w/v) 
f o e t a l c a l f serum (FCS). 
Discont inuous d e n s i t y sed imentat ion 
A number of 150 - 200 χ 10° n u c l e a t e d c e l l s in 35 ml s u s p e n s i o n i s layered on 
15 ml F i c o l l - I s o p a q u e ( s p e c i f i c d e n s i t y : 1.085 g/ml; pH : 6.6; osmolal i ty : 
300 mosm/kg) and c e n t n f u g e d at 500 g and 18° С for 20 minutes to remove t h e 
red c e l l s . The n u c l e a t e d c e l l s a t the i n t e r p h a s e are c o l l e c t e d , washed and 
r e s u s p e n d e d in 3 - 5 ml FCS. 
Light d e n s i t y c e l l s (g < 1.070 g/ml) are o b t a i n e d from l i n e a r g r a d i e n t s of 
Percol i with a d e n s i t y ranging from 1.050 - 1.085 g/ml as d e s c r i b e d before 
(6). 
Counterflow Centr i fugat ion 
Counterflow Centr i fugat ion (CC) i s performed with a Beekman J2 -21C 
r e f r i g e r a t e d c e n t r i f u g e equipped with a JE-6 e l u t r i a t i o n r o t o r and a 
s tandard s e p a r a t i o n chamber (Beekman Ins t ruments I n c . Palo Alto, Cal i f . ) . A 
c o n s t a n t counterflow r a t e i s obta ined by a p e r i s t a l t i c pump (Masterf lex-
Cole-Parmer I n s t r . Chicago, 111. USA), connected t o a p u l s e f l a t t e n i n g a i r -
chamber. The e l u t r i a t i o n system i s d i s i n f e c t e d by o v e r n i g h t i n c u b a t i o n with 
70 % e t h a n o l . HBSS supplemented with 1 % (w/v) h e a t - i n a c t i v a t e d FCS, 
maintained a t 18° C, i s used as e l u t r i a t i o n medium. The output of t h e 
e l u t r i a t o r i s c o n t i n u o u s l y sampled by means of a T-drain and analyzed for 
c e l l number and l i g h t s c a t t e r by the e l e c t r o - o p t i c a l u n i t of an Hemalog-D 
(Techmcon I n s t r . Corp., Tarrytown, USA). A specimen c o n t a i n i n g 100 χ 10° 
n u c l e a t e d c e l l s i s i n t r o d u c e d in to the e l u t r i a t o r r o t o r sp inning a t 2200 rpm, 
a t a counterf lowrate of 9 ml/min, by means of an in fusor (0.3 ml/mm). Only 
thrombocytes, e r y t h r o c y t e s and small lymphocytes are e l u t e d a t t h i s flow 
r a t e . The r o t o r s p e e d i s maintained at 2200 rpm throughout t h e procedure and 
the counterflow r a t e i s i n c r e a s e d s tepwise 1-2 ml/min whenever the number of 
e l u t r i a t e d c e l l s , as d e t e c t e d by the e l e c t r o - o p t i c a l system, f a l l s below 100 
c e l l s / s e c . Cel l c o u n t s of t h e d i f fe rent f r a c t i o n s a re performed with a 
Coulter Counter (Model ZF Coulter E l e c t r o n i c s , Hialeah, F lor ida , USA). 
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Morphological studies 
Cytocentnfuge preparations of the fractions obtained by density sedi-
mentation and elutriation are stained with May Grünwald-Giemaa. Differential 
counting of 200 ce l l s i s carried out by a single investigator (G.B.). 
Granulocyte/macrophage colony forming cel ls (CFU-GM) assay. 
All cultures are performed in 2 ml volumes in 35 mm plastic petri dishes 
(Costar). Dulbecco's modified eagle's medium (Flow Laboratories) is used 
with 20 % heat inactivated PCS from a preselected batch in 0.3 % Bacto-agar 
(Difco). Nucleated cells (2 χ ІО^ or less) are seeded per plate with 4 % (w/v) 
colony stimulating factor derived from human placenta conditioned medium in 
the presence of endotoxin (7). Duplicate cultures are incubated at 37° С in a 
fully humidified atmosphere of 5 % CO2 in air for 10 - 12 days. Aggregates 
consisting of 40 and more cells are scored as colonies and aggregates of 3-
40 cel l s as c lusters . 
Erythroid colony forming cel l s (BFU-E) assay 
The basic culture technique is adapted from the method of Iscove et al (8). 
The cel l suspensions at a concentration of 0.25 - 1 χ lO'/ml are plated in a 
substantially modified Dulbecco's Medium prepared from powder (IMDM, Gibco, 
formula 78 - 5220) (9) to which is added 0.8 % Methylcellulose (Flulca, 
Schweiz), 10"^ M α-thioglycerol, 10 % deionized bovine serum albumin (10), 
20 % heat inactivated FCS of a preselected batch (Rehatuin), 20 % leucocyte 
conditioned medium (11) and 2 units sheep erythropoetin/ml (Step III, 
Connaught Medical Research Laboratories). One-tenth mill i l i ters of this 
suspension are placed in flat bottomed microwells (Limbro, Titertex) and 
incubated at 37° С in a fully humidified, 5 % СОз-аіг mixture. Orange-to-red 
colonies of at least eight cells are scored as CFU-E in four microwells on 
the 7th day of culture. Orange-to-red bursts of at least three subclusters or 
single colonies of more than 300 cells are scored in four other wells on day 
fourteen of the culture. 
DNA-flowcytometry 
The nuclear DNA content of the cells is stained according to Krishan (12) by 
adding 0.5 χ 10" cel ls to 10 ml hypotonic ethidium bromide (0.1 % tnsodium 
ci t rate 25 mg/1 ethidium bromide). The relative fluorescence of about 10^ 
cel l s i s measured with an ICP-11 Pulse Cytophotometer (Phywé, Göttingen, 
West Germany) at a flowrate of 400 ce l l s / sec . 
The percentages of cel ls in different phases of the cell cycle are 
calculated according to Baish (13). 
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Hypotonie shock 
I n t e r p h a s e c e l l s o b t a i n e d from d i s c o n t i n u o u s d e n s i t y c e n t n f u g a t i o n are 
exposed to water for 15 seconds a t 0° С (14). I s o t o m c i t y i s r e s t o r e d with 
double s t r e n g t h I s c o v e DMEM. 
Determination of 3H-thymidine i n c o r p o r a t i o n 
Bone marrow samples are d i lu ted in Medium 199 (Flow l a b o r a t o r i e s ) buffered 
with 10 mM Tris (pH 7.4) and supplemented with 10 $ h e a t i n a c t i v a t e d f e t a l 
ca l f serum (Flow L a b o r a t o r i e s ) to a f i n a l c e l l c o n c e n t r a t i o n of 10° 
n u c l e a t e d c e l l s per ml. Four a l i q u o t s of 1 ml are i n c u b a t e d with 2 vCi ' н -
thymidine ( s p e c i f i c a c t i v i t y 5 Ci/mmol) for 60 mm at 37° С The i n c u b a t i o n 
i s s topped by a d d i t i o n of 2 ml i c e - c o l d medium with an e x c e s s of u n l a b e l e d 
thymidine. The c e l l s are c o l l e c t e d on g l a s s f ibre f i l t e r s ( S c h l e i c h e r and 
Schuil no. 9), washed and lysed with water, and p r e c i p i t a t e d with 1 M 
p e r c h l o r i c ac id (16). The t o t a l amount of r a d i o - a c t i v i t y in t h e p e r c h l o r i c 
acid p r e c i p i t a t e d f r a c t i o n i s counted in a l iqu id s c i n t i l l a t i o n c o u n t e r (LKB 
81000) with a count ing ef f ic iency of about 50 %. 
RESULTS 
Counterflow c e n t n f u g a t i o n of normal bone marrow c e l l s with a d e n s i t y 
< 1.085 g/ral 
The i n t e r p h a s e f r a c t i o n s with a dens i ty <1.085 g/ml were in t roduced i n t o 
t h e e l u t n a t o r r o t o r and the p r o l i f e r a t i o n p a t t e r n s of a l l c o l l e c t e d 
f r a c t i o n s were measured with DNA-flow cytometry in 5 d i f fe rent experiments 
(fig. 1A). Two s u b s e q u e n t peaks of S-phase c e l l s were observed in t h e 
f r a c t i o n s c o l l e c t e d a t counterflow r a t e s of r e s p e c t i v e l y 16 ml/min and 27 
ml/min. Each S-phase was followed by an a d d i t i o n a l peak of Gj + M c e l l s 
obtained a t a counterflow r a t e of 18 ml/min and 27 ml/min. The f i r s t peak of 
p r o l i f e r a t i n g c e l l s c o n s i s t e d mainly of n u c l e a t e d ery thro id c e l l s whi l s t t h e 
second peak c o n t a i n e d t h e immature myeloid c e l l s (fig. 1B). In two a d d i t i o n a l 
experiments t h e p r o l i f e r a t i o n p a t t e r n s as measured with DNA-flowcytometry 
were compared with Зн-thymidine- incorpora t ion (fig. 2) . No obvious d i s ­
c r e p a n c i e s were observed. 
Hypotonic l y s i s in d i s t i l l e d water for 15 s e c o n d s r e s u l t e d in t h e removal of 
the n u c l e a t e d e r y t h r o i d c e l l s from the 1.085 g/ml i n t e r p h a s e f r a c t i o n . A 
r e l a t i v e l y high proport ion of the immature e r y t h r o i d c e l l s p o s s e s s e s 
obvious p r o l i f e r a t i v e a c t i v i t y as hypotonic t rea tment caused a d e c r e a s e of 
t h e S - p h a s e from 13.1 ± 1.6 % to 9.3 ± 1.1 % and of the G 2 M - P h a 3 e from 4.0 ± 
1.1 t o 2.3 ± 0.6 % (n=5). The r e s u l t s of counterflow c e n t n f u g a t i o n of t h e s e 5 
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L_J LYMPHOCYTES 
^Ш NORMOBLAST 
SB IMMATURE MYELOCYTE 
{ ^ MATURE MYELOCYTE 
f i g . 1 
Counterflow c e n t r i f u g a t l o n of bone marrow c e l l s with a dens i ty S 1.085 g/ml 
(n=5). Comparison of DNA-flowcytometry (panel A) with morphology. Panel A: 
4n DNA: G2 + M-phase-cel l s ; 2n<DNA< 4n: S-phase c e l l s (expressed as 
p e r c e n t a g e per f r a c t i o n ) . Panel B: each bar r e p r e s e n t s mean d i f f e r e n t i a l 
c o u n t s of a f r a c t i o n with the four most important p o p u l a t i o n s dep ic ted . The 
remaining par t of a bar i s composed of mainly monocytes, p la smace l l s and 
megakaryocytes . 
bone marrow samples, exposed to hypotonic l y s i s , are shown in f igure 3. No 
p r o l i f e r a t i v e a c t i v i t y was measured in the f r a c t i o n s with counter f lowrates 
ranging from 11 to 18 ml/min due to removal of the n u c l e a t e d red c e l l s . The 
s i n g l e peak of p r o l i f e r a t i n g c e l l s coincided with the f r a c t i o n s enr iched for 
immature myeloid c e l l s . In v i t r o a s s a y s of the myeloid erythroid progeni tor 
c e l l s were performed in a l l f r a c t i o n s obta ined from CC. A t y p i c a l example i s 
shown in fig. 4. CFU-E and CFU-GM (scored a t day 7 of c u l t u r e ) e x h i b i t e d a 
peak in f r a c t i o n 19 and 21, but t h e peak of BFU-E and CFU-GM (scored a t day 
6 
S-phMe эН-ТИуітМІпе Incorporation 
% ( 0 — О ) (#—·)χιοοοορηνκί<Μ(Ι 
О 11 13 14 15 16 17 18 19 20 21 22 23 25 27 Ρ 
flow ml min 
f i g . 2 
Comparison of the measurement of t h e p e r c e n t a g e S-phase c e l l s by DNA-
flowcytometry and ^H-thymidine uptake of bone marrow c e l l s with a d e n s i t y 
1085 g/ml s e p a r a t e d by CC. (Example of one s e p a r a t i o n ) . 
f i g . 3 
Counterflow c e n t r i f u g a t i o n of bone marrow c e l l s with d e n s i t y ί 1.085 g/ml 
t r e a t e d with hypotonic l y s i s (n=5). For e x p l a n a t i o n of symbols see f ig. 1. 
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14 of culture) appeared in the fraction obtained at a flowrate of 13 ml/rain. 
This finding was very reproducible as shown by the results from 5 different 
experiments in table I. An almost complete separation of the lymphocytes and 
progenitor cel l s was observed (fig. kc). 
peak f r a c t i o n (ml/mln) 
day 7 day 14 
CFU-GM 
CFU-E/BFU-E 
21.2 ± I .0 
19.5 ± 3.4 
14.8 ± 2.0 
13.5 ± 2.5 
Table I. 
Influence of in vitro culture tune on the clutnation profile of 
myeloid and erythroid progenitor cells as measured by comparison 
of the fractions with the highest number of progenitor cells 
( peak fraction ) obtained from 5 different experiments ( mean ± 
SD ). 
О О CFU-GM к days 
• — · CFU-GM 7 days 
O O BFU-E 14 days 
· — · CFU-E 7da»s 
nucleated cells 
llowrate ml/mm 
fig. 4 
Profiles of myeloid (Panel A) and erythroid (Panel B) colony forming cells in 
day 7 (· ·) and day 14 (О O) cultures. 
The number of colony forming cells in each fraction is normalised to the peak 
value (100Ï) and expressed as percent per ml/min. 
The nucleated cell profile (panel C) shows the percent recovery of the 
loaded sample expressed as percent per ml/min. 
Counterflow centrifugation of low density bone marrow cel ls (d Í 1.070 
g/ml). 
The small size of the separation chamber in the elutriator limits the number 
of cells to be separated. To reduce the number of mature nucleated cel ls the 
bone marrow was separated in a continuous density gradient. The low density 
fraction (d < 1.070 g/ml) contained 25.4 ±5.3 % of the nucleated cel ls , 3.2 
± 2.7 % of the mature granulocytes and more than 90 % of the myeloid and 
erythroid progenitor cel ls (n=5). 
The percentage S-phase cells increased from 13.0 + З.1* % in the original 
sample to 20.6 ±1.1 Î in the low density fraction. Removal of the majority of 
the mature non-proliferating myeloid cel ls resulted in a disappearence of 
the dip between the two peaks of proliferating cellpopulations (fig. 5). 
9 11 13 M 15 te П 18 19 20 21 2 2 23 25 27 
FLOWRATE ML/MIN 
fig. 5 
Counterflow centrifugation of low density bone marrow cel ls (d Í 1.070 
g/ml). (n = 5). For explanations of symbols see fig. 1. 
I t was also noticed that appearance of the progenitor cel ls in the effluent 
of the elutriator coincided with a r ise in the percentage of S-phase ce l l s 
due to appearance of the first proliferating normoblasts. In an attempt to 
separate the small lymphocytes from the hematopoetic stemcells 875 x 10° 
low density cells from a healthy bone marrow donor were introduced into the 
elutriator at a low counterflow rate of 5.5 ml/min (table II) . From each 
fraction a sample was taken and analysed by FCM. A first increase of the 
percentage of S-phase cells was noted in the fraction obtained at 
counterflow rates of 10.5 ml/ min and a sharp increase in the fraction at a 
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Fraction 
ml/rain 
Lymphocytes 
Ζ 
Normoblasts 
% 
S-phasc-cells 
Ζ 
5.5 
6.5 
7 
β 
8.5 
9 
9.5 
10 
10.5 
11 
11.5 
12 
> 12 
loaded sample 
57 
99 
100 
100 
99 
95 
95 
90 
67 
27 
14 
12 
5 
40 
7 
1 
-
-
1 
3 
2 
3 
13 
31 
48 
42 
18 
15 
4.3 
3.5 
1 .1 
0.8 
1.0 
1.0 
1.0 
1.4 
2.4 
2.9 
6.3 
10.4 
18.5 
10.9 
Table II. 
Counterflow centrifugation of the low density cells ( d ' 1.070 
g/ml ) with small increments of flowrate. Relation of number of 
S-phase-cells with number of lymphocytes and nonnoblasts. 
Fraction 
ml/min 
Lymphocytes AET-pos. 
cells 
χ 106 
χ 10 10 
CFU-GM BFU-E 
χ 10 χ 10 
Loaded 
sample 
5.5 
6-10.5 
11 
> 11 
875 
63 
394 
40 
380 
350 
36 
366 
11 
19 
280 
26 
201 
16 
7 
55.3 
0 
0.7 
1.9 
44.8 
53.6 
0 
0 
2.5 
36.5 
Table III. 
Number of nucleated cells, lymphocytes, AET-E-rosette positive cells and 
progenitor cells in 4 fractions obtained by counterflow centrifugation 
of low density cells ( dr 1.070 g/ml ) with small increments of the flow-
rate. 
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flowrate of 11.5 ml/min. At the same time a sharp decline of the number of the 
lymphocytes was observed. Despite the considerable number of cel ls loaded 
into the elutr iator chamber,no progenitor cel ls were lost during intro-
duction of the ce l l s (see fraction: 5.5 ml/min, table III) . The pooled 
fractions obtained at flowrates of 6-10.5 ml/min contained the majority of 
the lymphocytes and the fractions at flowrates >11 ml/min the majority of 
progenitor ce l l s . At a flowrate of 11 ml/min a transit ion was found from the 
lymphocytes to the committed progenitor ce l l s . In 6 experiments described 
elsewhere (16) low density ( ¿1.070 g/ml) bone marrow cel ls were separated 
in 2 fractions with constant monitoring of light scat ter and immediate 
analysation of the S-phase cells by FCM. The large cell fractions contained 
4.8 ± i».0 % of the original number of AET-treated E rosette positive ce l l s , 
90.0 ± 15.6 % of the CFU-GM and 98.6 ± 14.3 % of the BFU-E. 
DISCUSSION 
Counterflow centnfugation provides a rapid and reproducible separation 
technique mainly based on differences in ce l l - s ize (1,2). An essent ia l 
improvement was the connection of a scat ter device to the effluent of the 
elutriator by means of a T-drain. Pretreatment of the marrow cel ls by a 
discontinuous gradient (Ficoll-Isopaque) with a density of 1.085 g/ml was 
necessary f or removal of erythrocytes. DNA-flowcytometry and Зн-thymidine-
uptake of the different fractions obtained by counterflow centnfugation 
revealed two peaks of proliferating ce l l s : one mainly representing the 
proliferating immature erythroid cel l s and the other representing proli­
ferating immature myeloid cel ls . Increase in cel l size coincided with an 
increase of percentages S-phase and G2+M-pha3e cel ls of both the erythroid 
and myeloid series (fig. 1). Lysis of the erythroid nucleated cel ls resulted 
in a complete disappeareance of the f irst peak of proliferating cel l s and 
left one single peak of proliferating cel ls representing the larger immature 
myeloid cel l s . Counterflow centrifugation did not result in a single dis t inct 
peak highly enriched for CFU-GM. This might not be expected, as each 
celltype shows an increase in cell size when i t passes through the 
replicative cycle (18). The velocity sedimentation studies of Dresch et a l 
(19) are consistent with these findings: they found a population of larger 
clonogenic cel l s with a high percentage of S-phase cel ls and a population of 
smaller clonogenic cel ls with a low percentage of S-phase cel ls . This is in 
agreement with the shift of the progenitor peak to fractions with a lower 
flowrate, when the in vitro culture time was extended from 7 to 14 days. 
Analysis of the DNA-histograras of the different fractions, obtained by 
counterflow centrifugation, revealed a coincidence of the first appearance 
in the effluent of proliferating normoblasts and the committed progenitor 
cel ls . Careful e l u t n a t i o n of normal low density bone marrow cel l s (d £ 1.070 
gr/l) with constant monitoring of the effluent for cel l number and cel l 
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s c a t t e r and a d d i t i o n a l DNA-flowcytometry made i t f e a s i b l e to d i s c r i m i n a t e 
the lymphocytes from the committed ery thro id and myeloid p r o g e n i t o r c e l l s . 
The committed p r o g e n i t o r c e l l s are the immediate progeny of the HSC, but not 
i d e n t i c a l to them. Murine CFU-S are more c l o s e l y r e l a t e d or even i d e n t i c a l t o 
t h e HSC. A r e c e n t s tudy of Inoue et a l (20) on CFU-S in bone marrow f r a c t i o n s 
obta ined by counterfow c e n t n f u g a t i o n showed t h a t the average c e l l volume 
in t h e peak f r a c t i o n of murine CFU-S was 175 um^, whereas the average 
volume of murine lymphocytes was 100 ym3. i f t h i s d i f ference in volume i s 
a l s o t r u e for human bone marrow one may use counterflow c e n t r i f u g a t i o n for 
t h e e l i m i n a t i o n of T-lymphocytes from donor bone marrow in an attempt to 
prevent GVHD in a l l o g e n e i c marrow t r a n s p l a n t a t i o n . 
In c o n c l u s i o n : DNA-flowcytometry and Зн-thyraidine i n c o r p o r a t i o n showed 
t h a t counterflow c e n t n f u g a t i o n s e p a r a t e s c e l l s mainly based on c e l l s i z e 
and within each popula t ion on i t s c e l l c y c l e phase . Separat ion of the T-
lymphocytes from the BFU-E and CFU-GM was almost complete. 
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CHAPTEH VI 
DEPLETION OF IMMUNOCOMPETENT LYMPHOCYTES FROM HUMAN PLURIPOTENT 
PROGENITOR CELLS (CFU-GEMM) BY MEANS OF COUNTERFLOW CENTRIFUGATION 
Τ de Witte, E. Koekman, E. Geestman, A. Plas, G. Blankenborg, J. 
Weasels and C.Haanen 
Submitted to Blut 
SUMMARY 
Counterflow e e n t n f u g a t i o n with continuoua monitoring of the output for c e l l 
number and c e l l s c a t t e r was used to s e p a r a t e low dens i ty (d S 1.070 g/ml) 
human bone marrow c e l l s in two f r a c t i o n s : one con ta in ing the majority of 
small s i zed lymphocytes and the o ther the majority of the l a r g e r s i z e d 
committed p rogen i to r c e l l s . The recovery of the p lu r i po t en t stem c e l l s (CFU-
GEMM) in the l a rge c e l l f rac t ion was complete ( 1 0 8 Í ) . The mitogenic 
r e a c t i v i t y of t h i s pu t a t i ve stem c e l l f rac t ion had decreased to 6 and 11 %, as 
measured with phytohemagglut inin s t imula t ion and one way mixed lymphocyte 
c u l t u r e r e s p e c t i v e l y . 
Counterflow e e n t n f u g a t i o n appeared to offer a p h y s i c a l s epa ra t ion t e c h -
nique, by which the majority of the immune - r e a c t i v e c e l l s can be s e p a r a t e d 
from the p l u r i p o t e n t hemopoietic stem c e l l s . 
INTRODUCTION 
Various c e l l s e p a r a t i o n methods have been app l i ed to obta in human bone 
marrow f r a c t i o n s devoid of immunocompetent c e l l s in an attempt to p revent 
graf t ve r sus hos t d i s e a s e (GVHD). I sopycnic sedimenta t ion e e n t n f u g a t i o n in 
bovine serum albumin g r a d i e n t s ( l b v e l o c i t y sedimenta t ion a t 1 g (2) , 
i ncuba t ion with monoclonal a n t i - T a n t i b o d i e s (3) and d i f f e r e n t i a l agg lu -
t i n a t i o n with l e c t i n s have been descr ibed (4) . T i l l now e i t h e r these methods 
have f a i l ed to show a d e c r e a s e in acute GVHD when appl ied to a l l ogene i c bone 
marrow t r a n s p l a n t a t i o n (BMT) in a d u l t s (5) or the low y i e ld of hematopoiet ic 
stem c e l l s (HSC) has l imited i t s a p p l i c a t i o n to young in fan t s (6). 
Counterflow e e n t n f u g a t i o n offers another approach to the e l iminat ion of 
lymphocytic c e l l s from human bone marrow. The s e p a r a t i o n t a k e s p lace mainly 
depending on c e l l s i z e (7) . Continuous monitoring of c e l l s i z e and c e l l 
number in the outflow of the sepa ra t ion chamber by a l i g h t s c a t t e r dev ice 
made t h i s s e p a r a t i o n method very r e p r o d u c i b l e and r e l i a b l e (8). Lymphocytes 
could be e l iminated almost completely from the committed progeni tor c e l l 
r i c h f r ac t ion (8) . 
This paper d e s c r i b e s an a n a l y s i s of the d i f fe ren t f r ac t i ons obta ined by 
counterflow e e n t n f u g a t i o n by means of in v i t r o c u l t u n n g of p l u r i p o t e n t 
stem c e l l s (CFU-GEMM) and assessment of T-lymphocyte function by in v i t ro 
s t imula t ion with phytohemagglutinin (PHA) and by us ing mixed lymphocyte 
c u l t u r e s (MLC). 
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MATERIALS AND METHODS 
Preparat ion of bone marrow с е і і з и з р п з ю п з 
Normal bone marrow fi?om p a t i e n t s undergoing c a r d i a c surgery i s c o l l e c t e d in 
buffered a c i d - c i t r a t e dext rose (pH 7.0). Bone marrow p a r t i ó l e s are d i s rup ted 
by r epea ted a s p i r a t i o n s through 16 gauge n e e d l e s and the suspens ion i s 
f i l t e r e d through a nylon f i l t e r (pores ize 70 vm). The c e l l s are washed in 
Ca+ + /Mg+ + - free Hanks' balanced s a l t so lu t ion (HBSS) for removal of plasma 
and fat and then resuspended in HBSS con ta in ing 5 % (v/v) f e t a l ca l f serum 
(FCS). Assessment of the number of c lonogenic c e l l s and E r o s e t t e p o s i t i v e 
c e l l s in whole bone marrow i s performed a f t e r removal of red c e l l s by us ing a 
discontinuous P e r c o l l - g r a d i e n t with a dens i ty of 1.085 g/ml. The recovery in б 
experiments was : n u c l e a t e d c e l l s : 91 ± 7Í', mature g r anu locy t e s (segment 
and band forms) : 77 ± 8$ and lymphocytes : 106 ± 1 9 Í . 
The small s i z e of the sepa ra t ion chamber in the e l u t n a t o r ro to r l imi t s t h e 
number of c e l l s to be sepa ra ted . To reduce the number of contaminat ing 
mature g r a n u l o c y t e s low densi ty c e l l s u s p e n s i o n s (d S 1.070 g/ml) a re 
prepared by i sopycn ic f lo t a t ion cen t r i fuga t ion in Perco l i g r a d i e n t s (8) . 
Counterflow cen t r i f uga t i on 
Counterflow cen t r i fuga t ion (CC)is performed with a Beekman J 2 - 2 1 C r e f r i -
gera ted cen t r i fuge equipped with a Beekman JE-6 e l u t n a t o r ro to r with a 
s tandard s e p a r a t i o n chamber (Beekman Ins t ruments Inc . Palo Alto, Cal. USA). 
The output of the e l u t n a t o r i s con t inuous ly sampled by means of a T-dra in 
and analyzed for c e l l number and l i gh t s c a t t e r by the e l e c t r o - o p t i c a l un i t 
of the Hemalog D (Techmcon Ins t ruments Corp. Tarrytown USA) (9) . Bone 
marrow specimens are in t roduced in to the e l u t r i a t o r ro to r sp inning a t 2200 
rpm with a f lowrate of 7 ml/mm. Bone marrow i s s epa ra t ed in to a lymphocyte 
r i ch f rac t ion and a progeni tor c e l l r i c h f rac t ion by i n c r e a s i n g the 
counterflow r a t e s tepwise 0.5 - 1 ml/min a s desc r ibed p rev ious ly (8) . 
Granulocyte/macrophage colony forming c e l l s (CFU-GM)-as3ay. 
Nucleated c e l l s (2 χ 10^ or a p p r o p r i a t e d i l u t i o n s ) are c u l t u r e d in 0.3% a g a r 
with 4? (w/v) colony s t imulat ing f a c t o r (CSF), der ived from human p l a c e n t a , 
condi t ioned in t h e p r e s e n c e of endotoxin (10). Dupl icate c u l t u r e s are s c o r e d 
a f t e r 14 days of i n c u b a t i o n . Aggregates c o n s i s t i n g of 40 and more c e l l s a re 
counted as c o l o n i e s . 
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Erythroid colony forming cel l s (ВРи-Е)-аззау 
The culture technique is adapted from the method of Ізсо е et al. (11). Cell 
suspensions at a concentration of 1 χ lO^/ml or less are plated in Iscove's 
modified Dulbecco's medium (IMDM, Gibco), to which is added 0.9$ (w/v) 
methylcellulose (Fluka, Schweiz), 10~ч M thioglycerol, 10Í (w/v) deionized 
bovine serum albumin (12), 20$ (w/v) heat inactivated fetal calf serum of a 
preselected batch (Rehatuin), 20% (w/v) human leukocyte conditioned medium 
(HLCM) (13) and 2 units sheep erythropoietin/ml (Step III, Connaught Medical 
Research Laboratories). Duplicate 0.5 ml aliquote are cultured in 16 mnrwells 
(Cluster , Costar). Orange to red bursts of at least 3 subclusters or one 
single colony of more than 300 cells are scored as BFU-E on day fourteen of 
culture. 
Pluripotent colony forming cel ls (CFU-GEMMi-assay 
Culture conditions, outlined by Fauser and Messner ( ΙΊ) with some modi­
fications according to Ash et al. (15) are followed. The culture conditions 
are identical to those of the BFU-E assay, but HLCM has been replaced by 5 % 
(w/v) human mononuclear leukocyte conditioned medium (PHA-HMCM) and the 
amount of erythropoietin has been reduced to one unit/ml. Mixed colonies are 
identified on day 16 of culture by their composite appearance. Individual 
colonies are removed by micropipetting into thin-tipped Pasteur pipettes, 
transferred onto s l ides and forcefully air-blown to spread the cel ls . Slides 
are stained with May Grtlnwald-Giemsa. 
Mitogenic stimulation 
PHA stimulation is determined as described elsewhere (16). Samples of 1 ml 
containing 3 x 1 0 ' nucleated cel ls are cultured in the presence of 25 yg PHA 
(Wellcome HA 15, Beckenham, England). Mixed lymphocyte cultures (MLC) are 
made by mixing 0.5 ml of a bone marrow fraction containing 1.5 x 10^ 
nucleated ce l l s with 0.5 ml of a lymphocyte suspension containing 1.5 χ 10^ 
irradiated (2000R) mononuclear cells of an unrelated healthy volunteer. 
Each fraction is tested against lymphocytes from 2 different volunteers. All 
cultures are carried out in tr iplo. The cultures to which PHA has been added 
are terminated after 3 days. The MLC's are harvested on day 6 of culture. 
DNA-synthesis is determined by addition of 0.25 vCi Зн-thymidine (specific 
activity 5 Ci/mmol, Amersham, England) 24 hours before termination of 
culture. The cultured cel ls are collected on glass fibre f i l ters (type AP 
20.025.00, Millipore Corp. Bedford, Mass. USA). The dried f i l ters are counted 
for 10 minutes (LKB 81000 Scintil lation Counter) in 7 ml scint i l lat ion fluid. 
Fractionated bone marrow suspensions contain different numbers of spon­
taneously dividing ce l l s . Results are therefore expressed as a mitogenic 
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response (MR) according to the formula: 
MR = DPM of stimulated cells minus 
DPM of spontaneously proliferating cells 
and as a stimulation index (SI) according to the formula: 
DPM of stimulated cells 
SI =^  
DPM of spontaneously proliferating c e l l s 
(DPM = dés intégrat ions per minute). 
DNA-synthesis of spontaneously dividing c e l l s i s measured by incubation in 
medium without PHA, or with 1.5 χ 10^ autologous ident ica l irradiated c e l l s 
in the MLC. 
E-Rosette formation 
The nucleated c e l l s of the different fract ions are incubated with AET-
treated sheep red blood c e l l s (17) in presence of complement. All nucleated 
c e l l s reset ted by 3 or more red c e l l s are considered pos i t i ve . 
RESULTS 
Low density bone marrow c e l l s (d S 1.070 g/ml) are separated in a small and a 
large c e l l fraction by means of counterflow centrifugation as described 
previously (8). The small c e l l fraction contains the majority of lymphocytes 
and a minor admixture of normoblasts and monocytes. The large c e l l fraction 
contains a l l myeloid c e l l s and the remaining normoblasts and monocytes. In 4 
experiments the presence of both the pluripotent and committed progenitor 
c e l l s and the Τ lymphocytes was a s s e s s e d . The recovery of the clonogenic 
c e l l s in the low density fraction was complete (table I ) . The large c e l l 
fraction contained 86 ± 2 2 * of the CFÜ-GM, 98 ± 17* of the BFU-E and 108 ± 
30К of the CFU-GEMM (table I). Remaining E rose t te pos i t i ve c e l l s in t h i s 
fraction were 3 ± 2%. The lymphocyte rich (small c e l l ) fractions contained 
about 3 Í of the clonogenic c e l l s . 
Mitogenic responses to PHA of the obtained marrow ft-aetions were tes ted for 
several concentrations of PHA. The resu l t s of the optimal concentration (25 
Ug/mDare presented in table II. Each bone marrow fraction contained 
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Bone marrow 
(n=4) 
Nucleated 
cells 
(d £ 1.085 
g/ml) 
Low density 
cells 
(d ί 1.070 
g/ml) 
Small cells Large cells 
Nucleated cells χ 10 
Lymphocytes χ 10 
Ε-Rosette pos.cells χ 10 
CFU-GM χ 103 
BFU-E χ 103 
CFU-GEMM χ 10 
296 ± 
53 ± 
31 ± 
135 ± 
221 ± 
21 ± 
* 
95 
8 
14 
32 
184 
9 
86 ± 
95 ± 1 
100 
100 
100 
100 
9 
I4 
27 ± 
42 ± 
44 ± 
120 ± 
119 ± 
92 ± 
recove 
5 
8 
9 
39 
18 
13 
ry (X) 
7 ± 
30 ± 
32 ± 
3 ± 
2 ± 
3 ± 
1 
4 
5 
4 
1 
5 
15 ± 2 
4 ± 3 
3 ± 2 
86 ± 22 
98 ± 17 
109 ± 30 
* mean ± SD 
Table I. 
Recovery of clonogenic myeloid, erythroid and pluripotent progenitor cells in two fractions obtained by 
counterflow centrifugation of low density (d S 1.070 g/ml) bone marrow cells. The number of nucleated 
cells and lymphocytes in the original bone marrow fractions was put at 100 %. The number of E-Rosette 
positive cells and clonogenic cells in the 1.085 g/ml interphase fraction was put at 100 %. Note : the 
low density fraction was obtained from whole bone marrow. 
mean ± SD 
H-thymidine incorporation 
3 5 
DPM χ 10 / 3 χ 10 nucleated cells 
Bone marrow fractions 
-PHA +PHA MR SI 
d á 1.085 g/ml 
d S 1.070 g/ml 
"small" cells 
"large" cells 
7.4 ± 1.0 
13.4 ± 0.3 
1.0 ± 0.8 
13.3 ± 4.4 
17.3 ± 4.4 
33.8 ± 4.2 
24.5 ± 11.3 
16.5 ± 5.5 
9.1 ± 3.2 
17.2 ± 6.3 
23.2 ± 10.5 
3.3 ± 3.9 
2.1 ± 0.3 
2.5 ± 0.3 
25.8 ± 12.1 
1.2 ± 0.4 
Table II. 
Mitogenic responses of bone marrow cells fractionated by isopycnic density sedimentation and counter-
flow centrifugation by phytohemagglutinin (PHA : 25 pg/ml). For definitions of mitogenic response 
(MR) and stimulation index (SI) see "Materials and Methods" (n=4). 
different numbers of spontaneously proliferating c e l l s , as shown by 
incubation in medium without a mitogen for 3 days (table II). Results are 
expressed as mitogenic response (MR) and stimulation index (SI). Removal of 
the small lymphocytes from the low density fraction by counterflow 
centrifugation resulted in a considerable depletion of PHA responding c e l l s 
in the remaining (large c e l l ) fraction. The mitogenic response to PHA 
decreased from 17.2 + 6.3 x юЗ DPM /3 x 10 5 c e l l s in the low density fraction 
to 3.3 ± 3.9 χ 1θ3 DPM in the large c e l l fraction. The stimulation index had 
fa l len from 2.5 to 1.2. The lymphocyte rich fraction responded very well to 
PHA with a MR of 23.2 ± 10.3 x 1θ3 DPM /3 x 1 0 5 c e l l s and a SI of 25.8 ± 12.2 
(table II). The calculated MR of a l l nucleated c e l l s in the large c e l l 
fractions was 6 ± 11 % of the MR in the unseparated bone marrow samples 
(table III). 
Bone marrow fractions Mitogenic response 
( χ 103 DPM/3 χ 105 NC ) 
d S 1.085 g/ml 9.1 t 3.2 
d f 1.070 g/ml 17.2 ± 6.3 
"small" cells 23.2 ± 10.5 
"large" cells 3.3 ± 3.9 
Total mitogenic 
( x 105 DPM ) 
58 ± 33 
51 ± 21 
21 t 11 
4 ± 4 
response 
( Ζ ) 
100 
89 t 15 
35 ± 15 
6 ± 11 
mean ± SD 
Mitogenic responses ( MR ) of bone marrow cell fractions obtained by isopycnic density 
sedimentation and counterflow centrifugation to PHA. Total MR of each fraction is calcu­
lated by multiplying the total number of nucleated cells ( NC ) and the MR / 3 χ 10 NC. 
Last column shows the relative response of each fraction compared to that in the 1.085 
g/ml interphase cells (n-4). 
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Η-thymidine incorporation 
3 5 
DPM χ 10 / 1.5 χ 10 nucleated cells 
Bone marrow fractions autologous MCL MR SI 
d < 1.085 g/ml 
d ¿1.070 g/ml 
"small" cells 
"large" cells 
2.3 ± 1.1 
4.6 ± 0.8 
2.5 ± 1.6 
10.6 ± 3.2 
4.4 ± 1.2 
9.4 ± 3.2 
11.8 ± 1.4 
12.3 ± 4.0 
2.1 ± 0.3 
3.5 ± 1.1 
9.2 ± 0.2 
1.7 ± 1.1 
2.1 ± 0.2 
1.7 ± 0.2 
12.7 ± 8.3 
1.2 ± 0.1 
mean ± SD 
Table IV. 
Stimulation of bone marrow cells fractionated by isopycnic density sedimentation and counterflow 
centrifugation in mixed lymphocyte culture (n=3). For definitions of mitogenic response (MR) and 
stimulation index (SI) see "materials and Methods". 
OD 
Spontaneous i n c o r p o r a t i o n of Зн-thymidine in f r a c t i o n a t e d bone marrow 
s u s p e n s i o n s i n c u b a t e d with autologous i d e n t i c a l i r r a d i a t e d bone marrow 
c e l l s for 6 days var ied cons iderab ly ( t a b l e IV). The small c e l l f r a c t i o n was 
highly s t imulatory in the MLC with a MR of 9.2 ± 0.2 χ Ю^ DPM per 1.5 χ IO 5 
n u c l e a t e d c e l l s and a SI of 12.7 ± 8.3. The l a r g e c e l l f r a c t i o n showed a MR of 
1.7 ± 1.1 x ЮЗ DPM /1.5 χ 10 5 nuc lea ted c e l l s and a SI of 1.2 ± 0.1. This 
f r a c t i o n c o n t a i n e d 12 ± 2% of the number of n u c l e a t e d c e l l s p r e s e n t in t h e 
s t a r t i n g bone marrow f r a c t i o n . The c a l c u l a t e d MR of a l l nuc lea ted c e l l s in 
t h i s f r a c t i o n was 11 ± 8 Í of the r esponse of the t o t a l number unsepara ted 
c e l l s ( t ab le V). 
Bone marrow fraction 
d i 1.085 g/ml 
d s 1.070 g/ml 
"small" cells 
"large" cells 
Mitogenic response 
( χ 10 3 DPM/1.5 χ 105 NC ) 
2.1 ± 0.3 
3.5 ± 1.1 
9.2 ± 0.2 
1.7 ± 1.1 
Total mitogenic response 
( χ 10 5 DPM ) ( % ) 
35 ± 2 
29 ± 4 
16 ± 3 
4 ± 3 
ICO 
78 ± 11 
45 ± 9 
11 ± 8 
mean ± SD 
Table V. 
Responses of bone marrow fractions obtained by isopycnic density sedimentation and counter-
flow centrifugation in mixed lymphocyte cultures. Total MR of each fraction is calculated 
by multiplying the total number of nucleated cells ( NC ) and the MR / 1.5 χ 10 NC. Last 
column shows the relative response of each fraction compared to the response in the 1.085 
g/ml interphase cells (n=3). 
DISCUSSION 
Counterflow c e n t r i f u g a t i o n (CC) has been shown to offer a r e l i a b l e and 
e f f i c i e n t t e c h n i q u e for s e p a r a t i o n of human bone marrow based upon c e l l 
s i z e (18). By c o n t i n u o u s monitoring of t h e e l u t n a t o r output with a l i g h t 
s c a t t e r dev ice we were ab le to s e p a r a t e t h e majority of small lymphocytes ( 
9 5 Ϊ ) from the la rge c e l l populat ion (19). This p r o g e n i t o r c e l l r ich f r a c t i o n 
conta ined l e s s than 5 Ϊ of the o r i g i n a l E+, 0КТз+ and WTi+ populat ion (19) . 
The WT·)"*" monoclonal ant ibody r e c o g n i z e s a human p r e - T - l i n e a g e s p e c i f i c 
a n t i g e n (20). The recovery of committed p r o g e n i t o r populat ion (BFU-E and 
CFU-GM) was about 8 0 * (19). CFU-GM and BFU-E form the immediate progeny of 
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the hematopoietic stem cella (HSC) and are rel iable indicators of bone 
marrow repopulation capacity of unseparated bone marrow (21), although the 
cel l aize of the HSC 13 not necessarily identical to that of the progenitor 
ce l ls . 
The human pluripotent hematopoietic stem cel l (CFÜ-GEMM) gives r ise in vitro 
to mature granulocytes, erythrocytes, macrophages, megakaryocytes and T-
lymphocytes (22) and i t has been shown to possess a limited self renewal 
capacity in vitro (15). This makes it a strong candidate for the pluripotent 
human HSC and comparable to the murine pluripotential stem cell : CFU-S. 
Separation of low density bone marrow cel ls into 2 fractions by CC resulted 
in a fraction of large cells with an apparent complete recovery of the CFU-
GEMM and a contamination of 3 per cent of the original number E-rosette 
positive ce l ls . Loss of the CFU-GEMM in the lymphocyte rich fraction was 
only 3$. The mitogenic stimulatory capacity of the stem cell rich fraction 
was investigated by means of PHA stimulation for 3 days and mixed lymphocyte 
culture for 6 days. The uptake of ^H-thymidine measured in a PHA and MLC 
reaction of fractionated bone marrow samples can be profoundly influenced 
by extraneous factors in the culture system including accessory cel ls , such 
as monocytes, spontaneously proliferating myeloid cel ls and stimulatory 
clonogenic ce l l s . This is shown by the varying spontaneous Зн-thymidine 
uptake after 3 and 6 days of incubation (tables II and IV). The mitogenic 
response in the lymphocyte rich fraction was markedly increased, but i t 
should be noted, that the MR to PHA in th i s fraction might be an under­
estimation, since the number of monocytes in this fraction was very low 
compared to the other fractions (mean 6%; range : 0-11}). The mitogenic 
response of the putative stem cel l fraction was 6 and 11 % measured with PHA 
stimulation and MLC-reactivity respectively (tables III and V). The major aim 
of this separation technique was to retain the full bone marrow repopulation 
capacity after removal of the majority of the lymphocytes. The definite proof 
will be provided by allogeneic bone marrow transplantation (BMT) with 
lymphocyte depleted bone marrow from HLA-identical, MLC-nonreactive 
siblings. The absolute number of lymphocytes in murine marrow grafts has 
been shown to be correlated with the incidence of GVHD (23). On the other 
hand several recent studies have shown a regeneration of 0КТз+, E+, l a " 
lymphocytes from an 0КТз~, E~, Ia + cel l population (24). Also Messner et a l . 
have shown the presence of T-lymphocytes in mixed colonies grown in the 
CFU - GEMM assay (22). Further c l inical evaluation will be necessary to 
assess whether 95% removal of the small lymphocytes can mitigate or 
decrease the incidence of severe acute GVHD. 
In conclusion: elimination of the majority of immune-reactive cel l s from the 
pluripotent hematopoietic stem cel ls appeared feasible by density equi l i­
brium centnfugation followed by counterflow centrifugation. Constant 
monitoring of the output for light scat ter improved cel l size discrimination 
during e l u t n a t i o n separation considerably. 
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CHAPTER VII 
BONE MARROW REPOPULATION CAPACITY AFTER TRANSPLANTATION OF LYMPHOCYTE 
DEPLETED ALLOGENEIC BONE MARROW USING COUNTERFLOW CENTRIFUGATION 
T. de Witte, R. Raymakera, A. P l a s , E. Koekman, H. W e s s e l s , С. Haanen 
A c c e p t e d for p u b l i c a t i o n by T r a n s p l a n t a t i o n ( 1 9 8 3 ) 
SUMMARY 
Bone marrow from s ix a l l o g e n e i c HLA matched and MLC n o n - r e a c t i v e s i b l i n g s 
was f r a c t i o n a t e d by means of i s o p y c n i c f l o t a t i o n c e n t n f u g a t i o n (IFC) and 
subsequent counterflow c e n t n f u g a t i o n (CO. The low d e n s i t y f r a c t i o n (d-i 
1.070 g/ml) obta ined by IFC conta ined 20$ of t h e n u c l e a t e d c e l l s and more 
than 90% of the myeloid and erythroid p r o g e n i t o r s . The p u t a t i v e stem c e l l 
f rac t ion obta ined by CC showed a s a t i s f a c t o r y recovery (88 %) of the CFU-GM 
and BFU-E and only 3.5 % of the o r i g i n a l number of T-lymphocytes. 
Bone marrow r e p o p u l a t i o n capac i ty was not impaired in comparison t o a 
comparable group of p a t i e n t s . Despite t h e average high age of t h i s group 
(29.6 угз) , only one of the four éva luab le p a t i e n t s developed GVHD. 
INTRODUCTION 
Graft v e r s u s host d i s e a s e (GVHD) i s one of the major drawbacks in a l l o g e n e i c 
bone marrow t r a n s p l a n t a t i o n (BMT) d e s p i t e in v i t ro matching of donor and 
r e c i p i e n t by HLA-analysis and mixed lymphocyte c u l t u r e s (1). Standard 
p rophylac t i c therapy with methotrexate (MTX) does not prevent the o c c u r -
rence of GVHD in the majority of a l l o g e n e i c graf t r e c i p i e n t s (2), with an 
ove ra l l morta l i ty of 30 percent or even h igher if a s s o c i a t e d f a t a l i t i e s due 
to i n t e r s t i t i a l pneumonitis and i n f e c t i o n s are taken in to account . 
Severa l methods have been explo i ted to reduce the inc idence and s e v e r i t y of 
GVHD, p o s t u l a t i n g t h a t acu te GVHD a r i s e s from immunologically competent 
mature T-lymphocytes p resen t in the graf t (3) . Antilymphocyte g lobul in (4) 
and Cyclosporin A (5) are used to suppres s the immune competent c e l l s a f t e r 
marrow in fus ion . Another approach i s s e l e c t i v e e l iminat ion of the T-
lymphocytes from the marrow graf t before infus ion . This was pioneered by 
Dicke et a l . (6) . Recently, in v i t ro incuba t ion with pur i f ied an t i -T se ra (7) 
and a n t i - T monoclonal an t i bod ie s (8) have been repor ted . 
This paper d e s c r i b e s a phys ica l method to s e p a r a t e the human lymphocytes 
from the committed myeloid and e ry thro id stem c e l l s us ing dens i ty g rad ien t 
c e n t n f u g a t i o n followed by counterflow cen t r i fuga t ion (9) . I sopycnic f l o -
t a t i o n c e n t n f u g a t i o n i s used to obta in a low dens i ty c e l l suspens ion devoid 
of the majority of e ry th rocy te s and mature g r a n u l o c y t e s . This low d e n s i t y 
c e l l suspens ion i s subsequent ly sub jec ted to counterflow c e n t n f u g a t i o n for 
s epa ra t ion according to c e l l s i z e . We have shown t h a t small s i zed 
lymphocytes can be separa ted from the majority of l a r g e r s i zed committed 
stem c e l l s (9) . 
The r e s u l t s of i sopycn ic f lo t a t ion cen t r i fuga t ion followed by counterflow 
cen t r i fuga t ion of donor bone marrow for a l l o g e n e i c BMT are p resen ted in t h i s 
s tudy. Analysis was performed by in v i t r o cu l tu re a s s a y s and the in vivo 
bone marrow repopula t ion capac i ty a f t e r a l l o g e n e i c t r a n s p l a n t a t i o n in s ix 
r e c i p i e n t s . 
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MATERIALS AND METHODS 
P a t i e n t c h a r a c t e r i s t i c s 
P a t i e n t s in t h i s s tudy are s u b j e c t s with a c u t e non-lymphocytio leukemia 
(ANLL). Bone marrow remiss ion had been induced by polychemotherapy (LAM-5 
and LAM-6 p r o t o c o l EORTC leukemias and hematosarcomas c o o p e r a t i v e 
group) . Six p a t i e n t s are s t u d i e d and a g e s range from 18 to 36 y e a r s (mean: 
29.5 ± 6.2 y r s ) . All bone marrow t r a n s p l a n t a t i o n s (BMT) are performed in f i r s t 
remiss ion and the study r e p r e s e n t s c o n s e c u t i v e BMT without any e x c l u s i o n s . 
T r a n s p l a n t procedure 
Bone marrow donors a re HLA-A, В, С and D i d e n t i c a l s i b l i n g s and mutual 
n o n r e a c t i v i t y in mixed lymphocyte c u l t u r e s i s demonstrated in a l l p a t i e n t s . 
Bone marrow remiss ion (defined аз l e s s than 5$ leukemic b l a s t s in bone 
marrow) was confirmed in a l l p a t i e n t s . The t r a n s p l a n t c o n d i t i o n i n g c o n s i s t s 
of cyclophosphamide 60 mg/kg/day for 2 days (days -6, -5) followed by 2 
m e r c a p t o e t h a n e s u l f o n a t e (Mesna") 28 mg/kg 0, 3i 6 and 9 hours a f t e r 
cyclophosphamide infus ion. F r a c t i o n a t e d t o t a l body i r r a d i a t i o n (TBI) i s 
adminis tered us ing an 18 mEV Saturne l i n e a r a c c e l e r a t o r on day -2 and - 1 . 
I r r a d i a t i o n was a t 5.5 rad (5.5 cGy) per minute to a t o t a l midline dose of 900 
Rad (9.0 Gy). Lung and eye s h i e l d i n g i s used on t h e second day of i r r a d i a t i o n 
from 770 Rad (7.7 Gy) onwards . Bone marrow i s infused i n t r a v e n o u s l y 24 
hours a f t e r completion of the TBI. S t e r i l i t y of the marrow graft i s confirmed 
by b a c t e r i o l o g i c a l s t u d i e s . Engraftment i s documented using red blood 
c e l l a n t i g e n s and karyotype a n a l y s i s . MTX i s used as r o u t i n e GVHD-
p r o p h y l a x i s for 102 days following t h e S e a t t l e regimen (10). P a t i e n t s are 
managed in s i n g l e rooms with f i l t e r e d a i r under p o s i t i v e p r e s s u r e throughout 
t h e t r a n s p l a n t period and a l l rece ived o r a l s e l e c t i v e gut decontaminat ion 
i n c l u d i n g c o t n m o x a z o l e , C o l i s t i n and miconazole. Hickman venous c a t h e t e r s 
are used for hypera l imentat ion throughout t h e acute pos t t r a n s p l a n t per iod. 
Dept. Radiotherapy (head: Prof. I . Kazem) 
Dept. Microbiology (head: Prof, van der Veen) 
Univers i ty Bloodtransfus ion s e r v i c e (head: Prof. V. Kunst) 
Dept. Cytogenet ic s (head: Dr. Hustinx) 
Bone marrow a s p i r a t i o n 
Bone marrow i s c o l l e c t e d under genera l or e p i d u r a l a n e s t h e s i a from t h e 
p o s t e r i o r i l i a c c r e s t s in d i s p o s a b l e s y r i n g e s c o n t a i n i n g 1 ml acid c i t r a t e 
d e x t r o s e formula- A with 50 U p r e s e r v a t i v e free hepar in . Syringe c o n t e n t s 
are i n j e c t e d d i r e c t l y i n t o two 600 ml t r a n s f e r packs (Fenwal) through a 70 vm 
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nylon f i l ter fitted in a Swinnex-25 f i l ter holder (Millipore). The transfer 
packs with the collected bone marrow are centrifuged (15 min; 500 g at 4° С) 
and supernatant fat and plasma are removed. 
Isopycnic flotation centnfugation (IFC) 
Isotonic stock* solutions of Percoli " (Pharmacia, Uppsala, Sweden) are made 
by mixing 9 parts of Percoli with one part of 10 χ concentrated HBSS. After 
determination of the remaining cel l- and plasma-volume a 1280 ml bone 
marrow cel l suspension is made with a density of 1.085 g/ml by adding 
appropriate amounts of Percoli stock solution and HBSS. A total number of 64 
discontinuous Percoli gradients are prepared containing from top to bottom: 
15 ml HBSS; 15 ml Percoli solution with a density of 1.070 g/ml and 20 ml 
cellsuspension with a density of 1.085 g/ml. The interphase fraction with a 
density S 1.070 g/ml is collected after centnfugation at 500 g and 18 0 .C 
for 30 minutes. To reduce the volume the low density fraction is washed in 
HBSS and resuspended in 50 ml PCS and stored at 4 0 С until use. 
Counterflow Centnfugation (CC) 
Counterflow Centnfugation is performed with a Beekman J2-21C refrigerated 
centrifuge equipped with a Beekman JE-6 Elutnation rotor with a standard 
separation chamber (Beekman Instruments Inc. Palo Alto, Calif.). The 
e lu tnat ion system is steri l ised by gas evaporation apart from the 
separation chamber which is s ter i l i sed by autoclaving (20 mm at 120° C). 
The system is assembled Just before operational use inside a laminar 
downflow cabinet. The tubing and collection system outside the Beekman 
centrifuge are kept within the downflow cabinet throughout al l separation 
procedures. A constant counter flowrate is obtained by a per i s ta l t ic pump 
(Masterflex-Cole-Parmer Instr. Chicago, 111, USA). The pump is connected to a 
pulse flattening air-chamber. HBSS supplemented with 1Ï (v/v) heat 
inactivated FCS is used as e lutnat ion medium and maintained at 18° С The 
output of the e l u t n a t o r is continuously sampled by means of a T-drain and 
analyzed for cell number and light scatter by the electro-optical unit of an 
Hemalog D (Techmeon Instr. Corp. Tarry Town, USA). The light scatter s ignals 
are accumulated and displayed on a ND-600 multichannel analyser (Nuclear 
Data Inc., Schaumberg, 111.USA). Specimens of 10 ml FCS containing 0.8 - 1.0 χ 
1θ9 nucleated low density cells are introduced into the elutr iator rotor 
spinning at 2200 rpm and at a counter flowrate of 7ml/min by means of an 
infusor pump. Only erythrocytes and small lymphocytes are eluted at th i s 
flow rate. The rotorspeed is maintained at 2200 rpm throughout the procedure 
and the counterflow rate is increased stepwise 0.5 - 1 ml/min whenever the 
number of elutriated ce l l s detected by the electro-optical system fal ls 
below 100 cells/sec. 
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Granulocyte-macrophage colony forming cel ls (CFU-GM) assay. 
All cultures are performed in 2 ml volumes in 35 ram2 plastic Petri dishes 
(Costar) using Dulbecco's modified Eagle's medium (Flow) with 20% heat 
inactivated FCS (Flow) from a preselected batch in 0.3Í Bacto-agar (Difco). 
Nucleated cel ls (2 χ 10-> or less) are seeded per plate with 4% (v/v) colony 
stimulating factor (CSF), derived from human placenta, conditioned in 
presence of endotoxin (HPCM, 11). Duplicate cultures are scored after 10-12 
days incubation. Aggregates consisting of 40 and more cel ls are counted as 
colonies. 
Erythroid colony forming cel ls (BFU-E)-assay. 
The basic culture technique is adapted from the method of Iscove et al (12). 
The cell suspensions at concentrations of 0.1 - 1 χ 10^/ml are plated in a 
substantially modified Dulbecco's Medium prepared from powder (IMDM, Gibco 
formula 78 - 5220) to which is added 0.Θ % Methylcellulose (Fluka, Schweiz), 
10~ч M thioglycerol, '\0% deionized bovine serum albumin (13) 20$ heat 
inactivated foetal calf serum of a preselected batch (Rehatuin), 20% 
leukocyte conditioned medium (14) and 2 Units sheep erythropoietin/ml (Step 
III, Connaught Medical Research Laboratories). One-tenth mil l i l i ters of this 
suspension are placed in flat bottomed raicrowells (Limbro, Titertex). 
Orange-to-red colonies of at least eight cel l s are scored as CFU-E in four 
microwells on the 7th day of culture. Orange-to-red colonies of at least 
three subclusters or one single colony of more than 300 cells are scored аз 
BFU-E in the other four wells on day fourteen of the culture. 
Ε-rosette formation 
The different fractions are incubated with AET-treated sheep red blood cel ls 
(15) in presence of human complement. All nucleated cells containing 3 or 
more red ce l l s are considered positive. 
DNA-Flowcytometry (DNA-FCM) 
The nuclear DNA content of the cells is stained according to Krishan (16) by 
adding 0.5 χ 10° cel l s to 10 ml hypotonic ethidium bromide (0.1 % trisodium 
ci t rate 25 mg/1 ethidium bromide). The relative fluorescence of about 10^ 
cel ls is measured with use of an ICP-11 Pulse Cytophotometer (Phywé, 
Göttingen, West Germany) at a flowrate of 400 cel ls /sec . The percentage of 
cel ls in different phases of the cell cycle are calculated according to 
Baish (17). 
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Bone marrow Low density fraction High density fraction 
(%) (%) 
Nucleated cell 
Lymphocytes 
E-rosette 
CFU-GM 
CFU-E 
BFU-E 
pos. 
s 
ce lis 
χ 
χ 
χ 
χ 
χ 
χ 
ΙΟ
9 
ΙΟ
9 
ΙΟ
9 
10b 
10b 
iob 
* mean ± SD 
** ND: not determined 
Table I. 
Isopycnic flotation centrifugation in discontinuous Percoli gradients (n=5). Recovery in the low 
density fraction ( d - 1.070 g/ml ) and loss in the high density fractions ( d > 1.070 g/ml ). 
23.3 ± 5.6 
3.5 ± 0.7 
2.7 ± 1.2 
7.2 ± 3.8 
29.1 ± 11.1 
13.7 ± 9.0 
4.5 ± 0.7 
1 .8 ± 0.3 
1.2 ± 0.4 
7.4 ± 3.1 
25.4 ± 9.7 
9.2 ± 7.6 
20.0 ± 3.6 
50.4 ± 3.2 
51.8 ± 20.7 
109.8 ± 32.6 
97.6 ± 44.5 
96.6 ± 36.7 
69.7 ± 9.3 
38.3. ± 7.8 
** 
ND 
3.6 ± 0.5 
ND 
ND 
RESULTS 
P r e p a r a t i o n of low d e n s i t y c e l l s 
The r e s u l t s of i s o p y c m c f l o t a t i o n c e n t n f u g a t i o n of bone marrow from 5 
donors are p r e s e n t e d in t a b l e I. Hecovery of the n u c l e a t e d c e l l s in the low 
d e n s i t y f r a c t i o n (d S 1.070 g/ml) was 20.0 ± 3.6$. This f r a c t i o n c o n t a i n e d 
about 50$ of t h e Τ - lymphocytes and almost a l l myeloid and e r y t h r o i d 
p r o g e n i t o r c e l l s . Loss of myeloid p r o g e n i t o r c e l l s in t h e f r a c t i o n with a 
d e n s i t y h igher than 1.070 g/ml was 3.6 ± 0.5%. To exclude the p o s s i b i l i t y of 
i n h i b i t i o n by t h e high number of mature g r a n u l o c y t e s (>75ϊ) p r e s e n t in t h i s 
f r a c t i o n , samples of t h i s f r a c t i o n were sub jec ted t o a d i s c o n t i n u o u s 
s e d i m e n t a t i o n g r a d i e n t of P e r c o l l R with a d e n s i t y of 1.070 g/ml. The recovery 
of n u c l e a t e d c e l l s was 3.2 ± 1.3 %, and the y i e l d of CFU-GM was 90.3 ± 26.7 % 
(n=4) showing t h a t i n h i b i t i o n by mature g r a n u l o c y t e s was not l i k e l y . In one 
experiment bone marrow of a donor was s e p a r a t e d in an i n t e r m i t t e n t flow 
c e l l s e p a r a t o r (Hemonetics 30) in order t o obta in a low d e n s i t y f r a c t i o n 
us ing d i s c o n t i n u o u s Perco l i g r a d i e n t s in a c losed system. 
Counterflow c e n t r i f u g a t i o n 
Low d e n s i t y bone marrow c e l l s were s e p a r a t e d by counterflow c e n t r i f u g a t i o n 
in 2 f r a c t i o n s in an attempt to remove the small s ized lymphocytes from t h e 
h e m a t o p o i e t i c stem c e l l s (HSC). The small s i z e of the s e p a r a t i o n chamber 
l imi t s the number of c e l l s t o be s e p a r a t e d . Therefore, specimens c o n t a i n i n g 
0.8-1.0 χ 10^ low d e n s i t y c e l l s were i n t r o d u c e d i n t o the e l u t r i a t i o n system. 
Nucleated cells 
Lymphocytes 
Ε-rosette pos.cells 
CFU-GM 
CFU-E 
BFU-E 
X 
κ 
X 
X 
X 
X 
,ο
9 
io9 
.o
a 
,о
ь 
,о
ь 
,o
b 
Low density 
4.9 ± 
1.7 ± 
1.2 ± 
7.9 ± 
22.6 ± 
12.6 ± 
* 
1.0 
0.4 
0.3 
3.1 
12.2 
6.4 
"Lymphocytic" 
1.7 ± 0.4 
1.4 ± 0.5 
1.0 ± 0.3 
0.3 ± 0.2 
0.2 ± 0.2 
0.5 ± 0.4 
"Stem cell" 
2.0 ± 0.3 
0.12 ± 0.05 
0.04 ± 0.02 
6.5 ± 3.6 
26.8 ± 14.6 
10.1 ± 5 0 
mean ± SD 
Table II. 
Counterflow centrifugation of low density bone marrow cells from 6 donors. 
Separation into 2 fractions : a small cellsized "lymphocytic" fraction and 
a larger cellsized "stem cell" rich fraction. 
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This made three to four additional runs necessary. A dist inct lymphocyte 
peak was always displayed by constant monitoring of the effluent for light 
scatter properties and by increasing the counterflowrate stepwise. This was 
followed by a separate peak indicating appearance of the first normoblasts 
in the effluent. At the same time small samples of the effluent were taken and 
analysed immediately for the presence of S-phase cel ls by means of DNA-
flowcytometry (DNA-FCM). Samples containing lymphocytes only showed 
Bone marrow "Stem cell" fraction 
recovery (%) 
Nucleated cells 
Lymphocytes χ 10 
E.rosette pos.cells χ 10 
CFU-GM 
CFU-E 
BFU-E 
χ 10 
24.4 ± 25.7 
3.7 ± 0.7 
2.8 ± 1.0 
8.1 ± 4.0 
25.4 ± 12.5 
15.3 ± 9 0 
8.6 ± 1.4 
3.5 ± 1.0 
3.4 ± 1.8 
88.3 ± 35.3 
94.6 ± 62 8 
88.2 ± 64.7 
* mean ± SD 
Table III. 
Recovery of lymphocytes and erythrold and myeloid progenitor cells in 
the "stem cell" rich fraction from bone marrow of 6 donors as obtained 
by isopycnlc flotation centnfugation and countcrflow centnfligation. 
negligable numbers of S-phase cel ls . An increase of the percentage S-phase 
cells indicated the appearance of normoblasts in the effluent. Elutnat ion 
of the f irst normoblasts coincided with the appearance of myeloid and 
erythroid progenitor ce l l s . Details of light scat ter and flowcytometry 
studies are to be published in a separate paper. The rotor was stopped, as 
soon as a separate peak indicating normoblasts in the effluent became 
visible on the scatter display screen, confirmed by the appearance of S-
phase ce l l s in DNA-FCM. The contents of the separation chamber were 
collected and stored in autologous plasma until use. Data of the pooled 
lymphocyte and stem cel l fractions are shown in table II . The loss of myeloid 
and erythroid progenitor cells in the lymphocyte rich fractions was less 
than Ί percent. The absolute number of lymphocytes and E-rosette positive 
cel ls contaminating the progenitor cel l rich fraction was very low, 
respectively 3.5 ± 1.0$ and 3.1* ± 1.8Í (table III) . The recovery of BFU-E and 
CFU-GM of the original donor bone marrow was higher than 85Í (table III) . 
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Bone marrow repopula t ion capac i ty 
The u l t imate proof of the presence of a s u f f i c i e n t number HSC in the marrow 
graf t i s de l ive red by the bone marrow repopu la t ion c a p a c i t y . Despite the low 
number of nuc lea ted c e l l s per kg p r e sen t in the graf t , bone marrow 
repopu la t ion was not impaired, taken in to account the inf luence of 
methotrexate GVHD-prophylaxis ( tab le IV). Granulocyte- recovery of one 
p a t i e n t and trombocyte recovery of 2 p a t i e n t s was not éva luab le due to f a t a l 
i n f e c t i o u s compl ica t ions . One of the éva luab le p a t i e n t s con t rac ted GVHD 
grade I I (18), which reso lved with spec i f i c the rapy . The c l i n i c a l data wi l l be 
p resen ted in a s e p a r a t e paper. 
Nucleated cells χ 107/kg 
CFU-GM χ 104/kg 
BFU-E χ 104/k.g 
Day .'Granulocytes > 0.5 χ 
Day:Thrombocytes > 20 χ 
109/1 
109/1 
( without platelet support ) 
I 
2.0 
9.7 
11.0 
20 
29 
II 
1.7 
6.1 
27.9 
22 
30 
III 
1.7 
2.9 
6.6 
21 
_a 
IV 
2.0 
12.6 
13.2 
_b 
-
v 
2.1 
15.9 
9.8 
19 
26 
VI 
2.6 
8.0 
14.9 
16 
19 
a. patient died on day 22 after BMT from systemic aspergillus 
b. patient died on day 8 after BMT from E-coli septicaemia 
Table IV. 
Number of nucleated cells and committed progenitor cel ls in marrow graft per kg body weight 
and i t s relation to bone marrow recovery. 
DISCUSSION 
Densi ty p r o f i l e s of the hematopoiet ic stem c e l l s and t h e immunocompetent 
c e l l s o v e r l a p c o n s i d e r a b l y (9) . This p r e c l u d e s d e n s i t y s e p a r a t i o n in 
a l l o g e n e i c BMT of a d u l t per sons . I t i s g e n e r a l l y accepted t h a t t h e 
morphological appearance of the HSC i s t h a t of a small lymphocytic c e l l (19). 
Van Der Engh (20), us ing l i g h t s c a t t e r p r o p e r t i e s determined with a l i g h t 
a c t i v a t e d c e l l s o r t e r , es t imated the diameter of the p u t a t i v e murine HSC 
(CFU-S) to be 7.2 ym whereas the s i z e of thymocytes was c a l c u l a t e d to be 6.0 
um. A r e c e n t study of Inoue (21), s e p a r a t i n g murine bone marrow by 
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counterflow centrifugation (CC) showed an average volume of CFU-S of 175 
ущЗ, and a mean volume of lymphocytes of 110 ущЗ. This is in agreement with 
earlier studies of Van Bekkum (22). CC has been shown to provide a rapid and 
gentle separation technique mainly based on differences in cell size with 
excellent recoveries of human bone marrow cel ls without impairment of 
progenitor cel l viability (23). Monitoring of cell number and cell size in the 
effluent continuously by means of a scatter device and the percentage of S-
phase cel l s by FCM made i t possible to separate lymphocytes almost 
completely from the committed progenitor cel ls (24). 
The small size of the separation chamber of the e l u t n a t o r and the large 
volume of donor bone marrow made a combination of 2 separation techniques 
necessary. Isopycnic flotation centrifugation in Percoli gradients yielded a 
low density fraction (d < 1.070 g/ml) of nucleated cel ls which contained more 
than 95% of the progenitors. This was due to the low viscosity and stabi l i ty 
of the Percoli gradients and due to a better recovery after flotation 
centrifugation compared to sedimentation centrifugation (9). Preparation of 
a total number of 64 gradients and collection of the low density fraction 
from these gradients is laborious, time consuming and it carries a potential 
risk for infections. A method was developed to obtain low density cells with 
use of Percoli gradients in the Hemonetics 30 cel l separator (patient 6). 
Details will be published separately. The recovery of committed progenitor 
cells after CC was satisfactory despite the high number of low density ce l l s 
to be separated. The stem cell fraction contained 88$ of the CFU-GM and BFU-
E with 3.5? of the original number of T-lymphocytes contaminating th i s 
fraction. 
Hematopoietic recovery could have been slowed down by a low number of HSC 
present in the graft despite a sufficient number of progenitors, but 
granulocyte and platelet recovery after BUT was comparable to that of a 
large group of patients similarly treated after BMT with methotrexate (25). 
Several c l inical studies showed a successful prevention of GVHD by 
elimination of immunocompetent cells from the marrow graft (26, 27, 28). The 
low recovery of HSC by albumin gradient centrifugation (26) or lectin 
fractionation (27) hampered an application in adults. Only one of the four 
patients at risk showed signs of GVHD (grade II) despite the average high age 
of these patients (29.5 yrs). 
In conclusion: a combination of density gradient centrifugation and 
counterflow centrifugation resulted in a cel l fraction rich in hematopoietic 
precursors and depleted of the bulk of T-lymphocytes. Hematopoietic 
recovery after BMT was not impaired despite the low number of nucleated 
cells per kg in the graft. 
This method may offer a new approach to prevention or mitigation of GVHD. 
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SUMMARY 
The prognosis of acute nonlymphoblaatic leukaemia (ANLL) is mainly 
determined by the duration of a f i rs t complete remission. "Standard" 
polychemotherapy has failed to improve substantially disease free survival. 
Bone marrow transplantation (BMT) performed in first remission of ANLL, has 
lead to a disease free survival of 50-80 per cent at two years. Graft versus 
host disease (GVHD) is the major cause of early mortality after BMT, despite 
matching for the major histocompatibility complex and standard prophylaxis 
with methotrexate (MTX). Cytotoxic lymphocytes present in the marrow graft 
are assumed to be responsible for the GVH-syndrome. Removal of the 
immunocompetent T-lymphocytes from donor marrow has been exploited in 
several ways. This thesis describes a physical depletion of lymphocytes 
from human bone marrow using a combination of density centrifugation and 
counterflow e lu tnat ion (Chapter I). 
Manipulation of human bone marrow prior to transplantation requires an 
accurate assessment of the number of hematopoietic stem cel ls (HSC). 
Committed myeloid and erythroid progenitor cel ls (CFU-GM and BFU-E) have 
proven to provide a reliable indication of the capacity to regenerate 
hematopoiesis after bone marrow ablative therapy. These progenitor cel ls 
proliferate in semisolid culture systems in the presence of specific growth 
regulators, such as colony stimulating factor (CSF) and erythropoietin 
(EPO). Standardization of the in vitro culture assays was improved by using a 
highly active CSF-source with a low level of inhibitors, by frozen marrow 
samples as an internal standard control and by estimation of peripheral 
nucleated cell contamination. Recently, an in vitro culture assay of the 
pluripotent stem cell has been developed, but i t s low number ( S 0.01 %) in 
human marrow hampers a reliable quantification (Chapter II). 
Density and size of the different celltypes in human bone marrow are the main 
physical character is t ics , which can be used for separation of these 
heterogeneous populations. Colloidal s i l ica coated with polyvinylpyr-
rolidone (Percoli") easily provides density gradients with constant phy-
sicochemical properties and low viscosity. Isopycnic separation with sample 
application to the bottom of continuous linear density gradients (flotation) 
improved the recovery and yielded a fraction 25 times enriched for CFU-GM. 
The average density of the fraction was 1.0615 g/ml. The fractions with a 
density ranging from 1.067 to 1.058 g/ml contained 10 per cent of the 
nucleated cel ls and 82 per cent of the CFU-GM (Chapter III). 
Counterflow centrifugation (CC) provides a rapid and r e p r o d u c i b l e 
separation technique mainly based on differences in cel l s ize. Constant 
monitoring of the effluent from the e lu tna to r for cel l number and light 
103 
scat ter ( л, cel l size) by a scatter device from the Hemalog D improved the 
reproducibility of the separation of different cell populations. CC did not 
result in a single dist inct peak highly enriched for CFU-GM. However, i t 
appeared feasible to separate the small lymphocytes almost completely from 
the median sized committed myeloid and erythroid progenitor cells, without a 
substantial loss of clonogenic cel ls . Further analysis of the obtained 
fractions for the presence of surface receptors for AET-treated sheep 
erythrocytes and monoclonal anti-T antibodies confirmed that the progenitor 
cel l rich fraction was almost completely devoid of T-lymphocytes, both the 
suppressor and the helper subset (Chapter IV). 
DNA-flowcytoraetry and ^.thymidine uptake of 16 different fractions 
obtained by CC revealed two separate peaks of proliferating ce l l s : one 
mainly representing the proliferating immature erythroid cells and the other 
the proliferating immature myeloid cel ls . Increase in cell size coincided 
with an increase of percentages S-phase and Gj+M-phase cells of both the 
erythroid and myeloid ser ies . The appearance of the first proliferating 
normoblasts in the effluent of the e l u t n a t o r coincided with that of the 
committed progenitor ce l l s . Careful e lu tnat ion with constant monitoring of 
the effluent for light scat ter and additional DNA-flowcytometry improved the 
discrimination of the lymphocytes from the committed progenitor cel l s 
(Chapter V). 
The human pluripotent hematopoietic stem cel l (CFU-GEMM) gives r ise in vitro 
to mature granulocytes, erythrocytes, macrophages, megakaryocytes and T-
lymphocytes and i t has shown a limited self renewal capacity in vitro. This 
makes the CFU - GEMM a strong candidate for the pluripotent human 
hematopoietic stem cell . The large cel l fraction obtained by CC of low 
density bone marrow cel l s ( d < 1.070 g/ml) showed a complete recovery of 
CFU-GEMM (108$) with an admixture of 3 per cent of the original number E 
rosette positive cel l s . T-lymphooyte function was tested by in vitro 
stimulation with phytohemagglutinin (PHA) for 3 days and one way mixed 
lymphocyte cultures (MLC) for 6 days. The mitogenic response (MR) of the 
large stem cel l rich fraction was 6 and 11 per cent of the MR of unseparated 
bone marrow as measured with PHA stimulation and MLC reactivity re­
spectively (Chapter VI). 
Bone marrow from six allogeneic HLA matched and MLC nonreactive siblings 
was fractionated by means of isopycnic flotation centrifugation (IFC) and 
subsequent counterflow centrifugation (CC). The small size of the separ­
ation chamber of the e l u t n a t o r (4 ml) and the large volume of donor marrow 
made a combination of 2 separation technique necessary. IFC in Percoli 
gradients yielded a low density fraction (d S 1.070 g/ml) with 20 per cent of 
the original number of nucleated cells and more than 95% of the progenitor 
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c e l l s . The pu t a t i ve stem c e l l f rac t ion ob ta ined by CC showed a s a t i s f a c t o r y 
recovery with 88% of erythroid and myeloid p rogen i to r c e l l s . 
Since p l a t e l e t and granulocyte recovery was comparable to t h a t of a la rge 
group p a t i e n t s s imi la r ly t r ea ted with methot rexa te a f t e r BMT, a s i g n i f i c a n t 
l o s s of HSC seems to be excluded. Only one of the s ix p a t i e n t s showed s igns 
of graft ve r sus host d i s e a s e (GVHD) d e s p i t e the average high age of t h e s e 
p a t i e n t s (30 yea r s ) (Chapter VII). 
GENERAL CONCLUSIONS 
Combination of two phys i ca l sepa ra t ion t e c h n i q u e s , based upon c e l l dens i ty 
and c e l l s i z e , r e s u l t e d in a c e l l f rac t ion r ich in hematopoie t ic c lonogenic 
c e l l s and dep le ted of 95 per cent of the o r i g i n a l number of T-lymphocytes. 
Hematopoietic recovery a f t e r BMT was not impaired d e s p i t e the low number of 
nuc lea ted c e l l s p re sen t in the marrow graf t . Fur ther c l i n i c a l eva lua t ion wil l 
be necessa ry to a s s e s s whether 95 per cent removal of small lymphocytes can 
dec rease the inc idence of severe acu t e GVHD. 
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SAMENVATTING 
Akute leukemie b i j volwassenen i s een z i e k t e die onbehandeld binnen 2 à 3 
maanden t o t de dood voer t . Tegenwoordig kan m.b.v. celdelingsremmende 
geneesmiddelen (cytostatica) bij 75 procent van de patiënten een komplete 
remissie bereikt worden. Dit betekent, dat bloed en beenmerg weer een 
normaal aspekt vertonen. Niet alle leukemische cellen blijken na de therapie 
te zijn opgeruimd en daarom treedt echter bij ca. 90 procent van de patiënten 
toch een recidief op, meestal binnen één jaar na het bereiken van de 
remissie. Hierdoor is de 5-jaarsoverleving van deze ziekte s lechts 10 
procent, ondanks een intensieve nabehandeling. Eradikatie van alle leu-
kemie-cellen, door bijvoorbeeld een totale lichaamsbestraling, zou leiden 
tot een onherstelbare beenmergbeschadiging. Door intraveneuze toediening 
van beenmergcellen van een weefsel-identieke broer of zuster na de 
bestraling kan dit voorkomen worden (allogene beenmergtransplantatie). 
Wordt deze transplantat ie verricht in een eerste komplete remissie (voor het 
optreden van het recidief) dan wordt een twee-jaarsoverleving bereikt van 
50-80 procent. Opmerkelijk is dat na 1 jaar na de transplantatie nauwelijks 
of geen recidieven van de leukemie meer optreden. Dit zou erop kunnen 
wijzen, dat bij een groot aantal sprake is van een definitieve genezing. De 
mortaliteit na de transplantat ie wordt voornamelijk veroorzaakt door een 
afstotingsreaktie van immuun-reaktieve witte bloedlichaampjes (T-lymfo-
cyten) aanwezig in het transplantaat en gericht tegen de gastheer: de zg. 
graft versus host disease (GVHD) of afstotingsziekte. GVHD kan grosso modo 
theoretisch op 2 manieren voorkomen worden ófwel door verwijdering van deze 
T-lymfocyten uit het donor-beenmerg voor de transplantatie ófwel door 
onderdrukking van de T-lymfocyten na de transplantat ie . Dit proefschrift 
beschrijft een fysische scheidingsmethode waarbij m.b.v. centnfugat ie-
techmeken gebaseerd op celdichtheid en celgrootte, T-lymfocyten uit het 
beenmerg verwijderd worden (hoofdstuk I). 
De hematopoietische stamcel (HSC) vormt in het beenmerg via meerdere 
tussenstadia alle rijpe cirkulerende cellen in het bloed. Door de lage 
frekwentie ( <0.01$) is een exakte visuele schatting van het aantal HSC 
niet mogelijk. Echter de direkte afstammelingen van de HSC, de zg. 
voorlopercellen van de rode (erythroide) en witte (myeloide) reeks, kunnen 
in vitro gekweekt worden. De myeloide en erythroide voorlopercellen, 
gekweekt in halfvaste voedingsbodems, vormen een kloon van cellen en deze 
zijn als aggregaten herkenbaar onder de microscoop. Voor in vitro groei van 
de myeloide voorlopercel i s een kolonie stimulerende faktor noodzakelijk; 
deze wordt door monocyten geproduceerd, maar ook bijvoorbeeld door 
placentaweefsel. De erythroide progemtorcel groeit in vitro o.i.v. ery-
thropoietine (EPO) en een faktor geproduceerd door humane leukocyten 
geimmobiliseerd in agar (BFA : burst promoting activity). Onder invloed van 
EPO en een faktor geproduceerd door humane mononucléaire cellen (na 
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stimulatie door phytohemagglutinine) groeit een pluripotente, donogene 
voorlopercel uit tot al le rijpe vormen die in het bloed en beenmerg 
aangetroffen worden. Mogelijk is deze cel identiek aan de HSC. Hoofdstuk II 
beschrijft deze cloneringsmethodieken en de wijze waarop de reproduceer-
baarheid van deze bepalingen verhoogd werd. 
De celdichtheid verschilt aanzienlijk voor de verschillende hemopoietische 
celtypen. Van deze eigenschap kan gebruik worden gemaakt om beenmerg te 
verrijken o.a. voor de heraatopoietische stamcel. Kolloidale s i l icagel 
omgeven door een laagje polyvinylpyrrolidone (Percoli") i s niet toxisch 
voor de heraatopoietische cellen en door zijn lage viskosi tei t en konstante 
fysisch-chemische eigenschappen uitstekend geschikt om dichtheidsgra-
dienten te maken. De cellen werden gebracht in een Percoli suspensie met een 
dichtheid ie t s hoger dan die van de kontinue lineaire dichtheidsgradienten 
en deze suspensie werd onder de gradient aangebracht. Na centrifugatie 
(flotatie) bleek de opbrengst van de donogene myeloide cellen groter dan 
bij de gebruikelijke methode, waarbij de cellen in medium bovenop de 
gradient aangebracht worden (sedimentatie). De fraktie met een gemiddelde 
dichtheid van 1.0615 g/ml was 25 maal verrijkt voor wat betreft de myeloide 
voorlopercel. De frakties met een dichtheid van 1.067 tot 1.058 g/ml bevatten 
10 procent van het oorspronkelijk aantal kernhoudende cellen en 82 procent 
van de progemtorcellen (hoofdstuk III) . 
Scheiding op celgrootte geschiedt m.b.v. technieken gebaseerd op de 
bezlnkingssnelheid van deeltjes, meestal in apart gevormde scheidings-
kamers (velocity sedimentation). Het grote nadeel is de lange tijdsduur van 
de scheiding (4-8 uur). De e lu tna tor rotor heeft dit nadeel ondervangen : 
cellen in een kleine scheidingskamer worden blootgesteld aan een centr i -
fugale, naar buiten gerichte kracht en een centripetale tegengestelde 
vloeistofstroom. Bij verlaging van de centrifugale kracht of een verhoging 
van de tegenstroom verlaten de kleinste cellen de scheidingskaraer het 
eerst . Bij menselijk beenmerg bleken lymfocyten de eerste kernhoudende 
cellen te zijn die de rotor verlieten, gevolgd door de normoblasten en de 
overige beenmergcellen. De myeloide en erythroide donogene cellen werden 
gevonden in de frakties van de middelgrote cellen, zonder dat er sprake was 
van een sterke verrijking (maximaal 3 x). Een belangrijk hulpmiddel bij deze 
scheiding was de kontinue regis t ra t ie van de lichtverstrooiing (light 
scatter) van de geëlutneerde cellen. Dit gaf informatie over de celgrootte 
tijdens de scheidingsprocedure. Mede hierdoor bleek het mogelijk beenmerg 
m.b.v. e lut r ia t ie te scheiden in twee frakties : een fraktie van kleine cellen 
met meer dan 95 procent van de lymfocyten en een fraktie van grotere cellen 
met meer dan 90% van de progemtorcellen en minder dan 5 procent van de 
lymfocyten. T-lymfocyten hebben als eigenschap om schape-erythrocyten aan 
zich te binden (zg. Ε-rosette) en specifieke oppervlakte-antigenen, 
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waartegen a n t i s t o f f e n ontwikkeld zi jn. Zowel de E-roaette-vorming, a l s de 
s p e c i f i e k e a n t i - T - a n t i s t o f f e n beves t igden dat minder dan 5 procent van de 
c e l l e n in de p r o g e n i t o r c e l r i j k e f r a k t i e T-lymfocyten waren (hoofdstuk IV). 
De c e l g r o o t t e v a r i e e r t s te rk t i j d e n s de c e l c y c l u s . Rustende ( n i e t in c y c l u s 
z i j n d e ) c e l l e n z i jn r e l a t i e f k l e i n en de lende c e l l e n z i jn r e l a t i e f g root . Het 
a l dan n i e t verkeren in c e l c y c l u s kan gemeten worden aan de hand van het 
DNA-gehalte per c e l m.b.v. DNA-flowcytometrie of aan de inbouw van de 
h o e v e e l h e i d Зн-thymidine. Humaan beenmerg b e s t a a t k w a n t i t a t i e f u i t twee 
h o o f d p o p u l a t i e s : een e r y t h r o i d e en een myeloide. Bij e l u t n a t i e bleek er 
inderdaad sprake t e z i jn van twee a p a r t e , p r o l i f e r e r e n d e p o p u l a t i e s . De 
p r o l i f e r e r e n d e e r y t h r o i d e p o p u l a t i e werd gevonden in de f r a k t i e s met 
middelgrote c e l l e n en de p r o l i f e r e r e n d e myeloide p o p u l a t i e werd gevonden in 
de f r a k t i e s met de a l l e r g r o o t s t e c e l l e n . Het bleek dat de e e r s t e p r o l i ­
f e r e r e n d e e r y t h r o i d e c e l l e n g e l i j k t i j d i g met de e e r s t e p r o g e n i t o r c e l l e n 
g e e l u t r i e e r d werden. Hierdoor kon een nog b e t e r e s c h e i d i n g van lymfocyten 
en p r o g e n i t o r c e l l e n worden verkregen (hoofdstuk V). 
Bij ve rdere e v a l u a t i e bleek ook de p l u r i p o t e n t e d o n o g e n e v o o r l o p e r c e l 
voornameli jk teruggevonden t e worden in de f r a k t i e met de g rotere c e l l e n . De 
funkt ie van de T-lyrafocyten in de v e r s c h i l l e n d e f r a k t i e s werd in v i t r o 
gemeten m.b.v. een mitogeen : phytohemagglut inine en in de gemengde 
lymfocytenkweek. De v e r o n d e r s t e l d e s t a m c e l - f r a k t i e bleek nog s l e c h t s б 
r e a p . 11 procent van de o o r s p r o n k e l i j k e mitogene a k t i v i t e i t t e b e v a t t e n 
(hoofdstuk VI). 
T e n s l o t t e werd het beenmerg (gemiddeld 1.2 l i t e r ) van 6 i d e n t i e k e donoren 
g e s c h e i d e n voor een a l l o g e n e b e e n m e r g t r a n s p l a n t a t i e . Eers t werden de g ro te 
meerderheid van de rode b loedl ichaampjes ( > 9 9 . 9 9 ί ) en de meerderheid van 
de kernhoudende c e l l e n (± 8 0 Í ) verwijderd m.b.v. d i c h t h e i d s c e n t r i f u g a t i e in 
g rad i ën t en met een d ich the id van 1.070 g/ml. Vervolgens werden de c e l l e n op 
g roo t t e gesche iden m.b.v. t egens t room-cen t r i fuga t i e . De duur van de gehe le 
procedure was ca. 14 uur. De f rak t ie met de grote ce l l en werd aan de p a t i e n t 
i n t r a v e n e u s toeged iend . Deze f rak t ie beva t t e ongeveer 12 procent van het 
oo r sp ronke l i jk a a n t a l kernhoudende c e l l e n , 5 procent van de T-lymfocyten 
en 88$ van de voo r lope rce l l en . De beenmergrepopulat ie bleek ongestoord en 
b i j s l e c h t s één p a t i e n t t rad een a f s t o t i n g s z i e k t e op (hoofdstuk VII). 
ALGEMENE KONKLUSIES 
Door kombinat ie van twee fys i sche scheidingsraethodieken, gebaseerd op 
c e l g r o o t t e en c e l d i c h t h e i d , werd een beenmergfraktie verkregen d ie s t e rk 
v e r r i j k t was voor de hematopoie t i sche s tamcel met minder dan 5 procent van 
het oo r sp ronke l i jk a a n t a l T-lymfocyten. 
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Ondanks het lage aantal kernhoudende cellen was het vermogen om het 
beenmergkompartiment wederom te bevolken niet afgenomen. 
Alhoewel uit dierexperimenteel onderzoek gebleken i s , dat er een nauwe 
relat ie bestaat tussen de frekwentie en de ernst van de afstotingaziekte 
enerzijds, en het aantal T-lymfocyten in het transplantaat anderzijds, zal 
uit verdere klinische evaluatie moeten blijken of dit bij de mens ook het 
geval i s . 
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DANKWOORD 
Het ia een schier onmogelijke taak om iedereen te bedanken die bijdragen 
geleverd hebben aan het tot stand komen van dit proefschrift en het 
onderzoeksproject (U.O.P. 79-1), waarvan de opdracht luidde : " Isola t ie en 
cryopreservatie van hematopoietische progemtorcellen". 
De cryopreservatie van beenmerg en buffy coat zou nooit mogelijk zijn 
geweest zonder de energieke inzet van Peter Geerdmk, die alle vereiste 
kennis en apparatuur in huis gehaald heeft. Dienstplichtig officieren Frank 
van den Ouweland,Reinier Haymakers en Cees Groot waren immer druk in de weer 
met het afnemen en invriezen van beenmerg en buffy coat, hierbij ge-
assisteerd door Marianne Preñen en Gaby Ticoalu. 
Bij het opzetten van de beenmergkweken heb ik bij velen om raad en steun 
gevraagd; т.п. Martin Salden, Trude Treskon (afd. Cyto-histologie), de 
medewerk(st)er3 van het laboratorium Experimentele Hematologie te Leiden 
en het Radiobiologisch Inst i tuut TNO te Rijswijk wil ik hiervoor danken. 
De leden van "Beenmergtransplant BV" : Everdien Koekman, Aart Plas, Gemma 
Blankenborg en wederom Reinier Haymakers waren onvermoeibaar tot in de 
kleine uurtjes. Daarnaast verzorgden zi j het leeuwendeel van de experi­
menten. Ook de overige medewerk(st)er3 van het laboratorium Hematologie wil 
ik hartelijk danken, т.п. die van de aangrenzende "lymfo-mono- klub" : Elly 
Geestman, John Smeulders en Enk van de Ven. 
De verpleegkundige zorg van de patiënten op afdeling A 51 en de i so la t i e -
unit is steeds toegewijd geweest en de samenwerking vlekkeloos. 
De heer C.P. Nicolasen van de afdeling Medische I l lus t ra t ie maakte de 
figuren van hoofdstuk III en de medewerkers van de afdeling Medische 
Fotografie verzorgden de afwerking van tabellen en figuren. 
Harry Crissman, Paul Giangrande en Pieter de Haan waren bereid mijn 
overtredingen tegen de engelse gramraatika te korrigeren. 
Marjan Janssen, Loes Baadenhuijsen-Haarsma en Angela van de Broek zorgden 
voor een korrekte en snelle afwerking van de typografische uitvoering van 
dit manuscript. 
Dankzij de medewerking van de kollega's van de afdeling Hart- en 
Vaatchirurgie en Cardio-anaestheaie bestond er een niet aflatende stroom 
van normaal beenmerg. 
Operatiekamertijd en faci l i tei ten voor afname van beenmerg bij donoren en 
patiënten werd genereus ter beschikking gesteld door de afdeling Urologie. 
De samenwerking met de afdeling Anaesthesie in deze verliep vlekkeloos. 
Vele medewerkers van de afdeling Hematologie heb ik niet bij naam genoemd, 
maar de meestal vanzelfsprekende hulp en medewerking worden daarom zeker 
niet minder op prijs gesteld. 
Els, dank je voor de supportive care. 
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CURRICULUM VITAE 
De a u t e u r dezes werd op 26 a p r i l li)1*? t e Nijmegen geboren. Op het Сапіз іиз 
College t e Nijmegen behaalde h i j in 1966 het Gymnasium 8-diploma. Het 
d o k t o r a a l examen in de Geneeskunde legde h i j af in 1972 aan de U n i v e r s i t e i t 
van Nijmegen. Na het artsexamen (1974) werd h i j a r t s - a s s i s t e n t op de 
a fde l ing Inwendige' Ziekten van het Akademisch Ziekenhuis te Nijmegen. De 
o p l e i d i n g in Nijmegen werd 1 Jaar onderbroken door een v e r b l i j f a l s 
r e g i s t r a r op de a fde l ing Bloedziekten van h e t Queen E l i s a b e t h Hospi ta l , 
Adelaide, South Aust ra l ia , alwaar h i j voor de hematologie " g e w o n n e n " werd. 
In 198O volgde i n s c h r i j v i n g a l s i n t e r n i s t in he t s p e c i a l i s t e n r e g i s t e r . 
Dankzij een s u b s i d i e van de U n i v e r s i t a i r e Onderzoek Pool v e r r i c h t t e h i j van 
september 1979 t o t november 1982 onderzoek op het laborator ium van de 
a fde l ing Bloedziekten van het Akademisch Ziekenhuis in Nijmegen. S e d e r t ­
dien i s h i j een min of meer v a s t e medewerker van die a fde l ing . 
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ABBREVIATIONS 
AET = 2-aminoethyli3othiouronium bromide 
ALL = acute lymphoblastic leukemia 
ANLL = acute nonlymphoblastic leukemia 
BFU-E = burst forming unit-erythrocyte 
Bl = blood 
BM = bone marrow 
BMT = bone marrow transplantation 
BPA = burst promoting activity 
CC = counterflow centnfugation 
CFU-E = colony forming unit-erythrocyte 
CFU-GEMM = colony forming unit-granulocyte/erythrocyte/macro-
phage/megakaryocyte 
CFU-GM = colony forming umt-granulocyte/macrophage 
CFU-S = colony forming unit-spleen 
CSF = colony stimulating factor 
CSA = colony stimulating activity 
DMEM = Dulbecco's modified Eagle's medium 
DNA = deoxyribonucleic acid 
DPM = désintégrations per minute 
EPO = erythropoietin 
FCM = flowcytometry 
FCS = fetal calf serum 
GCT = giant cell tumor 
G2+M = premitotic resting phase and mitotic phase 
GVHD = graft versus host disease 
Hb = hemoglobin 
HBSS = Hanks' balanced salt solution 
HLA = human leukocyte antigen 
HLCM = human leukocyte conditioned medium 
HMCM = human mononuclear cells conditioned medium 
HPCM = human placental conditioned medium 
HSC = hematopoietic stem cell 
LPS = lipopolysacharide 
MHC = major histocompatibility complex 
MLC = mixed lymphocyte culture 
MR = mitogenic response 
MTX = methotrexate 
NC = nucleated cells 
OKT3 = monoclonal antibody reactive with pan-T lymphocyte 
OKT4 = monoclonal antibody reactive with T-helper lymphocyte 
OKTß = monoclonal antibody reactive with T-suppressor 
lymphocyte 
PHA = phytohemagglutimn 
SI = stimulation index 
S-phase = replication phase of DNA 
TBI = total body irradiation 
WT·) = monoclonal antibody reactive with pan-thymocyte and 
pan-T lymphocyte 
Stellingen 
i 
Verwijdering van meer dan 95 procent van de lymfocyten uit donorbeenmerg heeft 
geen merkbare invloed op het repopulerend vermogen bij gebruik ervan voor been-
mergtransplantantie. 
Dit proefschrift. 
II 
Verwijdering van de lymfocyten uit het beenmerg met tegenstroomcentrifugering 
(elutriatie) kan alleen dán optimaal geschieden, indien de grootte van de cellen die de 
rotor verlaten continu wordt gecontroleerd met behulp van 'cell-scatter' apparatuur. 
Dit proefschrift. 
Ill 
S-fase-meting m.b.v. flowcytometrie is een additioneel hulpmiddel bij de scheiding van 
lymfocyten en stamcellen m.b.v. tegenstroomcentrifugatie, aangezien de voorlopercel-
len, gelijktijdig met prolifererende normoblasten, uit het beenmerg geëlutrieerd worden. 
Dit proefschrift. 
IV 
Dat het hemoglobinegehalte van een beenmerg-aspiraat een afspiegeling is van de hoe-
veelheid perifere bloedbijmenging, wordt bevestigd door de negatieve correlatie welke 
wordt gevonden tussen de concentratie progenitorcellen in een aspiraat en het hemo-
globine-gehalte ervan. 
Dit proefschrift. 
Holdrinet R.S.G., Egmond J. van, Wessels J.M.C., Haanen C , A method for 
quantification of peripheral blood admixture in bone mairow aspirates. Exp. 
Hematol. 1980; 8: 103. 
V 
Het gebruik van ingevroren monsters normaal beenmerg als standaard is van essen-
tieel belang bij de interpretatie van de resultaten van in vitro kweken met beenmerg 
of fracties daarvan. 
Dit proefschrift. 
VI 
Subsidieaanvragen en publicaties over celscheidingen met behulp van tegenstroomcen-
trifugering moeten roeien tegen de mode-stroom van de monoclonale antilichamen in. 
Eigen waarneming. 
VII 
De door vele onderzoekers uitgesproken mening dat de hematopoietische stamcel 
morfologisch sterk overeenkomt met de lymf осу t, berust op een onzorgvuldige inter­
pretatie van de literatuur. 
Bekkum D.W. van. Noord M J . van. Maat В., et al., Attempts at identification of 
hemopoietic stem cells in mouse. Blood 1971 ; 38: 547. 

Vili 
Polyvinyl gecoate silica gel (Percoli ) moge met toxisch zijn voor de hematopoietische 
stamcel, maar is dit wel voor de monocyt. 
Eigen waarneming. 
IX 
Sedert de invoering van de partiële darmdecontaminatie en het gebruik van centraal 
veneuze catheters is de stafylococcus epidermidis de meest geïsoleerde verwekker tij-
dens koortsperioden bij patiënten met ernstige granulocytopenic. 
Eigen waarneming. 
X 
De behandeling van secundaire acute myeloide leukemie bij patiënten onder de veertig 
jaar moet gericht zijn op inductie van een complete remissie, zo mogelijk gevolgd door 
een allogene beenmergtransplantatie. 
Preisler H.D., Eaily A JV, Raza A , et al., Therapy of secundary acute nonlympho-
cytic leukemia with cytarabine. Ne-w Engl. J Med. 1983, 308 21. 
Witte T. de, Blacklock H.A., Prentice II.G , et al.. Allogeneic bone marrow trans-
plantation in a patient with acute myeloid leukemia secundary to Hodgkin's 
disease. Cancer 1983, in the press. 
XI 
De geestelijk gehandicapte heeft dezelfde rechten op welzijns- en gezondheidsvoorzie-
ningen als een geestelijk volwaardige. 
Verklaring van de rechten der geestelijk gehandicapten. Algemene vergadering der 
Verenigde Naties. 20 december 1971 
XII 
Gestoord gedrag eist een zekere mate van intelligentie. 
Ρ .P.M. van der Schoot, persoonlijke mededeling. 
XIII 
Bij rheumatoide arthritis is het serumgastrme gehalte verhoogd ten gevolge van een ver­
minderde capaciteit tot maagzuur-secretie. Bijt rheumatoide arthritis in de gewrichten 
en likt het de maag? 
Witte Τ de, Geerdmk P.J., Lamers C.B., et al., Hypochlorhydria and hypergas-
trinemia in rheumatoid arthritis Rheum. Dis. 1979, 38 14. 
XIV 
Wanneer een curatieve behandeling niet mogelijk is, dan behoeft dit met het einde van 
actief medisch handelen te betekenen. 
XV 
Het aanwezig zijn van de faciliteiten voor het opvangen van patiënten die een been-
merg-lethale bestraling ondergaan hebben, mag en kan niet gebruikt worden in een dis-
cussie over kernbewapening. 
Abrams H.L , Kacnel W£. von, Medical problemens of survivors of nuclear war. 
Wew Engl J. Med 1981, 305 1226 
Caldicott U.M., The final epidemic. Physicians could never reverse the ravages of 
nuclear war. The Sciences 1982 16. 
Nijmegen, 30 juni 1983 T.J.M. DE WITTE 



